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ABSTRACT 
Analysis of the transcriptional regulatory network underlying heart development 
 
Heart development is a highly complex process with a series of precisely spatially and 
temporally ordered events on molecular level. To understand how these events are 
controlled and coordinated, it is necessary to study the underlying gene expression and its 
regulation. While many studies have been carried out in the examination of single genes and 
their expression patterns, comprehensive analyses of genome-wide expression profiles 
associated with cardiomyogenesis (i.e. the differentiation of stem cells into cardiomyocytes) 
are still rare. In fact, no study exists to date which compares and consolidates the publicly 
available genome-wide measurement for cardiomyogenesis. Such endeavour however is 
important, as it is well known that individual microarray studies can be seriously 
compromised by artefacts. In contrast, the combination of various expression studies, which 
was performed in my study, can lead to more reliable results and help elucidate the different 
aspects of heart development and repair. Furthermore, a brief study was performed 
regarding the potential risk of originating cancer or teratomas from stem cell therapy. 
Finally, I carried out a network-based analysis, to identify regulatory actions between genes, 
based on published interaction data. This type of analysis can also help to identify novel 
genes with a role in heart development and provide new valuable targets to future 
experimental laboratorial analysis. The combination of the multiple dataset is thus an 
important approach to gain better insights of the different heart development processes as 
well as regenerative medicine applied to the heart. 
 
 
 
 
Keywords: Cardiomyocytes, Gata4, heart development, induced cardiomyocytes, Meis1, 
microarray, networks, Smyd1 
  
  
RESUMO 
Análise da rede reguladora de transcrição subjacente ao desenvolvimento cardíaco 
 
O desenvolvimento cardíaco é um processo extremamente complexo com uma série de 
eventos espácio-temporais precisos ao nível molecular. Para compreender como estes 
eventos são controlados e coordenados, é necessário estudar a expressão genética 
subjacente em diferentes organismos, estadios de desenvolvimento celular e a sua 
regulação. Enquanto que muitos dos estudos realizados foram executados para uma análise 
individual dos genes e seus padrões de expressão, uma análise compreensiva dos perfis de 
expressão do genoma associada à diferenciação das células estaminais em cardiomiócitos 
ainda não existe. No presente trabalho foi realizada uma meta-análise de resultados 
publicados em 4 trabalhos independentes prévios, num total de 25 microarrays, que 
definiram a expressão diferencial “pangenómica” durante a diferenciação de células 
estaminais embrionárias em cardiomiócitos ou durante a transdiferenciação de células 
somáticas em cardiomiócitos. Este tipo de análise é no entanto essencial, pois a utilização 
das expressões de um único microarray é pouco fiável, podendo este estar seriamente 
comprometido por artefactos de natureza humana ou das próprias condições experimentais. 
Foi realizado um breve estudo relativamente ao risco de ocorrer a formação de teratomas a 
partir da terapia com células estaminais, com o objectivo de verificar se os genes que são 
comuns ao cancro e às celulas estaminais são semelhantes aos genes responsáveis pela 
formação dos cardiomiócitos e/ou cardiomiócitos induzidos. 
Este tipo de análise é bastante importante, porque não se baseia apenas nos valores de 
expressão dos genes das experiências, esta análise vai também procurar validar a expressão 
dos genes por estudos estatísticos, sendo apenas considerados os genes que têm valores p-
value ajustados significativos (<0.1). Este tipo de tratamento dos microarrays torna possível 
que os dados obtidos sejam mais fiáveis, podendo considerar que os genes adquiridos na 
análise apresentam consistentemente o mesmo padrão de expressão nos vários estudos em 
processos similares, procurando assim incluir genes que ainda não tenham sido ligados ao 
desenvolvimento e regeneração cardíaca. O estudo dos genes importantes para o 
desenvolvimento cardíaco definiu certos factores de transcrição essenciais para o 
desencadeamento desse processo. Esses mesmos factores marcam/promovem de tal forma 
  
o desenvolvimento de linhagens de células cardíacas que a expressão exógena destes 
factores em células somáticas com funções diferentes leva a uma modificação radical da 
função e das propriedades destas células, tornando-as em células semelhantes a 
cardiomiócitos. O mecanismo molecular deste processo chamado transdiferenciação ainda é 
pouco claro, mas é provavel que involva genes que também sejam importantes para o 
desenvolvimento cardíaco ou diferenciação. 
Para elucidar os mecanismos regulatórios subjacentes, foi construída uma rede de 
interações (networks) dos vários genes obtidos, com base em dados publicados de outros 
artigos. Foram tidos em consideração os factores de transcrição mais relevantes (tais como o 
Hand2, Mef2c e Gata4) que têm a capacidade de controlar o destino das células cardíacas. A 
combinação dos dados de expressão e interacção providenciaram um panorama detalhado 
da dinâmica dos mecanismos de regulação. Foi possível verificar qual a expressão temporal 
dos genes obtidos através da sua correlação e que tipo de interacção proteína-proteína 
existia entre os diversos genes. 
A meta-análise dos vários estudos de expressão de genoma utilizados neste trabalho, 
faz com que este trabalho seja único e original, pois tal tipo de análise nunca foi realizada no 
contexto de tentar encontrar “novos” genes que estejam ligados ao desenvolvimento 
cardíaco. Este trabalho permitiu elucidar os diferentes aspectos do desenvolvimento e 
recuperação cardíaca e que genes podem estar envolvidos nesse processo. Através deste 
trabalho também foi possivel identificar, com algum grau de confiança, alguns genes 
potencialmente importantes e que ainda não foram completamente associados ao 
desevolvimento cardíaco, tal com é o caso dos genes Meis1, Smyd1 ou Zfpm2 e providenciou 
muitos outros indicadores para possíveis futuras experiências laboratoriais. 
A combinação dos diversos microarrays foi um passo importante para compreender 
melhor os diferentes aspectos que estão envolvidos intrinsecamente com o 
desenvolvimento cardíaco e a medicina regenerativa. A sua posterior combinação com as 
redes de interação entre os genes levou a uma melhor interpretação dos resultados, 
possibilitando a compreensão do funcionamento temporal e como interagem entre si. 
 
Palavras-chave: Cardiomiócitos, desenvolvimento cardíaco, Gata4, Meis1, microarray, 
networks, Smyd1 
  
INDEX  
Figure Index ................................................................................................................................. i 
Table Index ................................................................................................................................ vii 
Abbreviations .............................................................................................................................. x 
Introduction ................................................................................................................................ 1 
1. Biological Background ......................................................................................................... 4 
1.1. Embryonic Stem Cells ................................................................................................... 4 
1.2. iPSc ............................................................................................................................... 5 
1.3. Transdifferentiation of Cardiac Fibroblasts ................................................................. 6 
1.4. Cancer Cells .................................................................................................................. 7 
2. Methodology ....................................................................................................................... 9 
2.1. Microarray Technologies & Data Sets .......................................................................... 9 
2.1.1. General Genetic Expression in Mouse Embryonic Stem Cells ........................... 11 
2.1.2. Rosetta 1............................................................................................................. 11 
2.1.3. Rosetta2 ............................................................................................................. 12 
2.1.4. Stanford .............................................................................................................. 12 
2.1.5. Human Gene Atlas .............................................................................................. 12 
2.1.6. Mouse Gene Atlas .............................................................................................. 12 
2.1.7. Reprogramming Mouse Fibroblast into Functional Cardiomyocites by 
Defined Factors ............................................................................................................... 13 
2.1.8. Reprogramming Non-Myocytes with Cardiac Transcription Factors ................. 14 
2.1.9. hiPSc Differentiation Toward Cardiomyocytes .................................................. 14 
2.2. Gene Expression Analysis ........................................................................................... 16 
2.2.1. Preprocessing of Microarray Data ..................................................................... 16 
2.2.2. Detection of Differential Expression .................................................................. 17 
2.2.3. Clustering of Gene Expression Data ................................................................... 18 
2.2.4. Functional Enrichment Analysis ......................................................................... 18 
2.3. Heart Expression ........................................................................................................ 20 
2.4. Network Analysis ........................................................................................................ 21 
2.5. Gene Comparative Analysis with Stem and Cancer Cells .......................................... 22 
2.5.1. Gene List for Cancer and Pluripotency ............................................................... 22 
2.5.2. Assessing Significance of Common Genes ......................................................... 22 
3. Results ............................................................................................................................... 23 
  
3.1. General Genetic Expression in Mouse Embryonic Stem Cells ................................... 24 
3.2. Genetic Expression in Different Tissues ..................................................................... 40 
3.3. Genetic Expression Between Cardiac Fibroblast and Induced Cardiomyocytes and 
Differentiation into Cardiomyocytes ................................................................................... 44 
3.3.1. Reprogramming Mouse Fibroblast into Functional Cardiomyocites by 
Defined Factors ............................................................................................................... 45 
3.3.2. Reprogramming Non-Myocytes with Cardiac Transcription Factors ................. 52 
3.3.3. hiPSc Differentiation Toward Cardiomyocytes .................................................. 58 
3.4. Comparison of Biological Process, Molecular Functions and KEGG Pathways 
between Cardiac Data Sets and Mouse ESc ........................................................................ 71 
3.4.1. Biological Process ............................................................................................... 71 
3.4.2. Molecular Functions ........................................................................................... 73 
3.4.3. KEGG Pathways .................................................................................................. 74 
3.5. Comparison of Individual Gene Profiles Between Cardiac Data Sets and Mouse ESc75 
3.5.1. Positive Early Gene Expression .......................................................................... 76 
3.5.2. Positive Intermediate Gene Expression ............................................................. 79 
3.5.3. Positive Late Gene Expression............................................................................ 82 
3.6. Network Strutural Analysis ........................................................................................ 87 
3.6.1. Correlation Network ........................................................................................... 87 
3.6.2. PPI Data Network ............................................................................................... 90 
3.7. Gene Comparative Analysis with Stem Cells and Cancer Cells .................................. 92 
3.8. “HeartEXpress” Interactive Platform ......................................................................... 97 
4. Conclusion ......................................................................................................................... 99 
5. References ....................................................................................................................... 102 
Annex ...................................................................................................................................... 109 
Annex I ............................................................................................................................... 110 
Annex II .............................................................................................................................. 117 
Annex III ............................................................................................................................. 118 
Annex IV ............................................................................................................................. 119 
Annex V .............................................................................................................................. 120 
 
 i 
 
FIGURE INDEX 
1. Biological Background 
1.4. Cancer Cells 
Figure 1.4.1. Possible roles for the four transcription factors in the generation 
of iPSc or tumor cells (adapted from Yamanaka, 2007). . . . . . . . . . 8 
2. Methodology 
2.1. Microarray Technologies and Data Sets 
Figure 2.1.1. One-colour channel microarray platform, Affymetrix GeneChip 
(on the left) and Illumina (on the right). . . . . . . . . . . . . . . . . . . . . . . 10 
2.2. Gene Expression Analysis 
2.2.1. Preprocessing of Microarray Data 
Figure 2.2.1.1. Simple steps from CEL files to expression set. It starts with an 
affybatch file, it is submitted to a background correction, 
normalization, pm correction and summarization and finally is 
turned in to an expression set (adapted from Gautier et al., 2003). 17 
2.4. Network Analysis 
Figure 2.4.1. A simplified schematic overview of the Cytoscape functionality. 
(Schematic adapted from Shannon et al., 2012). . . . . . . . . . . . . . . . 21 
3. Results   
3.1. General Genetic Expression in Mouse Embryonic Stem Cells 
Figure 3.1.1. Cluster dendrogram for Gaspar et al. 2012 data set. . . . . . . . . . . . . 24 
Figure 3.1.2. Expression of Nanog homeobox on Gaspar et al. 2012 data set. . .  26 
Figure 3.1.3. Expression of SRY-box containing gene on Gaspar et al. 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 
Figure 3.1.4. Expression of DNA (cytosine-5-)-methyltransferase 3-like on 
Gaspar et al. 2012 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 
Figure 3.1.5. Expression of POU domain, class 5, transcription factor 1 on 
Gaspar et al. 2012 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 
Figure 3.1.6. Expression of developmental pluripotency associated 2 on Gaspar 
et al. 2012 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 
   
 ii 
 
Figure 3.1.7. Expression of neurofilament (light polypeptide) on Gaspar et al. 
2012 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 
Figure 3.1.8. Expression of T Brachyury on Gaspar et al. 2012 data set. . . . . . . . 31 
Figure 3.1.9. Expression of eomesodermin homolog on Gaspar et al. 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 
Figure 3.1.10. Expression of heart and neural crest derivatives expressed 
transcript on Gaspar et al. 2012 data set. . . . . . . . . . . . . . . . . . . . . . 33 
Figure 3.1.11  Expression heart and neural crest derivatives-expressed protein 2 
on Gaspar et al. 2012 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 
Figure 3.1.12. Expression of collagen and calcium binding EGF domains 1 on 
Gaspar et al. 2012 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 
Figure 3.1.13. Expression of Cbp/p300-interacting transactivator 2 on Gaspar et 
al. 2012 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 
Figure 3.1.14. Expression of troponin T type 2 (cardiac) on Gaspar et al. 2012 
data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 
Figure 3.1.15. Expression of actin, alpha, cardiac muscle 1 on Gaspar et al. 2012 
data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 
Figure 3.1.16. Expression of myosin, heavy chain 7, cardiac muscle, beta on 
Gaspar et al. 2012 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 
Figure 3.1.17. Expression of ankyrin repeat domain 2 (stretch responsive 
muscle) on Gaspar et al. 2012 data set. . . . . . . . . . . . . . . . . . . . . . . . 39 
3.2. Genetic Expression in Different Tissues 
Figure 3.2.1. Mean expression in density of transcription factor that are up 
regulated vs. down regulated Rosetta 1. . . . . . . . . . . . . . . . . . . . . . . 41 
Figure 3.2.2. Mean expression in density of all genes that are up regulated vs. 
down regulated Rosetta1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 
Figure 3.2.3. Genes with the highest averaged expression in all tissue in 
Rosetta 1 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42 
Figure 3.2.4. Genes with the highest averaged expression in all tissue in 
Rosetta 1 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42 
Figure 3.2.5. Group of genes that are clustering together in Rosetta 1. . . . . . . . . 43 
 
 
 
 iii 
 
3.3. Genetic Expression Between Cardiac Fibroblast And Induced Cardiomyocytes and 
Differentiation into Cardiomyocytes 
3.3.1. Reprogramming Mouse Fibroblast Into Functional Cardiomyocytes by Defined 
Factors 
Figure 3.3.1.1. Cluster dendrogram for the Ieda et al. 2010 data set. . . . . . . . . . . . 45 
Figure 3.3.1.2. Expression of myocyte enhance factor 2C in several cells types on 
Ieda et al., 2010 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 
Figure 3.3.1.3. Expression of GATA binding protein 4 in several cells types on 
Ieda et al., 2010 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 
Figure 3.3.1.4. Expression of T-box 5 in several cells types on Ieda et al., 2010 
data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47 
Figure 3.3.1.5. Expression of myosin, heavy chain 7, cardiac muscle, beta in 
several cells types on Ieda et al., 2010 data set. . . . . . . . . . . . . . . . . 48 
Figure 3.3.1.6. Expression of Fibroblast growth factor 1 in several cells types on 
Ieda et al., 2010 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48 
Figure 3.3.1.7. Expression of troponin T type 2 (cardiac) in several cells types on 
Ieda et al., 2010 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49 
Figure 3.3.1.8. Expression of actin, alpha, cardiac muscle 1 in several cells types 
on Ieda et al., 2010 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49 
Figure 3.3.1.9. Expression of fibroblast growth factor receptor 1 in several cells 
types on Ieda et al., 2010 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . 50 
Figure 3.3.1.10. Expression of discoidin domain receptor tyrosine kinase 2 in 
several cells types on Ieda et al, 2010. data set. . . . . . . . . . . . . . . . . 50 
Figure 3.3.1.11. Expression of fibroblast growth factor 2 in several cells types on 
Ieda et al., 2010 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51 
3.3.2. Reprogramming Non-Myocytes With Cardiac Transcription Factors 
Figure 3.3.2.1. Cluster dendrogram for the Song et al., 2012 data set. . . . . . . . . . . 52 
Figure 3.3.2.2. Expression of GATA binding protein 4 on Song et al., 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53 
Figure 3.3.2.3. Expression of heart and neural crest derivatives expressed 
transcript 2 on Song et al., 2012 data set. . . . . . . . . . . . . . . . . . . . . . 53 
Figure 3.3.2.4. Expression of myocyte enhance factor 2C on Song et al., 2012 
data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54 
Figure 3.3.2.5. Expression of T-box 5 on Song et al., 2012 data set. . . . . . . . . . . . . 54 
 iv 
 
Figure 3.3.2.6. Expression of myosin heavy chain beta on Song et al., 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 
Figure 3.3.2.7. Expression of troponin T type 1 on Song et al., 2012 data set. . . . . 55 
Figure 3.3.2.8. Expression of actin, alpha cardiac muscle 1 on Song et al., 2012 
data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56 
Figure 3.3.2.9. Expression of fibroblast growth factor receptor 1 on Song et al., 
2012 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57 
Figure 3.3.2.10. Expression of discoidin domain receptor family, member 1, on 
Song et al., 2012 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57 
3.3.3. hiPSc Differentiation Toward Cardiomyocytes 
Figure 3.3.3.1. Cluster dendrogram for the Uosaki et al., 2011 data set. . . . . . . . . . 58 
Figure 3.3.3.2. Expression of Nanog homeobox on Uosaki et al., 2011 data set. . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60 
Figure 3.3.3.3. Expression of Pou domain, class 5, transcription factor 1 on 
Uosaki et al., 2011 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60 
Figure 3.3.3.4. Expression of SRY-box containing gene 2 on Uosaki et al., 2011 
data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60 
Figure 3.3.3.5. Expression of T Brachyury on Uosaki et al., 2011 data set. . . . . . . . 62 
Figure 3.3.3.6. Expression of eomesodermin homolog on Uosaki et al., 2011 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62 
Figure 3.3.3.7. Expression of ISL LIM homeobox 1 on Uosaki et al., 2011 data set. 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64 
Figure 3.3.3.8. Expression of heart and neural crest derivatives expressed 
transcript 1 on Uosaki et al., 2011 data set. . . . . . . . . . . . . . . . . . . . 64 
Figure 3.3.3.9. Expression of GATA binding protein 4 on Uosaki et al., 2011 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66 
Figure 3.3.3.10. Expression of Nkx2 homeobox 5 on Uosaki et al., 2011 data set. . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67 
Figure 3.3.3.11. Expression of myocyte enhancer factor 2C on Uosaki et al., 2011 
data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67 
Figure 3.3.3.12. Expression of T-box 5 on Uosaki et al., 2011 data set. . . . . . . . . . . . 68 
Figure 3.3.3.13. Expression of myosin, heavy chain 7, cardiac muscle, beta on 
Uosaki et al., 2011 data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69 
   
 v 
 
Figure 3.3.3.14. Expression of actin, alpha, cardiac muscle 1 on Uosaki et al., 2011 
data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69 
Figure 3.3.3.15. Expression of troponin T type 2 (cardiac) on Uosaki et al., 2011 
data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70 
3.4. Comparison of Biological Process, Molecular Functions and KEGG Pathways between 
Cardiac Data Sets and Mouse ESC 
3.4.1. Biological Process 
Figure 3.4.1.1. Heat map for biological processes. . . . . . . . . . . . . . . . . . . . . . . . . . . 72 
3.4.2. Molecular Functions 
Figure 3.4.2.1. Heat map for molecular function. . . . . . . . . . . . . . . . . . . . . . . . . . . . 73 
3.4.3. KEGG Pathways 
Figure 3.4.3.1. Heat map for KEGG pathways. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74 
3.5. Comparison of Individual Gene Profiles Between Cardiac Data Sets and Mouse ESc 
3.5.1. Positive Early Gene Expression 
Figure 3.5.1.1. Venn diagram with number of shared genes for the comparative 
analysis for heart expression. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76 
Figure 3.5.1.2. Biological function (on the right) and expression (on the left) for 
some of the obtained genes in the overlap for positive early gene 
expression. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78 
3.5.2. Positive Intermediate Gene Expression 
Figure 3.5.2.1. Biological function (on the right) and expression (on the left) for 
the obtained genes in the overlap for positive intermediate gene 
expression. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79 
Figure 3.5.2.2. Venn diagram with number of shared genes for the comparative 
analysis for heart expression. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80 
3.5.3. Positive Late Gene Expression 
Figure 3.5.3.1. Venn diagram with number of shared genes for the comparative 
analysis for heart expression. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82 
Figure 3.5.3.2. Biological function (on the right) and expression (on the left) for 
the obtained genes in the overlap for positive late gene 
expression. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86 
 
 
 vi 
 
3.6. Network Structural Analysis 
3.6.1. Correlation Network 
Figure 3.6.1.1. Protein-Protein Interaction Network filtered from publically 
available interaction studies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88 
Figure 3.6.1.2. Gene expression network with correlation >0.75 in cytoscape for 
Day 0 expression values in Gaspar (2012) data set. . . . . . . . . . . . . . 89 
3.6.2. PPI Data Network 
Figure 3.6.2.1. Figure 3.7.2.1. Protein-Protein Interaction Network filtered from 
publically available interaction studies. . . . . . . . . . . . . . . . . . . . . . . . 90 
3.7. Gene Comparative Analysis With Stem Cells and Cancer Cells 
Figure 3.7.1. Venn diagram with number of shared genes for the comparative 
analysis for genes down-regulated during ESc differentiation. . . . . 93 
Figure 3.7.2. Venn diagram with number of shared genes for the comparative 
analysis for genes up-regulated during ESc differentiation. . . . . . . . 95 
3.8. “HeartEXpress” Interactive Platform 
Figure 3.8.1. HeartEXpress user interface. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97 
Figure 3.8.2. A mouse click on the displayed expression of a gene will open 
another page displaying all genes that are co-expressed with the 
chosen gene. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98 
 
 vii 
 
TABLE INDEX 
2. Methodology 
2.3. Heart Expression 
Table 2.3.1. Heart expression analysis parameters. . . . . . . . . . . . . . . . . . . . . . . . . 20 
3. Results 
3.1. General Genetic Expression in Mouse Embryonic Stem Cells 
Table 3.1.1. Biological functional analysis in Day 0 on Gaspar et al. 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 
Table 3.1.2. Biological functional analysis in Day 1 on Gaspar et al. 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 
Table 3.1.3. Biological functional analysis in Day 2 on Gaspar et al. 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 
Table 3.1.4. Biological functional analysis in Day 3 on Gaspar et al. 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 
Table 3.1.5. Biological functional analysis in Day 4 on Gaspar et al. 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 
Table 3.1.6. Biological functional analysis in Day 5 on Gaspar et al. 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 
Table 3.1.7. Biological functional analysis in Day 6 on Gaspar et al. 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 
Table 3.1.8. Biological functional analysis in Day 7 on Gaspar et al. 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 
Table 3.1.9. Biological functional analysis in Day 10 on Gaspar et al. 2012 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 
3.3. Genetic Expression Between Cardiac Fibroblast And Induced Cardiomyocytes and 
Differentiation into Cardiomyocytes 
3.3.3. hiPSc Differentiation Toward Cardiomyocytes 
Table 3.3.3.1. Temporal alignment between some key marker genes present in 
Mouse and Human. (General Genetic Expression In Mouse 
Embryonic Stem Cells and hiPSc Differentiation Toward 
Cardiomyocytes) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59 
   
 viii 
 
Table 3.3.3.2. Biological functional analysis in Day 0 on Uosaki et al., 2011 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61 
Table 3.3.3.3. Biological functional analysis in Day 2 on Uosaki et al., 2011 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63 
Table 3.3.3.4. Biological functional analysis in Day 5 on Uosaki et al., 2011 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 
Table 3.3.3.5. Biological functional analysis in Day 7 on Uosaki et al., 2011 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66 
Table 3.3.3.6. Biological functional analysis in Day 9 on Uosaki et al., 2011 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68 
Table 3.3.3.7. Biological functional analysis in Day 11 on Uosaki et al., 2011 data 
set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70 
3.4. Comparison of Biological Process, Molecular Functions and KEGG Pathways between 
Cardiac Data Sets and Mouse ESC 
Table 3.4.1. Data sets used for the comparison of the multiple processes. . . . . . 71 
3.5. Comparison of Individual Gene Profiles Between Cardiac Data Sets and Mouse ESc 
Table 3.5.1. Gene lists used for comparative analysis regarding heart gene 
expression in early, intermediate and late stage. . . . . . . . . . . . . . . . . 75 
3.5.1. Positive Early Gene Expression 
Table 3.5.1.1. Number of genes present in the overlap with determined biological 
functions in an early stage. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77 
3.5.2. Positive Early Gene Expression 
Table 3.5.2.1. Number of genes present in the overlap with determined biological 
functions in an intermediate stage. . . . . . . . . . . . . . . . . . . . . . . . . . . . 80 
3.5.1. Positive Early Gene Expression 
Table 3.5.3.1. Number of genes present in the overlap with determined biological 
functions in a late stage. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83 
3.7. Gene Comparative Analysis With Stem Cells and Cancer Cells 
Table 3.7.1. Gene lists used for comparative analysis. . . . . . . . . . . . . . . . . . . . . . . 93 
Table 3.7.2. Significance of common genes in different combinations of gene 
lists. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93 
Table 3.7.3. Gene lists used for comparative analysis. . . . . . . . . . . . . . . . . . . . . . . 95 
   
 ix 
 
Table 3.7.4. Significance of common genes in different combinations of gene 
lists. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  95 
  
 x 
 
ABBREVIATIONS 
ACFGHMT – Adult Cardiac Fibroblast with Gata4, Hand2, Mef2c and Tbx5 
CF – Cardiac Fibroblasts 
c-Myc – v-myc myelocytomatosis viral oncogene homolog 
ESc – Embryonic Stem cells 
eSet – Expression Set 
Gata4 – Transcription factor, gata binding protein 4 
GEO – Gene Expression Omnibus 
GHMT – Gata4, Hand2, Mef2c and Tbx5 
GMT – Gata4, Mef2c and Tbx5 
GO – Gene Ontology 
Hand2 – Transcription factor, heart and neural crest derivatives expressed transcript 2 
hESc – human Embryonic Stem cells 
(h)iPSc – (human) induced Pluripotent Stem cells 
iCM – induced Cardiomyocytes 
iPSc – induced Pluripotent Stem cells 
Klf6 – Kruppel-like factor 6 
Mef2c – Transcription factor, myocyte enhancer factor 2c 
mESc – mouse Embryonic Stem cells 
mESCDiff – mouse Embryonic Stem Cell Differentiation 
MyoCD – Myocardin 
Nanog – Nanog homeobox 
Pou5f1 – Transcription factor also known as Oct4, POU class 5 homeobox 1 
PPI – Protein-Protein Interaction 
Tbx5 – Transcription factor T-box 5 
TP53 – Tumor suppressor protein p53 
WiCM – Week induced Cardiomyocytes 
 
Analysis of the transcriptional regulatory network underlying heart development 
 
Rui Sotero Rodrigues Machado   1 
INTRODUCTION 
The process of heart development is highly complex, involving a series of precisely 
spatially and temporally ordered events on molecular level. To better understand how these 
events are controlled and coordinated, it is necessary to study the gene expression and its 
regulation, ideally on a genome-wide level. Using microarray technology, several studies 
genome-wide expression profiles associated with heart development have been carried out. 
Although they have given comprehensive views of expression changes during cardiogenesis, 
they may have their pitfalls. It is well known that single microarray experiment might be 
seriously compromised by artefacts. Thus, it is important to compare and consolidate the 
genome-wide microarrays studies. However, to date no meta-analysis of microarray data for 
cardiogenesis have been attempted. Such lack of assessment can be considered as a serious 
obstacle on the way to understand how to improve our knowledge in cardiac regenerative 
medicine. 
This thesis aims to provide such critical meta-analysis, which integrates publically 
available data sets for cardiogenesis to obtain a detailed and reliable comprehensive view of 
expression changes in cardiogenesis. Using the consolidated data, I elucidate the networks 
underlying heart development which are still only rudimentarily understood. Such 
endeavour will help to get a better view of this intrinsically complex process and give 
valuable cues for regenerative medicine applied to heart.  
The thesis can be divided in three different parts: In the first part, I will describe the 
collection of publicly available data sets from various studies. These data sets comprise 
expression data for various types of cells, such as, embryonic stem cells, induced 
cardiomyocytes derived from cardiac fibroblast, cancer cells and several types of tissue 
samples. Such a broad basis can help to distinguish transcriptional patterns which are 
specific to heart development from more generic gene expression patterns. 
The second part focuses on the analysis of those data sets and provides a 
comprehensive view of the dynamics of gene expression during cardiomyogenesis. The 
analyses included some standard pre-processing, background correction and summarization 
of expression values. I also applied clustering methods to identify potential co-regulated 
genes. 
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Subsequently, I have identified transient expression patterns through clustering 
methods and evaluated their functional relevance to obtain indications which processes are 
active during the different stages of differentiation. Besides stem cell differentiation, a focus 
of the thesis is set on the reprogramming of somatic cells into cardiomyocytes. Originally, it 
has been demonstrated in the landmark studies led by Shinya Yamanaka that fibroblasts can 
be turned into to so called “induced Pluripotent Stem cells” (iPSc) through expression of 
mere four transcription factors which have a critical role in Embryonic Stem cells (ESc) 
properties [1]. These iPSc appear to be indistinguishable from ESc in their morphology, 
proliferation and gene expression, but care might be needed, as iPSc have been linked to 
teratoma formation [1] and immune responses [2]. Notably, it is also possible to induce 
cardiomyocytes from iPSc efficiently [3]. Interestingly, the ectopic expression of pro-
cardiogenic transcription factors in fibroblast will originate cells with properties similar to 
those of cardiomyocytes. For reprogramming fibroblasts into cardiomyocytes, a single 
master regulator has not been found for cardiac differentiation, but several core 
transcription factors are being extensively studied [4]. 
As last part of this work, a network analysis was carried out. Here, I constructed a 
molecular interactions networks to examine regulatory actions occur based on published 
interaction data.  
Combining expression and interaction data, gives a detailed picture of the dynamic 
regulatory mechanisms underlying heart development. In the end, by putting all things 
together, I will seek to identify and characterize any additional key regulators, which will 
possibly provide some major candidates for a future experimental validation in 
cardiomyogenesis.  
 
Reprogramming of cells toward cardiac fate  
There are core set of transcription factors that are highly conserved through evolution, 
controlling cell fate, cardiac gene expression and heart development. Remarkably, it was 
reported a few years ago that the exogenous expression of Gata4, Mef2c and Tbx5 were 
capable of converting neonatal cardiac fibroblast into cardiomyocytes-like cells in vitro [4]. 
Ieda and co-workers also revealed that it was possible to reprogram fibroblasts directly into 
“induced cardiomyocytes” (iCM) without first becoming a stem or progenitor cells. 
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The cooperative interaction between these transcription factors is consistent with their 
ability to activate cardiac gene expression and activate each other’s expression in adult 
cardiac cells [5]. A subsequent study has indicated that the most effective combination of 
transcription factors for this process is Gata4, Hand2, Tbx5 and Mef2c. [5]. The efficiency of 
cellular reprogramming into induced cardiomyocytes by these 4 transcription factors is 
comparable to the reprogramming iPSc by pluripotency factors. Finding an ideal combination 
is not easy, as including additional factors might promote but might also hinder 
reprogramming. For instance, Song (2012) determined that Nkx2-5, a primary marker of 
cardiomyocytes, decreased the efficiency of the five transcription factors used in his 
experiment. Another gene that is important for cardiomyogenesis is Isl1 that is transiently 
expressed in early cardiac progenitor cells before further cardiac differentiation. However, it 
may not be activated during reprogramming, as Inagawa and colleagues [6] observed that 
fibroblast are converted directly into differentiated cardiomyocytes without passing through 
a progenitor cell state, showing that expression of Isl1 is not essential for creating iCMs. To 
confirm the correct transdifferentiation of cells into induced cardiomyocytes, the expression 
of standard cardiac markers necessary for cardiomyocyte functions, such as cardiac troponin 
T, also known as Tnnt2 and alpha-myosin heavy chain, also known as Myh7, in late cell 
differentiation or in differentiated cell stage [5] was analysed. 
While the reprogramming event appears to be stable at the epigenetic level, the global 
gene expression of iCMs and neonatal cardiomyocytes are similar, but not identical. Despite 
remarkable progress, it still remains important to optimize the combination of transcription 
factors for reprogramming of cells such as fibroblasts into fully functional induced 
cardiomyocytes-like cells, as so far the efficiency of reprogramming is fairly limited. This 
achievement would be even greater if the cultured cells do not need to go through an 
induced pluripotent cell (iPSc) stage.  
Moreover, it is important in this context, to carefully assess the similarity of gene 
expression patterns of induced pluripotent cells with cancer cells, because these can share 
some characteristic features such as the capacity of infinite division. 
Finally, combination of various expression studies and the subsequent analysis of the 
interaction networks can help elucidate the different aspects of heart morphology, 
development and repair.  
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1. BIOLOGICAL BACKGROUND 
For a better understanding of the differentiation and/or transdifferentiation process of 
an ESc, iPSc and somatic cell towards a cardiac cell fate, I analysed several publically 
available microarrays data sets obtained from embryonic stem cells and induced pluripotent 
stem cells at various stages of differentiation, as well as transdifferentiation of cardiac 
fibroblasts into cardiomyocytes. I used this comparative analysis to distinguish commonly 
expressed genes from genes activated only under certain conditions that are relevant for 
cardiac differentiation. In the following, I will introduce and describe the main types of cells 
whose expression was analysed in my study. 
1.1. EMBRYONIC STEM CELLS 
ESc are derived from the inner cell mass of blastocyst embryos and they have a unique 
capacity to proliferate extensively while maintaining pluripotency [2]. 
ESc can be easily identified, isolated and maintained in a pluripotency state. Notably, it is 
possible to keep them in culture for long periods of time, serving as a back-up cells, ready to 
use [7]. As they are pluripotent, they can differentiate into germ cells or any derivative of the 
three primary embryonic germ layers: Endoderm (lungs); Mesoderm (muscle, blood, heart); 
Ectoderm (epidermal tissue and nervous system). They can also be genetically manipulated 
and numerous protocols have been established that allow the differentiation of embryo-
derived stem cells into almost any type of cell [7]. For maintenance and regulation of 
pluripotency, specific transcription factors in ESc such as the Pou5f1, Sox2 and Nanog, play a 
very important role. 
Oct4 expression is restricted to the blastomeres of the developing mouse embryo, in the 
inner cell mass of the blastocyst, epiblast and germ layers. It is also expressed in pluripotent 
stem cells, including embryonic stem cells, embryonic germ cells and embryonic carcinoma 
cells [2]. Oct4 plays an important role in the maintenance of pluripotency and promoting 
differentiation [2]. 
Sox2 also marks the pluripotent lineage of the early mouse embryo and, unlike Oct4, 
Sox2 is also expressed by multipotent cells of extra embryonic ectoderm [2]. Its expression is 
also associated with uncommitted dividing stem cells and precursor cells of the central 
nervous system [2]. 
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Nanog is expressed in ESc and not expressed in differentiated cells, indicating that this 
gene expression is responsible for pluripotency cell maintenance [8]. Endogenous Nanog 
expression in parallel with Stat3 drives ESc self-renewal [8]. Nanog overexpression is enough 
for clonal expansion of ESc, maintaining Oct4 levels elevated. This shows that this 
transcription factor is essential for defining ESc identity [8]. Down regulation of Nanog cause 
ESc to lose pluripotency and to differentiate into extraembryonic endoderm lineage [9]. 
Nevertheless, there remain some challenges in determine optimal conditions to maintain 
cells pluripotent or promote their efficient and reliable differentiation using ESc: (i) 
Experimental conditions or small variations of culture techniques can lead to different 
outcomes; (ii) Onset and shutdown of important biological factors occur in a narrow time 
window, so we could fail to detect or interpret correctly important biological processes; (iii) 
comprehensive functional genomics technologies, stringent statistical criteria and 
bioinformatics analysis are necessary to get a deep view into the complex biological 
processes occurring at the different time points of the differentiation. 
Despite these potential obstacles, ESc lines are considered as encouraging donor sources 
to repair or replace damaged tissue, reverse diseases and injuries and cell transplantation 
therapies for diseases such as diabetes, cardiovascular and blood diseases [2, 10]. For 
applications related to tissue regeneration (“regenerative medicine”), it will be crucial to 
understand in detail how stem cells organise in vivo the generation, maintenance and 
regeneration of tissue, while preventing or suppressing abnormal growth and avoiding 
depletion [7]. 
1.2. IPSC 
It was showed that iPSc can be generated from adult human and mouse fibroblast and 
other somatic cells by ectopic expression of four transcription factors (Klf4, Sox2, c-Myc and 
Pou5f1 - also known by Oct4) [1, 2] that play important roles in the maintenance of 
pluripotency. Although, other combinations of factors have been shown to also achieve 
reprogramming of iPSc, the quartet of Oct4, Sox2, Klf4 and c-Myc (OSKM), referred 
commonly as Yamanka’s factors, are the most commonly used for reprogramming [1, 2, 11, 
12]. The established human iPSc are similar to hESc in many aspects such as morphology, 
proliferation, gene expression and promoter activities, surface markers, in vitro 
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differentiation and teratomas formation [1]. Besides Oct4 and Sox2, two transcription 
factors are used:  
c-Myc is an oncogene found in human cancers, involved in the transactivation of CBP 
and p300, which have histone acetylase activities, immortalizing, regulating the expression 
of non-coding RNAs and opening the chromatin of the cells [2]. 
Klf4 is a member of the family of Krüppel-like transcription factors and has an 
ambivalent role. It is highly expressed gene in differentiated post-mitotic epithelial cells of 
the skin and fibroblast. High levels of Klf4 RNA can be found in cells during growth arrest and 
it is almost undetectable in cells that are in exponential phase of proliferation, indicating to 
function as a tumor suppressor. Depending on the status of its target genes (especially of 
p21 and p53), it can also act as an oncogene promoting proliferation. This role is also 
supported by a high expression observed in some cancers as well as in mouse ESc [2]. 
During the reprogramming process, c-Myc promotes the immortalization and opens the 
chromatin, whereas Klf4 is essential to suppressed p53 (a tumor suppressor gene) and c-
Myc-induced apoptosis [2, 13], so the balance of expression between the two factors might 
be critical for the reprogramming process from somatic cells/fibroblast into iPSc. 
Forced expression of c-Myc and Klf4 alone would result in generation of tumor cells 
(figure 1.4.1), so it would be necessary to combine their induction with other factors, and 
here Oct4 plays an important role that prevents cells from turning into tumor cells. However, 
Oct4 alone is not sufficient to induce pluripotency, being Sox2 also required to active 
multiple target genes for generating iPSc [1, 2]. 
1.3. TRANSDIFFERENTIATION OF CARDIAC FIBROBLASTS 
The heart is composed approximately by 30% of cardiomyocytes and 60-70% of cardiac 
fibroblast, being cardiac fibroblasts the prevailing cell type in the adult mammalian heart [4, 
5]. The large population of cardiac fibroblast existing in the heart could be a potential source 
for induced cardiomyocytes for the purpose of regenerative medicine [4]. 
Indeed, cardiac fibroblast were already successfully reprogrammed into pluripotent cells 
and subsequently directly reprogrammed or transdifferentiated into induced 
cardiomyocytes (iCM), by combination of cardiac lineage-associated transcription factors [1, 
2, 5, 14, 15]. A core set of evolutionary transcription factors controls cardiac gene expression 
and heart development, amongst which,Gata4 is considered a master regulator in heart 
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development, being capable of binding Mef2c and Tbx5 to their specific target sites, leading 
to complete activation of the cardiac programming process [5]. 
Recently, Gata4, Mef2c and Tbx5 (GMT), master regulators of cardiac development, 
were reported to be capable of converting neonatal fibroblast into cardiomyocytes in vitro 
when exogenously overexpressed during 2 weeks [4, 15]. In another study, these 
transcription factors in in combination with Hand2 (GHMT), another transcription factor 
involved in heart development, were used to convert cardiac fibroblasts into functional 
cardiomyocytes in vitro and directly in vivo in mouse infracted hearts [5]. 
The direct conversion of cardiac fibroblasts into cardiomyocytes constitutes an 
attractive paradigm. In this case, reprogramming into iPSc before cardiac differentiation is 
not necessary and this direct conversion would probably significantly lower the risk of 
originating teratomas or non-specific tissue. This approach is also attractive for future heart 
therapies, since a great amount of cardiac fibroblast can be cultivated from a simple cardiac 
biopsy, and performing an in vitro transduction with the defined factors to obtain a large 
amount of iCM is relatively easy, before their delivery into the damaged heart. More 
interestingly, is the potential delivery of cardiomyocytes reprogramming factors to convert 
in vivo cardiac fibroblasts of the scar tissue generated in infracted hearts into functional 
cardiomyocytes. Furthermore, it is proven that the expression of the core GHMT factors in 
mouse infracted hearts reduces fibrosis and improves cardiac function in vivo [5]. It is also 
possible that other mechanisms like enhancement survival of cardiomyocytes, 
differentiation of activated cardiac progenitors into cardiomyocytes, blockade of the 
activation of cardiac fibroblasts are affected in a positive way by this core transcription 
factors in the heart myocardial infarction [5]. 
1.4. CANCER CELLS 
Cancer cells are cells that grow and divide at a high rate, without any regulation from 
the host organism. Many factors can play an important role in the development of cancer 
cells, such as genetics, age, environment, immune system. Due to these factors, cells can 
lose their ability to mark and destroy damaged cells and lead to cancer cells. One of the most 
studied processes of the apoptosis of damaged cells is the functionality of the tumor 
suppressor tp53[16], in which this gene loses the functionality and does not mark for 
apoptosis. 
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Stem cells and cancer cells share some characteristic features such as the capacity to 
infinite division and self-renewal [17, 18]. Thus, common processes and genes may be 
activated in both types of cells. Indeed, studies have showed that both stem and cancer cells 
can share a significant number of common activated genes, which points to the execution of 
a common molecular program in both types of cells[17]. 
For most cancers, the transforming genetic mutations are still not exactly known. 
Nevertheless, some types of cancers appear to arise from mutations that accumulate in stem 
cells [16, 17]. In general, there are many apparent connections between stem cells and 
cancer that are important to understand [17]. In particular, understanding the process for 
the control of self-renewal of normal stem cells could give new insights into the origins of 
cancer. 
 
 
Figure 1.4.1. Possible roles for the four transcription factors in the generation of iPSc or 
tumor cells (adapted from Yamanaka, 2007).  
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2. METHODOLOGY 
This chapter details the microarrays chosen for the gene expression data sets analysis 
and the methods used to filter and treat all the data sets gathered along this study. It 
contains a brief description of the data sets, bioinformatic tools used in this study and the 
network analysis procedures. Finally, it describes methods used for the comparative gene 
analysis between stem cells and cancer cells. 
2.1. MICROARRAY TECHNOLOGIES & DATA SETS 
Although, the DNA content is the same in every cell of an organism, tissues show an 
amazing diversity of functions due to the tissue-specific gene expression. To understand 
better this diversity, genome-wide measurements of expression have been made in many 
types of tissues from various organisms. Nowadays, the study of expression of a remarkably 
large number of genes is routinely performed using the microarrays technology. 
Microarrays have therefore become a great tool to perform genome-wide 
measurements, being a crucial tool to create a comprehensive gene expression atlas for 
different organisms, to facilitate rapid identification of new marker genes for improved 
diagnosis and target genes. This kind of atlas would increase general understanding in gene 
expression and give new information about functions of genes. 
Generally, microarrays are based on the hybridization of labelled transcripts to a 
complementary nucleotide sequences attached to a solid surface. There are two types of 
microarrays, two-channel and one-channel microarray. The two-channel microarrays, in two 
samples are co-hybridized on the same array and the one-channel microarray, where only a 
single sample is hybridized on a microarray.  
In this work the main types of microarrays are one-channel microarrays from the 
companies Affymetrix and Illumina. These microarrays platforms can be reliable due to their 
accuracy and precision. 
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Figure 2.1.1. One-colour channel microarray platform, Affymetrix GeneChip [19] (on the left) 
and Illumina [20] (on the right). 
 
Affymetrix produces an oligonucleotide microarray (also called GeneChips) that are 
manufactured using photolithography [19]. Photolithography is a process of using light to 
control the manufacture of multiple layers of material. For GeneChip production, Affymetrix 
uses photolithography masks that contains tiny holes designed to let light through for the 
sequence that is receiving the next nucleotide[19]. The sequences that are protected from 
light will not receive another nucleotide to the DNA strand and the ones that are not 
protected from the light will receive a nucleotide to add in the growing DNA chain[19]. Each 
mask is designed to add new nucleotides in different sequences and this process is repeated 
over and over again with a new mask until the desired sequences are completed [19]. 
Illumina microarray or BeadArrays contain of oligonucleotides immobilized in beads that 
are held in microwells on the array substrate. It is highly reproducible since it was a high 
level of bead type redundancy (in average 30 beads per probe) [20]. These beads are 
randomly distributed across the array and the unique sequences present in each bead are 
used for identifying the location of each bead [20]. Each probe location and sequence 
combination on Illumina bead chip is carefully selected bioinformatically [20]. Hybridization 
of the whole-gene expression assay offers the highest capability for simultaneously profile 
more than 47000 transcripts. To identify the unique sequences on the beads, Illumina uses 
sequencing by synthesis technology, which consists in sequencing tens of millions of clusters 
on the array [20]. During each sequencing cycle, a nucleotide is added to the nucleic acid 
chain. Nucleotide label serves as a terminator for polymerization, so after each inserted 
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nucleotide, the fluorescent dye is imaged to identify the base used. Inserted nucleotides are 
identified directly from signal intensity measurements during each cycle [20]. 
2.1.1. GENERAL GENETIC EXPRESSION IN MOUSE EMBRYONIC STEM CELLS 
A dataset produced by Gaspar et al. 2012 [21], which profiled the RNA expression in the 
first 10 days of in vitro differentiation of mouse CGR8 ESc, was used in my study. CGR8 is a 
cell line that was established from the inner cell mass of a 3.5 day male pre-implantation 
embryo (Mus musculus, strain 129) [21]. These pluripotent cells retain their ability to 
participate in normal embryonic development. Supplementation of LIF (Leukaemia Inhibiting 
Factor) in the culture media allows culture of undifferentiated CGR8 ESc without the use of 
any feeder layers. 
For this study, cRNA was prepared according to the standard Affymetrix protocol. From 
the 45,101 probe sets represented on the Mouse 430 version 2 array, expression data of 
30,526 gene associated transcripts were analysed after eliminating transcripts without 
annotation and of unknown origin, as well as hypothetical transcripts or proteins. These 
expression measurements were performed in triplicates from biologic independent samples 
[21]. In total, the dataset comprises of 27 samples taken at different time points days of age 
(0, 1, 2, 3, 4, 5, 6, 7, 10 days).  
The results of the microarray were deposited in the EBI ArrayExpress, data set E-
TABM-672. The CEL files were downloaded from there and were submitted to background 
correction, normalization and summarization of gene expression (rma), through a package 
called limma implemented in programming language “R” (see below for a description of 
these methods). 
2.1.2. ROSETTA 1 
The data set Rosetta 1 was generated using Agilent spotted oligonucleotide microarrays 
and contains expression patterns for 10000 genes in 52 different types of tissue and cell lines 
[22]. 
For further analyses and to facilitate the comparison, the samples were assigned to 19 
main tissue classes based on their physiology and histology [23]. The data was log 
transformed and subsequently normalized using the quantile normalization which is based 
on the transformation of the original value to the corresponding quantile value of a 
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reference chip [23].This data set was retrieved from BMC Genomics Site in the additional 
files, additional file 1 (http://www.biomedcentral.com/1471-2164/11/305/additional) [23]. 
2.1.3. ROSETTA2 
Data set Rosetta2 was generated using Agilent spotted oligonucleotide microarrays and 
contained expression patterns for 50000 genes in 54 different types of tissue [24]. As in the 
Rosetta 1 data set, the data used was merged into 19 main tissue to facilitate comparison 
[23]. This data set was retrieved from BMC Genomics Site in the additional files tab, 
additional file 2 (http://www.biomedcentral.com/1471-2164/11/305/additional) [23]. 
2.1.4. STANFORD 
In this study, Shyamsundar and co-workers (2005) measured gene expression in 115 
tissue samples on a dual channel cDNA microarray containing 39,711 human cDNA, 
representing 26,260 different genes [25]. Tables with the pre-processed expression values 
for the analysed data were taken from (http://www.biomedcentral.com/1471-
2164/11/305/additional) [23]. 
2.1.5. HUMAN GENE ATLAS 
Su (2004) created a genome-wide expression profile of 79 human tissues using 
Affymetrix HG-U133A and customized GNF1H comprising 42.865 probe sets and expression 
summaries were obtained using the Affymetrix Microarray Suite 5 (MAS5) [26]. 
That data processed by MAS5 was downloaded from the BioGPS website 
(http://biogps.org/downloads/), the annotations for the GNF1H were also taken from the 
same website. Annotations for the Affymetrix HG-U133A were obtained through 
R/Bioconductor package (hgu133a.db). Probes that could not be mapped were excluded 
from the analysis. 
2.1.6. MOUSE GENE ATLAS 
Su (2004) also created a genome-wide expression for mouse, containing 61 types of 
tissue and a total of 153 samples. They used a custom design array with the whole genome 
expression, containing 36.182 transcripts, with the identification by Affymetrix as GNF1M 
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The used expression data set was downloaded from the BioGPS website 
(http://biogps.org/downloads/), the annotations for the GNF1M were also taken from the 
same website. Annotations for the Affymetrix GNF1M were obtain trough a package present 
in R, called org.Mm.eg.db (Genome wide annotation for Mouse), extracting from the 
package the annotation about gene id, symbol and description of the gene. Probes that 
could not be mapped were excluded from the analysis. These 61 physiologically normal 
tissues were obtained from adult (10-12 weeks) C57Bl/6 mice (4 male, 3 female) by 
dissection [26].  
2.1.7. REPROGRAMMING MOUSE FIBROBLAST INTO FUNCTIONAL CARDIOMYOCITES BY 
DEFINED FACTORS 
In a landmark study, Ieda and co-workers showed that it is possible to reprogram 
murine cardiac fibroblasts into cells with great similarities to cardiomyocytes [4]. 
In their study, they combined the exogenous expression of three fundamental heart 
development transcription factors (Gata4, Tbx5 and Mef2c) to transdifferentiate in vitro 
rapidly and efficiently post-natal cardiac fibroblast directly into differentiated 
cardiomyocytes-like cells. These so called iCM expressed cardiac-specific markers and have a 
global gene expression profile analogous to native cardiomyocytes. [4]. Notably, the authors 
also showed that the reprogramming occurs in a direct manner i.e. the fibroblasts are 
reprogrammed to iCMs without first becoming a stem or progenitor cells. Importantly, this 
induced transdifferentiation can also occur in vivo, as fibroblast cells showed that were 
transplanted into mouse hearts one day after transduction of the three factors and 
differentiated into iCMs [4]. 
These findings suggest that functional cardiomyocytes can be directly obtained from 
differentiated somatic cells by induction of defined factors [4]. Ieda and co-workers also 
performed genome wide expression analyses using Affymetrix Mouse Gene 1.0 ST Array. 
Besides profiling neo-natal murine cardiomyocytes and cardiac fibroblasts, the expression of 
successfully and non-successfully reprogrammed fibroblasts was measured. The success of 
reprogramming was measured using transgenic GFP under control of an aMHC promoter. 
GFP
+
 and GFP
-
 were collect by fluorescent-activated cell sorting (FACS) after 2 and 4 weeks of 
culture [4]. Microarray analyses were performed in triplicate from independent biologic 
samples, according to standard Affymetrix Genechip protocol [4]. 
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The results of the microarray were deposited in GEO, with the accession number 
GSE22292. For my study, the CEL files were downloaded from there and were submitted to 
background correction, normalization and summarization of gene expression (rma), through 
a package present in “R” called affy. 
2.1.8. REPROGRAMMING NON-MYOCYTES WITH CARDIAC TRANSCRIPTION FACTORS 
Song (2012) demonstrated that the combination of GHMT (Gata4, Hand2, Mef2c, Tbx-5) 
factors could reprogram cardiac fibroblast into functional cardiomyocytes-like cells in vitro 
and in vivo. First they could demonstrate that the chosen combination of transcription 
factors correlated with their ability to convert fibroblasts into so called cardiac-like induced 
myocytes which express markers for cardiomyocytes. They showed that exogenous GHMT 
expression in non-cardiomyocyte in the infarcted heart reduces fibrosis and improves 
cardiac function in vivo [5]. 
Notably, it appears that the efficiency of transdifferentiation is greater in vivo than in 
vitro, indicating that the native environment of the heart is a more permissive environment 
than the plastic tissue culture dishes for functional reprogramming [5]. In this study, the 
obtained RNA was isolated from the uninfected cardiac fibroblasts as well as, cardiac 
fibroblasts transduced for 2 or 4 weeks with either an empty vector or a GHMT retrovirus 
and cardiomyocytes from adult mice. Microarray analysis was performed on the platform of 
Illumina Mouse-6 Beadchip and analysed using GeneSpring GX software (Agilent) [5].  
Data from this study was deposited in GEO with the accession number GSE37057. The 
CEL files were downloaded from there and were submitted to background correction, 
normalization and summarization of gene expression (rma), through a package present in 
“R” called affy. 
2.1.9. HIPSC DIFFERENTIATION TOWARD CARDIOMYOCYTES 
Besides direct conversion from other types of differentiated cells, differentiation of 
hESc/iPSc could be a promising cell source of cardiomyocytes in cardiac regenerative 
medicine [3]. Uosaki and colleagues differentiated hiPSc towards cardiomyocytes applying 
sequential administration of activin, bone morphogenetic protein 4 (BMP4), fibroblast 
growth factor 4 (FGF4) and Dickkopf 1 homolog (DKK1). For expression profiling, they used 
Affymetrix Human Gene 1.0 ST arrays. at day 0, 2, 5, 7, 9 and 11 during differentiation [3]. 
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Data from this study was deposited in GEO with the accession number GSE28191. The 
CEL files were downloaded from there and were submitted to background correction, 
normalization and summarization of gene expression (rma), through a package present in 
“R” called affy. For my study, 33010 genes were included that were annotated. 
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2.2. GENE EXPRESSION ANALYSIS  
In the next sub-chapters it will be addressed the main computational algorithms and 
approaches that I applied for the data analysis including, the comparison and clustering of 
temporal gene profiles. Most of the computational analysis was performed in R which is a 
programming environment with favourable numerical capability, flexible visualization and a 
wide range of statistical and mathematical algorithms. Notably, R is gaining a widespread 
usage within the computational biology and bioinformatics, and is the basis for the 
Bioconductor platforms which provides many add-on packages for microarray data analysis 
and toolset to work with [27]. 
Examples for the infrastructure concepts could be the ExprsSet class from the Biobase 
package. The fundamental object for gene expression analysis in R/Bioconductor is the 
ExprsSet, which is a data structure binding together array-based expression measurements 
with information about the samples [27]. Important Bioconductor package used for my work 
are Affy and Limma, which are outlined below [27]. 
2.2.1. PREPROCESSING OF MICROARRAY DATA 
Before analysing expression changes of genes, the microarray data need to be pre-
processed. This includes performing background correction, normalization, pm correction 
and summarization. Figure 2.2.1.1 presents an overview of these steps which were carried 
out using the Affy package in this study. For Affymetrix experiments, CEL files that contain 
probe intensities derived from the scan of the GeneChip. CEL data is a very simple structure, 
storing all probe intensities from the chip. Information about the probe identity, location of 
each probe and very limited sequence data is stored in the .cdf object generated by the 
program. 
As there is always some amount of background noise in every scanned image, so this 
background correction function will check the distribution of probe intensities and this will 
be used to estimate overall background noise level and adjust it. 
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Figure 2.2.1.1. Simple steps from CEL files to expression set. It starts with an affybatch file, it 
is submitted to a background correction, normalization, pm correction and summarization 
and finally is turned in to an expression set (adapted from Gautier et al., 2003 [28]). 
 
Normalization is required because no step in the hybridization process is perfectly 
controlled, so the quantity of RNA in a sample varies slightly from chip to chip. Normalization 
procedures attempt to detect and correct systematic differences between chips, so data 
from different chips can be directly compared [28]. 
Pm correction (perfect match correction) is for mismatch probes that exist in Affymetrix 
GeneChips to quantify non-specific and cross-hybridization. This mismatch probes are used 
to correct perfect match probes. As each transcript is targeted on the GeneChip by multiple 
probes, a final step is the summarization over different probes associated with a gene one or 
more probe sets. 
2.2.2. DETECTION OF DIFFERENTIAL EXPRESSION 
To detect differential expression, a linear model approach was applied using the Limma 
package. This method requires construction of two types of matrices: (i) the first one is the 
design matrix which associates the RNA samples with the array, and (ii) the contrast matrix 
that specifies which are the comparisons that the user would like to make between the RNA 
samples [29]. For statistical analysis and assessing differential expression, limma uses an 
empirical Bayes method to moderate the standard errors of the estimated fold changes [29]. 
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2.2.3. CLUSTERING OF GENE EXPRESSION DATA 
Cluster 3.0 is a program that provides a computational environment for analysing data 
from DNA microarray experiments and other genomic data sets. This program can only read 
tab-limited (.txt files) in a particular format. After data input, it is submitted to a set of filters 
that allows the treatment of the data, such as, removing all genes that have missing values in 
at least one condition of the experiment. 
Posteriorly it was performed a hierarchical clustering, which organizes genes in a 
hierarchical structure based on their expression pattern. It was used Single Linkage 
Clustering, in which the distances between two items x and y is minimum of all pair wise 
distances between items contained in x and y. This kind of hierarchical clustering can be 
used to cluster large sets of gene expression [30]. 
Output files are opened with Java treeview, a program that can provide a graphical 
environment for analysing data from microarrays experiments and other types of data sets 
[31]. This program allows an interactive graphical analysis of the results from the Cluster 3.0, 
reading the output files. 
2.2.4. FUNCTIONAL ENRICHMENT ANALYSIS 
To detect whether differential genes tend to be associated with a particular processes, 
functional enrichment analysis was performed. Here, the statistical significance is calculated 
based on the observed number of genes associated with the same process among the total 
set of differentially expressed genes. Moreover, biological processes, molecular function and 
cellular components can be tested based on the annotation in Gene Ontology (GO), which 
organizes genes into categories for a number of different organisms [32]. The statistical 
evaluation was performed using R as well as using the FatiGo tool from the Babelomics 
(http://babelomics.bioinfo.cipf.es/) website [33]. 
FatiGO is a simple and powerful tool to extract relevant GO terms for a list of genes with 
respect to a set of genes of reference (usually the rest of the genome). This program uses 
the most widely accepted ontologies in GO, which organizes information for molecular 
function, biological processes and cellular components for a number of different organisms 
[32]. FatiGO program returns 4 main columns of interest: GO, that represents what are the 
biological processes, list of gene input, so it compares to the all genes that are present in the 
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biological functions; list of positive hits, which means the number of genes that participate in 
the biological functions; adjusted p-value, is ordered by increasing value, facilitating the 
selection of GO terms with the most significance for the experience [32].The FatiGO program 
present in Babelomics website was used for the studies presented in sub-chapters 3.1 and 
3.3.3.For the comparison of biological processes, molecular functions and KEGG pathways 
between cardiac data sets and mESc (sub-chapter 3.4), all 3 gene ontology processes were 
analysed through R, which facilitates comparison and systematic inspection of the results. 
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2.3. HEART EXPRESSION 
This study was made to understand which genes could be linked between the different 
data set analysed, so it was compared several genes associated to heart development and 
morphogenesis, after the choice of certain parameters for each stage of development (early, 
intermediate and late) present in table 2.3.1. It was not possible to choose from Song data 
set [5] and Ieda data set [4] the early and intermediate stage, since this two data sets do not 
have time course gene expression.  
 
Table 2.3.1. Heart expression analysis parameters. (Description of parameters: Song et al., 
2012 – ACFGHMT – Adult Cardiac Fibroblast transdifferentiated with transcription factors 
Gata4, Hand2, Mef2c and Tbx5; Ieda et al., 2010 – 2WiCM – 2Weeks induced 
Cardiomyocytes, 4WiCM – 4Weeks induced Cardiomyocytes.) 
Authors Abbreviation Parameter Stage 
Song et al.,2012 CF into iCM ACFGHMT Late 
Ieda et al., 2010 Rep into iCM 2WiCM, 4WiCM Late 
Hideki et al., 2011 iPSc into iCM 
Day 0 Early 
Day 2, Day5 Intermediate 
Day 7, Day 9 Late 
Gaspar et al., 2012 mESCDiff 
Day 0, Day 1 Early 
Day 3, Day 4 Intermediate 
Day 6, Day 7 Late 
 
Genes of these data sets have been compared between themselves for the early, 
intermediate and late stage. The log fold change chosen for this analysis has a cut-off of 0.5 
log fold change expression (these values were obtained through “limma”). 
For comparison, all genes were mapped with mouse EntrezGene Ids. It was recorded 
which genes are present in each data set and which genes are overlapping in the different 
combinations of these data sets. 
It was created a web based program (HeartExpress: http://heartexpress.sysbiolab.eu/) 
[34] that provides researchers a direct access to the collected data and enables independent 
investigations. Heart Express allows to explore a genome-wide expression data for heart 
development and morphogenesis.  
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2.4. NETWORK ANALYSIS 
For the analysis of networks, the Cytoscape software was utilized [35]. This software can 
generally be used for analysing protein-protein, protein-DNA and genetic interactions that 
are increasingly available for different model organisms [36]. Cytoscape has the purpose of 
modelling and integrate biomolecular interaction networks and states [36]. Cytoscape core 
handles basic features such as network layout and mapping of data attributes to visual 
displays properties. Dynamic states on molecules and molecular interactions are handled as 
attributes on node and edges, whereas static hierarchical data, such as, protein functional 
ontologies are supported by use of annotations [36]. Besides the graphical image presented 
by Cytoscape, there are other functionalities that allow the user to modulate the network 
(figure 2.5.1.). 
 
Figure 2.4.1. A simplified schematic overview of the Cytoscape functionality. Besides the 
Cytoscape main window, which gives graphical presentation of interactions of the genes, the 
other functionalities allow the user to modulate the results, according to what is needed. 
(Schematic adapted from Shannon et al., 2012 [36]). 
 
This tool was used to visualize the sets of the identified genes with early, intermediate 
and late expression during cardiomyogenesis within a network context and understand their 
behaviour. First, a large molecular interaction network was generated. This large network 
was examined for smaller sub-networks that could be of interest for this purpose of the 
study. This approach helped to identify other key players that have not been considered to 
be involved in heart development to date.  
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2.5. GENE COMPARATIVE ANALYSIS WITH STEM AND CANCER CELLS 
To examine the link between cancer and stem cells, several relevant gene sets were 
gathered: a list of genes connected to pluripotency (Oct4 screen hits [37]) and two lists 
connected to cancer cells (Cancer Gene Census [38] & Genetic Association Database [39]). 
2.5.1. GENE LIST FOR CANCER AND PLURIPOTENCY 
Oct4 screen hits [37] data set has originated from a genome-wide RNA interference 
screen to identify genes which regulate self-renewal and pluripotency properties in hESc 
[37]. A genome wide screen was performed and genes targets identified which are 
associated with a reduced Oct4 expression. In total, 566 genes were detected. 
Cancer Gene Census [38] data set results from an effort by Sanger Institute to catalogue 
all genes for which mutations have been causally implicated in cancer. Number of genes 
present in the used data set: 487 genes. (http://www.sanger.ac.uk/genetics /CGP/Census/). 
Genetic Association Database [39] is an archive of human genetic association studies of 
complex diseases and disorders. The database provides summary data extracted from 
published papers in peer reviewed journals on candidate gene and GWAS studies. The goal 
of this database is to allow the user to rapidly identify polymorphism from the large volume 
of polymorphism and mutational data. Number of genes present in the used data set: 3214 
genes. (http://geneticassociationdb.nih.gov/). 
2.5.2. ASSESSING SIGNIFICANCE OF COMMON GENES 
The statistical significance of the detected overlap between the different lists, the 
hypergeometric test was applied. The calculated significance indicates whether more 
common genes were found in two lists than expected by chance. The hypergeometric test is 
equivalent to Fisher’s test. Significance (p-value) of enrichment in common genes was 
calculated for each potential combination. For visualization of the number of genes present 
in the overlap, Venn diagrams were produced. 
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3. RESULTS 
Several microarrays data sets were analysed and compared in various ways to obtain a 
comprehensive view of transcriptional changes during cardiomyogenesis. Various types of 
approaches were performed, since there were many types of microarrays, which range from 
temporal gene expression to gene expression in specific types of tissues, such as, in cardiac 
fibroblasts and induced cardiomyocytes. First, I examined temporal gene expression data for 
in vitro differentiation of mouse ESc, although this differentiation method is not specific for 
cardiomyogenesis and generates cells derived from the three germ layers, the analysis gave 
important cues about the temporal order of expression during stem cell differentiation. 
Furthermore, in the molecular mechanisms involved in ESc differentiation towards cardiac 
cell lineages are comparable to the developmental mechanisms. 
Subsequently, I analysed microarray data sets which are closely associated with 
cardiomyogenesis. The results obtained from the four microarray data sets (Table 2.3.1.), 
were used to get biological processes, molecular functions and KEGG pathways and to 
compare the overlapping gene expression in order to derive a more accurate and reliable 
sets of genes that were expressed in an early, intermediate and late stage of cardiac cell 
lineage differentiation. This last method helps to filter from the significant genes linked to 
heart development that were previously described in the literature. Also, network-based 
analyses were carried out to interpret the observed gene expression changes. Finally, to 
assess if any genes associated with heart development could be linked to cancer stem cells 
or stem cells expression, a brief comparison of the genes included in different gene sets 
conclude the analyses carried out within this study. To compile all this gathered and finely 
tuned information, it was developed a website that contains data, where an independent 
user can check his genes of interest. 
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3.1. GENERAL GENETIC EXPRESSION IN MOUSE EMBRYONIC STEM CELLS 
Differentiation of stem cells is a complex process with a defined temporal order. To 
elucidate the underlying dynamics, I analysed a microarray data set, which captured 
expression changes in murine stem cells during differentiation induced by the hanging drop 
method [21]. Although this approach generates not only cardiomyocytes, but rather a 
mixture of differentiated cell types representative of the three germ cell layers, it provides 
valuable insights in the temporal order of the expression of genes. To gain an overview of 
the expression patterns as well as to assess the quality of microarray measurements, it was 
checked the gene expression day by day, searching for the genes that are more expressed at 
each time point. This type of analysis was made to determine (specific) gene expression 
variation through the differentiation time points. 
A dendrogram cluster of gene expression was made and the genes associated in three 
different groups. Notably, no outlier was detected indicating a high reproducibility of the 
measurements. Moreover, day 0, 1, 2; day 3, 4, 5; day 6, 7, 10 are clustering together, 
showing that gene expression between them are similar and clearly dividing themselves in 
early, intermediate and late stage. The most expressed genes in day 0 to day 2 are genes 
related to the undifferentiated cell state; from day 3 to day 5 expressed genes are linked to 
cell fate commitment and anatomical structure formation involved in heart morphogenesis 
and from day 6 to day 10 the most expressed genes are linked to organ and tissue 
development. 
 
Figure 3.1.1. Cluster dendrogram for Gaspar et al. 2012 data set [21]. It is possible to observe 
that the respective days are clustering together and dividing themselves according to an 
early/intermediate/late stage. 
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To get the most up-regulated genes in each day, it was obtained “topTables” in R, 
trough the “limma” package. These “toptables” contains all genes that have a defined 
significant adjusted p-value, that in this case is <0.1, and ease the visualization of the genes 
that are most expressed in each day of differentiation. Amongst these genes, I selected 
those with a strong positive fold change and a significant adjusted p-value to ensure the 
specificity of expression of these genes to the specific time points. Subsequently, a 
functional analysis through Babelomics 4.3 (http://babelomics.bioinfo.cipf.es) was 
performed to determine the biological processes in which the selected genes participate at 
the relevant time points [33]. 
In the following section, I will present the expression profiles along the differentiation 
process of genes important ESc undifferentiated state, including Nanog, Sox2 and Pou5f1 
and genes involved in differentiation into cardiac cells, for instance, Gata4, Tbx5, and Mef2c. 
The expression profiles of genes involved in the transition from pluripotent stem cells to 
mesoderm and endoderm, such as, T-brachyury and Eomes are also presented. 
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DAY 0 
Genes up-regulated at day 0, in comparison to the rest of the time points, are associated 
with maintenance and proliferation of undifferentiated cells, such as Nanog and Sox2 and 
show a strong expression (figure 3.1.2 and 3.1.3). Dnmt3l is a DNA Methyltransferase that 
methylates DNA. It can cause epigenetic modifications and mediate transcriptional 
repression through interaction with histone deacetylase1 [40]. 
 
 
Figure 3.1.2. Expression of Nanog homeobox on Gaspar et al. 2012 data set. 
 
Figure 3.1.3. Expression of SRY-box containing gene on Gaspar et al. 2012 data set. 
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Figure 3.1.4. Expression of DNA (cytosine-5)-methyltransferase 3-like on Gaspar et al. 2012 
data set. 
 
In table 3.1.1. the main genes, that are overexpressed, are linked to stem cell 
maintenance and development, negative regulation of differentiation, regulation of cell 
differentiation and meiosis. All these processes together are promoting stem cell 
maintenance and proliferation, while inhibiting cell differentiation. 
 
Table 3.1.1. Biological functional analysis in Day 0 on Gaspar et al. 2012 data set. 
GO Description Input genes Positives %Perc Adj p-value 
GO:0019827 stem cell maintenance 253 9 3.56 3.85E-09 
GO:0048864 stem cell development 253 9 3.56 3.85E-09 
GO:0048863 stem cell differentiation 253 9 3.56 3.29E-08 
GO:0045596 negative regulation of cell 
differentiation 
253 15 5.93 4.74E-06 
GO:0007283 spermatogenesis 253 15 5.93 1.38E-04 
GO:0032526 response to retinoic acid 253 6 2.37 1.42E-03 
GO:0048468 cell development 253 26 10.28 2.00E-03 
GO:0045595 regulation of cell differentiation 253 17 6.72 3.27E-03 
GO:0033189 response to vitamin A 253 6 2.37 3.27E-03 
GO:0007548 sex differentiation 253 9 3.56 3.53E-03 
GO:0006520 cellular amino acid metabolic 
process 
253 12 4.74 3.53E-03 
GO:0033273 response to vitamin 253 7 2.77 3.64E-03 
GO:0007127 meiosis I 253 5 1.98 4.30E-03 
GO:0009880 embryonic pattern specification 253 5 1.98 4.30E-03 
GO:0050793 regulation of developmental process 253 24 9.49 4.43E-03 
GO:0045165 cell fate commitment 253 9 3.56 4.43E-03 
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DAY 1 
Pou5f1 has a higher peak of expression at day 1, and that could mean that its 
overexpression could be responsible for the initiation of cell differentiation and regulation of 
development process [41], while is also involved in stem cell maintenance [13]. 
Dppa2 is also significantly over-expressed in pluripotent cells. Knock down of this gene 
induces differentiation of stem cells causing a slight down regulation of Sox2 and Pou5f1 
expression [42]. Dppa2 expression decreased prior to Pou5f1 at day 1 and day 2, indicating 
that Dppa2 might regulate the expression of master transcription factor Pou5f1 [42]. Thus, 
Dppa2 could also be a good marker for pluripotency and the regulation of ESc pluripotent 
state [42]. 
 
Figure 3.1.5. Expression of POU domain, class 5, transcription factor 1 on Gaspar et al. 2012 
data set. 
 
 
Figure 3.1.6. Expression of developmental pluripotency associated 2 on Gaspar et al. 2012 
data set. 
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Although most of the positively differentially expressed genes are linked to pluripotency 
and negative regulation of cell differentiation, a number of genes related to development 
have their expression increased at this stage, suggesting that ESc are moving towards cell 
fate commitment (last biological process present in the table 3.1.1. and 3.1.2.). 
 
Table 3.1.2. Biological functional analysis in Day 1 on Gaspar et al. 2012 data set. 
GO Description Input genes Positive %Perc p-value 
GO:0007399 nervous system development 138 21 15.22 4.37E-04 
GO:0048468 cell development 138 20 14.49 4.47E-04 
GO:0007283 spermatogenesis 138 11 7.97 5.16E-04 
GO:0050793 regulation of developmental process 138 19 13.77 6.20E-04 
GO:0022008 neurogenesis 138 15 10.87 1.27E-03 
GO:0009887 organ morphogenesis 138 17 12.32 1.27E-03 
GO:0048598 embryonic morphogenesis 138 11 7.97 1.53E-03 
GO:0045814 negative regulation of gene expression, 
epigenetic 
138 4 2.9 1.76E-03 
GO:0016458 gene silencing 138 5 3.62 2.29E-03 
GO:0006366 transcription from RNA polymerase II 
promoter 
138 15 10.87 2.73E-03 
GO:0007420 brain development 138 10 7.25 2.73E-03 
GO:0048839 inner ear development 138 6 4.35 2.73E-03 
GO:0060052 neurofilament cytoskeleton 
organization 
138 3 2.17 2.73E-03 
GO:0045595 regulation of cell differentiation 138 12 8.7 3.30E-03 
GO:0010628 positive regulation of gene expression 138 13 9.42 3.50E-03 
GO:0009952 anterior/posterior pattern specification 138 7 5.07 3.50E-03 
GO:0045165 cell fate commitment 138 7 5.07 3.50E-03 
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DAY 2 
At day 2, the commitment to cells of the nervous system is initiated, as verified by the 
increased expression of Nefl, a gene responsible for nervous system development which is 
the most abundant cytoskeletal component of neurons [43]. All main processes in the neural 
commitment occur during this day, and the expression of genes involved in central nervous 
system to forebrain development is detected (table 3.1.3). 
 
Figure 3.1.7. Expression of neurofilament (light polypeptide) on Gaspar et al. 2012 data set. 
 
Genes involved in the general nervous system development are more expressed at day 3 
in comparison to day 2 (table 3.1.3 and table 3.1.4.). Comparing day 2 with day 3, it is clear 
that the processes in the top 5 in day 2 are linked to nervous system development, but they 
are no longer present under the top ranked of day 3, although they still have a higher 
significance. Processes linked to pluripotent stem cell maintenance are also starting to fade 
and are not present anymore in day 3. 
 
Table 3.1.3. Biological functional analysis in Day 2 on Gaspar et al. 2012 data set. 
GO Description Input genes Positive %Perc Adj p-value 
GO:0007399 nervous system development 89 20 22.47 8.13E-07 
GO:0048468 cell development 89 17 19.1 5.46E-05 
GO:0030900 forebrain development 89 8 8.99 1.73E-04 
GO:0007417 central nervous system development 89 11 12.36 2.06E-04 
GO:0048598 embryonic morphogenesis 89 10 11.24 2.09E-04 
GO:0048729 tissue morphogenesis 89 8 8.99 2.96E-04 
GO:0009887 organ morphogenesis 89 14 15.73 3.25E-04 
GO:0019827 stem cell maintenance 89 4 4.49 4.29E-04 
GO:0048864 stem cell development 89 4 4.49 4.63E-04 
GO:0007420 brain development 89 9 10.11 4.78E-04 
GO:0009888 tissue development 89 13 14.61 4.83E-04 
GO:0007492 endoderm development 89 4 4.49 5.02E-04 
GO:0060052 
neurofilament cytoskeleton 
organization 
89 3 3.37 6.32E-04 
GO:0050793 regulation of developmental process 89 14 15.73 8.02E-04 
GO:0048863 stem cell differentiation 89 4 4.49 8.34E-04 
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DAY 3 
T Brachyury (also known as T) is considered to be one of the most important early 
markers for early mesendoderm and is widely used in the field of developmental biology to 
track meseodermal germ layer development [21, 44]. Brachyury is initially expressed in all 
mesodermal cells and its expression declines when cells suffer patterning and specification 
processes to give rise to more specified mesodermal-derived tissues such as skeletal muscle, 
cardiac muscle and connective tissue [44]. The expression profile and values we observed 
(figure 3.1.9), show a significantly high expression around day 3. T Brachyury also 
participates, in interaction with other genes, on the neural tube development and 
segmentation [44]. 
 
Figure 3.1.8. Expression of T Brachyury on Gaspar et al. 2012 data set. 
 
 
Similar to T Brachyury, the expression of Eomes is transient and peaks at day3 (figure 
3.1.10). Eomes is essential for mesoderm formation and defines a conserved molecular 
pathway controlling the gem layer formation and also controlling gastrulation and 
trophoblast differentiation in mammals [45]. This gene is precociously detected in 
trophoblast cell lineage, starting in the trophoectoderm. Its expression starts in the posterior 
part of the epiblast and later extends distally into the primitive streak and nascent 
mesoderm [45]. 
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Figure 3.1.9. Expression of eomesodermin homolog on Gaspar et al. 2012 data set. 
 
Thus, the expression of T Brachyury and Eomes peak at day 3 and these genes are the 
key regulators for embryonic morphogenesis and development, gastrulation, tissue 
development and anatomical structure formation involved in morphogenesis, but essentially 
for mesoderm development. The expression of these two genes presents a peak, because 
they are most active during tissue morphogenesis and are not involved in other types of 
processes. 
 
Table 3.1.4. Biological functional analysis in Day 3 on Gaspar et al. 2012 data set. 
GO Description Input genes Positives %Perc Adj p-value 
GO:0007389 pattern specification process 100 29 29 5.78E-29 
GO:0048598 embryonic morphogenesis 100 28 28 1.88E-25 
GO:0009790 embryo development 100 33 33 2.02E-24 
GO:0007369 gastrulation 100 16 16 1.21E-20 
GO:0009888 tissue development 100 31 31 1.21E-20 
GO:0009887 organ morphogenesis 100 31 31 9.00E-20 
GO:0009952 
anterior/posterior pattern 
specification 
100 18 18 5.16E-19 
GO:0007399 nervous system development 100 32 32 3.66E-18 
GO:0007498 mesoderm development 100 13 13 1.60E-17 
GO:0048646 
anatomical structure formation 
involved in morphogenesis 
100 22 22 3.01E-17 
GO:0048729 tissue morphogenesis 100 18 18 4.27E-17 
GO:0001707 mesoderm formation 100 11 11 7.60E-17 
GO:0048332 mesoderm morphogenesis 100 11 11 1.13E-16 
GO:0007417 central nervous system development 100 21 21 3.38E-15 
GO:0048468 cell development 100 28 28 5.79E-15 
GO:0045165 cell fate commitment 100 15 15 8.20E-15 
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DAY 4 
Hand1 (figure 3.1.11) is involved in early heart differentiation and plays an essential, but 
poorly understood role in cardiac morphogenesis [46], and is required for a normal 
progression of cardiac and extraembryonic development [47]. Risebro (2006) described 
Hand1 as an important cardiac transcription factor in regulating cardiomyocytes exit from 
cell cycle, to control the balance between cell proliferation and differentiation. Its high 
expression originates a pool of undifferentiated cardiomyocyte precursors [46]. 
 
Figure 3.1.10. Expression of heart and neural crest derivatives expressed transcript on 
Gaspar et al. 2012 data set. 
 
In table 3.1.5. it is possible to observe that most of the biological processes related to 
heart development and angiogenesis are starting to appear significantly enriched in over-
expressed genes, indicating that genes related to heart development start to be expressed 
from day 4. By day 4 biological processes linked to pluripotency do not appear any more 
among the most significant biological functions. 
 
Table 3.1.5. Biological functional analysis in Day 4 on Gaspar et al. 2012 data set. 
GO Description Input genes Positives %Perc Adj p-value 
GO:0009887 organ morphogenesis 84 30 35.71 6.38E-20 
GO:0007389 pattern specification process 84 18 21.43 6.84E-15 
GO:0007507 heart development 84 17 20.24 6.84E-15 
GO:0009790 embryo development 84 23 27.38 2.22E-14 
GO:0003007 heart morphogenesis 84 11 13.1 1.72E-12 
GO:0009888 tissue development 84 21 25 2.19E-11 
GO:0035295 tube development 84 14 16.67 2.94E-11 
GO:0001568 blood vessel development 84 15 17.86 2.94E-11 
GO:0001944 vasculature development 84 15 17.86 3.37E-11 
GO:0048646 
anatomical structure formation 
involved in morphogenesis 
84 16 19.05 8.02E-11 
GO:0048598 embryonic morphogenesis 84 15 17.86 2.13E-10 
GO:0008283 cell proliferation 84 21 25 2.95E-10 
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DAY 5 
Hand2 is an early cardiac marker and is required in the formation of the heart, and is 
specifically involved in the development of the secondary heart field [14, 46, 47]. Smyd1 
activity is necessary for Hand2 expression in cardiac precursors and Smyd1 is a direct target 
of Mef2c, which plays a role in myogenesis, suggesting that these transcription factors 
regulate development of ventricular cardiomyocytes [14] and have been shown to regulated 
transcription factors by mediating distinct chromatin modifications [48]. 
 
Figure 3.1.11. Expression Heart- and neural crest derivatives-expressed protein 2 on Gaspar 
et al. 2012 data set. 
Once again, genes involved in heart development process still appear at day 5 of ESCs 
differentiation (table 3.1.6.), as expected, but not in the top 10 biological functions. This 
could mean that the genes linked to heart development are not displaying a strong 
expression, but the process is still active. 
 
Table 3.1.6. Biological functional analysis in Day 5 on Gaspar et al. 2012 data set. 
GO Description Input genes Positives %Perc Adj p-value 
GO:0048856 anatomical structure development 118 58 49.15 2.08E-31 
GO:0048513 organ development 118 51 43.22 1.31E-29 
GO:0009653 anatomical structure morphogenesis 118 41 34.75 4.44E-27 
GO:0009887 organ morphogenesis 118 35 29.66 5.78E-27 
GO:0009888 tissue development 118 29 24.58 1.49E-20 
GO:0001501 skeletal system development 118 23 19.49 8.86E-20 
GO:0030154 cell differentiation 118 40 33.9 1.84E-19 
GO:0009790 embryo development 118 26 22.03 4.83E-18 
GO:0048523 negative regulation of cellular process 118 34 28.81 3.71E-16 
GO:0001944 vasculature development 118 19 16.1 5.18E-16 
GO:0007507 heart development 118 17 14.41 8.32E-16 
GO:0048646 
anatomical structure formation 
involved in morphogenesis 
118 18 15.25 4.85E-14 
GO:0030334 regulation of cell migration 118 13 11.02 1.01E-12 
GO:0003007 heart morphogenesis 118 11 9.32 1.59E-12 
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DAY 6 
Ccbe1 and Cited2 have a peak of expression at day 6 of ESCs differentiation and their 
expression has been highly correlated to general organ development and anatomical 
structure morphogenesis. Also, some studies have indicated that they are linked to heart 
development and morphogenesis, and quite intimately linked to cardiac progenitors [49, 50]. 
Facucho-Oliveira (2011) confirmed that this gene is expressed in early cardiac 
progenitors that emerge from the primitive streak. Ccbe1 is expressed in the cardiogenic 
mesoderm and in the cardiogenic plate [49]. The expression of Ccbe1 in the cardiac 
mesoderm and absence in later stages of heart development suggests that its expression in 
only present in multipotent and proliferative cardiac progenitors and down regulated upon 
commitment into a more specific cardiac cell type [49]. However, during ESCs differentiation 
Ccbe1 expression is maintained at high levels until day 10, suggesting that cardiac 
progenitors persist in time or that Ccbe1 is expressed in non-cardiac cell types. 
 
Figure 3.1.12. Expression of collagen and calcium binding EGF domains 1 on Gaspar et al. 
2012 data set. 
 
Cited2 is essential for the embryonic development of many different structures, such as, 
adrenal, neural crest, liver, lung, lens and placenta [50]. Macdonald (2012) showed that 
Cited2 also played a cell autonomous role in mouse cardiac myocytes, being required for 
myocardial thickening and coronary vessels development [50]. Although, Cited2 expression 
peaks at day 6, its expression is already high in undifferentiated cells (day 0) and decreases 
at days 1-2 before increasing again at day 3. Interestingly, Cited2 is required to ESCs self-
renewal by controlling the expression key genes involved in the maintenance of pluripotency 
and for the optimal differentiation of ESCs towards cardiac cell lineages (José Bragança, 
personal communication). The results presented in Figure 3.1.14 suggest that the expression 
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of Cited2 is down-regulated at the beginning of ESCs differentiation to allow the 
differentiation process, but its expression rises before the initiation of the cardiac 
differentiation. 
 
Figure 3.1.13. Expression of Cbp/p300-interacting transactivator 2 on Gaspar et al. 2012 data 
set. 
 
It is still possible to see processes such as heart development and morphogenesis in day 
6 (table 3.1.7). This day shows an increasing number of genes that participate in heart 
development and morphogenesis. 
 
Table 3.1.7. Biological functional analysis in Day 6 on Gaspar et al. 2012 data set. 
GO Description Input genes Positives %Perc Adj p-value 
GO:0048513 organ development 228 89 39.04 1.28E-47 
GO:0009653 anatomical structure morphogenesis 228 67 29.39 5.88E-39 
GO:0009887 organ morphogenesis 228 51 22.37 1.14E-32 
GO:0009888 tissue development 228 48 21.05 4.02E-31 
GO:0007155 cell adhesion 228 47 20.61 5.91E-27 
GO:0001944 vasculature development 228 32 14.04 1.86E-25 
GO:0030154 cell differentiation 228 63 27.63 4.34E-25 
GO:0001568 blood vessel development 228 31 13.6 1.73E-24 
GO:0007507 skeletal system development 228 28 12.28 1.87E-24 
GO:0048646 heart development 228 29 12.72 1.08E-20 
GO:0048468 extracellular matrix organization 228 41 17.98 2.72E-20 
GO:0007517 
anatomical structure formation 
involved in morphogenesis 
228 24 10.53 1.74E-18 
GO:0048514 muscle organ development 228 24 10.53 6.02E-18 
GO:0008015 blood vessel morphogenesis 228 19 8.33 1.13E-14 
GO:0001525 cell development 228 19 8.33 1.13E-14 
GO:0048738 heart morphogenesis 228 14 6.14 1.13E-14 
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DAY 7 
Most of the highly expressed genes at day 7 are markers of mature cardiac cells, such as, 
Tnnt2 (figure 3.1.14), Actc1 (figure 3.1.15) and Myh7 (figure 3.1.16). These genes indicate 
that the heart-cells differentiation process is coming to an end, since in day 10 (table 3.1.9) 
the relevant biologic functions are no longer among most significant enriched in over-
expressed genes. . 
These biomarkers are very important, because they help us to track cells of interest , i.e. 
in our case cardiac cells, differentiated [3, 51] or transdifferentiated [4, 52, 53], and to 
examine whether these cells present a similar expression profile compared to normal cardiac 
cells [4, 5]. 
 
Figure 3.1.14. Expression of troponin T type 2 (cardiac) on Gaspar et al. 2012 data set. 
 
Figure 3.1.15. Expression of actin, alpha, cardiac muscle 1 on Gaspar et al. 2012 data set. 
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Figure 3.1.16. Expression of myosin, heavy chain 7, cardiac muscle, beta on Gaspar et al. 
2012 data set. 
 
In comparison of day 7 (table 3.1.8.) against day 10 (table 3.1.9), it is possible to assert 
that between these time points, biological functions linked to heart development are not 
listed among the processes with the highest enrichment in differentially expressed genes. 
 
Table 3.1.8. Biological functional analysis in Day 7 on Gaspar et al. 2012 data set. 
GO Description Input genes Positives %Perk Ad p-value 
GO:0048513 organ development 283 100 35.34 2.37E-52 
GO:0009653 anatomical structure morphogenesis 283 71 25.09 1.61E-39 
GO:0009887 organ morphogenesis 283 57 20.14 6.85E-37 
GO:0009888 tissue development 283 50 17.67 3.56E-31 
GO:0007155 cell adhesion 283 50 17.67 8.35E-28 
GO:0001944 vasculature development 283 33 11.66 4.05E-26 
GO:0030154 cell differentiation 283 68 24.03 1.26E-25 
GO:0001568 blood vessel development 283 32 11.31 4.05E-25 
GO:0001501 heart development 283 34 12.01 1.58E-24 
GO:0007507 
anatomical structure formation 
involved in morphogenesis 
283 28 9.89 4.38E-24 
GO:0030198 cell development 283 20 7.07 2.69E-21 
GO:0048646 muscle organ development 283 29 10.25 2.97E-20 
GO:0048523 skeletal system development 283 55 19.43 1.14E-19 
GO:0007517 blood vessel morphogenesis 283 25 8.83 2.14E-19 
GO:0009605 heart morphogenesis 283 45 15.9 4.37E-19 
GO:0048514 blood circulation 283 24 8.48 7.93E-18 
GO:0048468 angiogenesis 283 39 13.78 2.81E-17 
GO:0003007 cardiac muscle tissue development 283 16 5.65 4.21E-17 
GO:0050793 extracellular matrix organization 283 39 13.78 6.59E-17 
GO:0042221 muscle contraction 283 50 17.67 9.39E-17 
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DAY 10 
The analysis of genes expressed at day 10 (table 3.1.9), show that they are mainly linked 
to fibroblast cells, so it seems that most of the genes linked to heart development and 
morphology are showing lower levels of expression or at least the pathways for heart 
development are slowly shutting down. 
 
Figure 3.1.17. Expression of ankyrin repeat domain 2 (stretch responsive muscle) on Gaspar 
et al. 2012 data set. 
 
 
Nevertheless, it is still possible to see some genes linked to heart development and 
morphology expressed, like Ankrd1 (figure 3.1.17). Interestingly, expression of Ankrd1 is 
peaking only at day 10 (or later). Ankrd1 is known to be a transcription co-factor and early 
differentiation marker of cardiac myogenesis expressed in the heart during embryonic 
development [54].The observed expression pattern may supports a potential role of Ankrd1 
as a negative regulator of cardiac expression, although this is not yet demonstrated in vivo 
[55]. 
 
Table 3.1.9. Biological functional analysis in Day 10 on Gaspar et al. 2012 data set. 
GO Description Input genes Positives %Perc Adj p-value  
GO:0048513 organ development 509 143 28.09 1.76E-55 
GO:0009653 anatomical structure morphogenesis 509 106 20.83 7.69E-46 
GO:0009605 response to external stimulus 509 91 17.88 2.20E-37 
GO:0009888 tissue development 509 74 14.54 1.12E-36 
GO:0009887 organ morphogenesis 509 77 15.13 1.12E-36 
GO:0042221 response to chemical stimulus 509 102 20.04 3.06E-34 
GO:0009611 response to wounding 509 67 13.16 4.02E-34 
GO:0030154 cell differentiation 509 109 21.41 8.54E-33 
GO:0010033 response to organic substance 509 71 13.95 2.52E-29 
GO:0050793 regulation of developmental process 509 74 14.54 2.52E-29 
GO:0008283 cell proliferation 509 68 13.36 9.74E-27 
GO:0001944 vasculature development 509 45 8.84 1.07E-26 
GO:0006950 response to stress 509 109 21.41 1.44E-26 
GO:0007155 cell adhesion 509 67 13.16 1.52E-26 
GO:0001568 blood vessel development 509 44 8.64 5.10E-26 
GO:0042127 regulation of cell proliferation 509 57 11.2 1.45E-24 
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3.2. GENETIC EXPRESSION IN DIFFERENT TISSUES 
The analyses described in the previous section showed a characteristic sequence of 
activated genes during stem cell differentiation. Moreover, genes could be classified with 
respect to the time point when their expression reaches a maximum. Genes associated with 
stem cell maintenance and proliferation showed an early peak in their expression, whereas 
genes associated with organ development are up-regulated at later time points. These 
characteristic profiles point to distinct cellular ‘programmes’ for tissue generation. A 
fundamental question is whether these programmes also underlie tissue regeneration, or 
whether they are restricted to developmental phase of an organism. To obtain some insights 
into this matter, I analysed the expression in differentiated tissue using five microarray data 
sets (Rosetta1, Rosetta2, Stanford, Mouse Gene Atlas and Human Gene Atlas). First, I 
assessed whether genes down-regulated during stem cell differentiation remain generally 
down-regulated in a wide range of tissue. Similarly, I examined whether genes up-regulated 
during differentiation remain at a high expression level. These sets of up-and down-
regulated genes during differentiation were obtained directly from the study by Gaspar et al 
(2012), which used a filter approach for their identification (supplementary table 1, Annex 
V). Due to the importance of transcription factors in this context, special lists were 
generated including only these proteins. 
In general, we will see that the down-regulated genes show a lower expression and the 
up-regulated genes show a higher expression. As all 5 data sets showed similar patterns in 
their gene expression, only the Rosetta1 experiment is presented here, whereas the results 
from the other 4 data sets (Rosetta2, Stanford, Mouse Gene Atlas and Human Gene Atlas) 
will be displayed in the supplementary figure 1-8 (Annex I). 
Analysis of the transcriptional regulatory network underlying heart development 
 
Rui Sotero Rodrigues Machado   41 
 
Figure 3.2.1. Mean expression in density of transcription factor that are up regulated vs. 
down regulated Rosetta 1. 
 
As expected, the distribution of expression values for down-regulated genes show a 
peak at a lower expression compared to the up-regulated genes. This means that the down-
regulated genes display a lower expression values in differentiated cells with a peak at log2 
of 9 (meaning that expression intensity is around 512) and the up regulated genes present a 
higher expression with a peak at log2 of 11 (expression around 2048). We can observe this 
type of pattern in both line plots, showing that the selection applied was behaving as 
expected, as in the other data sets it was the same behaviour (supplementary figure 1-8, 
Annex I). 
 
Figure 3.2.2. Mean expression in density of all genes that are up regulated vs. down 
regulated Rosetta1. 
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Additionally I generated some barplots and line plots to show average expression of the 
up- and down-regulated genes and transcription factors in all tissues. Essentially, the bar 
plots show individual gene expression, and the objective is to look for the most and less 
expressed genes present in each data set, for example, Lgals1, KLF6, TPM1 are the most 
expressed genes in every data set for tissue expression , while Nanog, Pou5f1, Sox2, Esrrb, 
Fgf4 were the lowest expressed genes in almost every data set (Supplementary figure 9-16, 
Annex I). 
I also calculated the average of each gene in all tissues, to check which genes were most 
commonly up- and down-regulated in differentiated cells (Figure 3.2.3). 
As expected, most of the genes that are up-regulated in differentiated cells, such as 
CD44, Klf6, Mef2a, Tnnc1, Lgals1 and Rpl13 which are majorly linked to regulation of cell 
proliferation. 
 
Figure 3.2.3. Genes with the highest averaged expression in all tissue in Rosetta 1 data set. 
 
On the other hand, the down-regulated genes were essentially genes that are usually 
highly expressed in undifferentiated cells such as ESRRB, DNMT3L and FGF4. 
 
 
Figure 3.2.4. Genes with the highest averaged expression in all tissue in Rosetta 1 data set. 
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After identification of genes up- and down-regulated, I clustered and analysed them. 
Remarkably, this cluster showed that the transcription factors responsible for the 
undifferentiated cell state are clustering all together (Pou5f1, also known as OCT4), Nanog, 
Jarid2), indicating that these genes remain co-regulated in differentiated tissue. A striking 
observation here is that the gene expression of this set of genes appears to correlate with 
known regenerative capacity of tissues. For instance, liver which is known to have high 
regenerative capacity shows a prominent up-regulation of these genes, whereas heart, 
which is known to have limited regenerative capacities, displays low expression of this gene 
set. This observation strongly suggests that it is possible to define a gene signature for the 
regenerative capacity of tissues. Further analyses need to be performed to clarify this 
remarkable finding. 
 
Figure 3.2.5. Group of genes that are clustering together in Rosetta 1. 
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3.3. GENETIC EXPRESSION BETWEEN CARDIAC FIBROBLAST AND INDUCED 
CARDIOMYOCYTES AND DIFFERENTIATION INTO CARDIOMYOCYTES 
In this sub chapter, we compare the expression pattern of different experiments in 
which cardiomyocytes were generated in vitro:  
• Gene expression in mouse neonatal cardiomyocytes, cardiac fibroblasts, cardiac 
fibroblast that failed reprogramming into iCMs (GFP- cells), and reprogrammed 
iCMs (GFP+) [4]; 
• Heart repair by reprogramming non-myocytes with cardiac transcription factors 
[5]; 
• Time-course expression of human iPSc differentiation toward cardiomyocytes 
[3]. 
The analysis focuses on genes coding for proteins of known importance for heart 
morphogenesis and development as well as their interacting partners, such as transcription 
factors that are believed to be related to heart cell fate, namely Gata4, Mef2c, Tbx5, Hand2, 
Isl1 and Nkx2-5 [3-5]. These three studies give diversified options for the reprogramming of 
iCM, such as utilization of three or four reprogramming transcription factors or the direct 
differentiation of hiPSc towards cardiac cell fate. Moreover, with these three studies it is 
possible to cover more genes for study of the differentiation and/or transdifferentiation into 
cardiomyocytes. 
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3.3.1. REPROGRAMMING MOUSE FIBROBLAST INTO FUNCTIONAL CARDIOMYOCITES 
BY DEFINED FACTORS 
Reprogramming of fibroblast cells to iPSc shows the possibility that a somatic cell can be 
reprogrammed to an alternative differentiated fate without first becoming a pluripotent 
stem cells or a progenitor cells [4]. So Ieda’s group (2010) reported that the combination of 
three transcription factors essential for heart developmental (i.e. Gata4, Mef2c and Tbx5) 
could rapidly and efficiently reprogram cardiac fibroblast directly into functional 
differentiated cardiomyocyte-like cells, so called induced Cardiac Myocytes (iCM) [4]. iCM 
expressed cardiac-specific markers and had a global gene expression profile similar to 
cardiomyocytes and contracted spontaneously. 
 
Figure 3.3.1.1. Cluster dendrogram for the data set published by Ieda et al. 2010. 2WRFCF (2 
Weeks Reprogramming Fibroblast Cells Failed); 2WRFCF (4 Weeks Reprogramming Fibroblast 
Cells Failed); NNCF (Neonatal Cardiac Fibroblasts); 2WiCM (2 Weeks Induced 
Cardiomyocytes); 4WiCM (4 Weeks Induced Cardiomyocytes); NNC (Neonatal 
Cardiomyocytes). 
 
For the analysis of this data set, I first generated a cluster dendrogram to examine if the 
different cell types and replicates were clustering together. Otherwise if they do not cluster 
together correctly, these measurements could be compromised by artefacts. Assessment of 
the dendrogram, however, shows that is not the case. Moreover, we can observe that 
replicates are clustering together and the 2 main branches are divided in cardiomyocytes 
and cardiac fibroblast. I will present some of the analysis of the most relevant genes in each 
category, these genes being cardiac differentiation, cardiomyocytes, and cardiac fibroblast 
markers. 
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CARDIAC TRANSDIFFERENTIATON MARKERS 
Gata4, Mef2c, and Tbx5 were the factors used to induce cardiac fibroblast to 
cardiomyocyte transdifferentiation. These gene are highly expressed during the 
transdifferentiation process, and show a higher expression in induced cardiomyocytes 
(2WiCM and 4WiCM) than in neonatal cardiomyocytes (NNC) (figure 3.3.1.2; figure 3.3.1.3; 
figure 3.3.1.4). As explain previously in this work, these transcription factors are known to be 
important genes in the transdifferentiation into cardiac cells [4, 5, 15, 52, 53]. 
 
Figure 3.3.1.2. Expression of myocyte enhance factor 2C in several cells types on Ieda et al., 
2010 data set. 
 
 
Figure 3.3.1.3. Expression of GATA binding protein 4 in several cells types on Ieda et al., 2010 
data set. 
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Figure 3.3.1.4. Expression of T-box 5 in several cells types on Ieda et al., 2010 data set. 
 
 
Isl1 and Nkx2-5, which are key factors involved in heart development and are marker 
genes for cardiac progenitor cells showed an unexpected expression. The expression of 
Nkx2-5 in iCMs is lower than in in NNC, and Isl1 shows a very odd expression (Supplementary 
figure 1-2, Annex II). Nkx2.5 is express in different cardiac subtypes (such as ventricular 
cardiomyocytes, atrial cardiomyocytes and other cells...), whereas the iCMs were shown to 
behave like ventricular cardiomyocytes [4]. The number of Isl1-expressing cells in neonatal 
hearts decrease rapidly and do not mark mature cardiomyocytes, which confirms that iCM 
are fully mature cardiomyocytes and the transdifferentiation process of cardiac fibroblast do 
not go via an intermediate progenitor cell type. 
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MATURE CARDIAC MARKERS 
In the following barplots, I present some of the most important cardiac markers for 
mature cardiomyocytes. As expected, they are expressed in neonatal cardiac cells but were 
not detected in cardiac fibroblasts (figures 3.3.1.5, 3.3.1.6, 3.3.1.7 and 3.3.1.8). However, 
these markers are also expressed in iCM at week 2 and 4, showing that these cells are 
getting transdifferentiated correctly into functional cardiomyocytes. To confirm if the cardiac 
fibroblasts transdifferentiated correctly into induced cardiomyocytes I also assessed the 
expression profiles of standard cardiac markers, such as, Myh7 (figure 3.3.1.5.), Fgf1 (figure 
3.3.1.6.) and Tnnt2 (figure 3.3.1.7). We can observe a comparable expression in the neonatal 
cardiac cells and the induced cardiomyocytes which was similar expression to the neonatal 
cardiomyocytes. 
 
Figure 3.3.1.5. Expression of myosin, heavy chain 7, cardiac muscle, beta in several cells 
types on Ieda et al., 2010 data set. 
 
 
Figure 3.3.1.6. Expression of Fibroblast growth factor 1 in several cells types on Ieda et al., 
2010 data set. 
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Figure 3.3.1.7. Expression of troponin T type 2 (cardiac) in several cells types on Ieda et al., 
2010 data set. 
 
The expression of Actc1, which is involved in cell motility, heart development and 
morphogenesis and cell differentiation, was consistent in reprogrammed iCMs and neonatal 
cardiomyocytes (figure 3.3.1.8). 
 
 
Figure 3.3.1.8. Expression of actin, alpha, cardiac muscle 1 in several cells types on Ieda et 
al., 2010 data set. 
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CARDIAC FIBROBLASTS MARKERS 
Interestingly, we observed that genes related to cardiac fibroblast, such as, Fgfr1 (figure 
3.3.1.9.), Ddr2 (figure 3.3.1.10.) and Fgf2 (figure 3.3.1.11) are expressed in early 
transdifferentiated induced cardiomyocytes and in neonatal cardiac fibroblast. This could 
mean that they can be somewhat important in the cell development or establishment of 
these cells into cardiac muscle, or it could mean that the characteristics of the cardiac 
fibroblast - or at least the normal expression of the genes linked to cardiac fibroblast - start 
to fade away. 
 
Figure 3.3.1.9. Expression of fibroblast growth factor receptor 1 in several cells types on Ieda 
et al., 2010 data set. 
 
 
Figure 3.3.1.10. Expression of discoidin domain receptor tyrosine kinase 2 in several cells 
types on Ieda et al, 2010 data set. 
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Figure 3.3.1.11. Expression of fibroblast growth factor 2 in several cells types on Ieda et al., 
2010 data set.  
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3.3.2. REPROGRAMMING NON-MYOCYTES WITH CARDIAC TRANSCRIPTION FACTORS 
As cardiac fibroblasts account for the majority of cells present in the heart and potential 
cellular source for restoration of cardiac function, Song’s research team (2012) used four 
transcription factors, Gata4, Hand2, Mef2c and Tbx5, showing that these genes can 
cooperatively reprogram cardiac fibroblast into beating cardiac-like myocytes in vitro [5]. 
Song (2012) also showed that forced expression of these factors in dividing non-
cardiomyocytes in vivo reprograms these cells into functional cardiac-like myocytes and 
reduces adverse heart remodelling after cardiac infarction [5]. 
I performed a cluster dendrogram analysis of the genes expressed in adult 
cardiomyocytes, in adult cardiac fibroblasts (ACF) and reprogrammed cardiomyocytes from 
the data previously obtained [5]. After the analysis of the data, we observed that the 
expression pattern of ACF transduced with the reprogramming factors differ from those of 
control ACF, presenting a differential expression of several and important heart 
development linked genes, that will be described below. 
 
Figure 3.3.2.1. Cluster dendrogram for the Song et al., 2012 data set. AH (Adult Heart); ACF 
(Adult Cardiac Fibroblast); ACF-GHMT2 (2 weeks Adult Cardiac Fibroblast reprogrammed 
with GHMT transcription factor); ACF-GHMT4 (4 weeks Adult Cardiac Fibroblast 
reprogrammed with GHMT transcription factors); ACF-Empty2 (2 weeks Adult Cardiac 
Fibroblast reprogrammed with empty vector); ACF-Empty4 (4 weeks Adult Cardiac Fibroblast 
reprogrammed with empty vector). 
 
Exogenous Gata4, Hand2, Mef2c and Tbx5 transcription factors (GHMT) were used in 
vivo in an injured myocardium to reprogram heart resident cardiac fibroblasts and led to an 
improvement in the function and structure of an infracted myocardium. [5]. The apparent 
efficiency of reprogramming was greater in vivo than in vitro perhaps due to environment 
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surrounding the heart, like extracellular matrix, growth factors, surrounding contractile cells 
and other cell types, being more permissive than artificial tissue culture [5]. 
 
CARDIAC TRANSDIFFERENTIATON MARKERS 
In this section, I present the expression of the in vivo reprogramming transcription 
factors used for the transdifferentiation of cardiac fibroblast into induced cardiomyocytes-
like cells. With the exception of Mef2c, the expression of GHMT factors is not considerably 
higher than their expression in control ACF and ACF transduced with empty vectors after 2 
or 4 weeks (ACF-Empty2 and 4). As expected, the transdifferentiated cardiomyocytes 
derived from cardiac fibroblast displayed a similar, although smaller, gene expression to 
normal adult heart cardiomyocytes (figure 3.3.2.2. – 3.3.2.5.). 
 
Figure 3.3.2.2. Expression of GATA binding protein 4 on Song et al., 2012 data set. 
 
Figure 3.3.2.3. Expression of heart and neural crest derivatives expressed transcript 2 on 
Song et al., 2012 data set. 
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Figure 3.3.2.4. Expression of myocyte enhance factor 2C on Song et al., 2012 data set. 
 
 
Figure 3.3.2.5. Expression of T-box 5 on Song et al., 2012 data set. 
 
Observing these results it is possible to infer that this transcription factors can be 
important to heart development and morphogenesis, but even so it will be required in-depth 
analysis of this data set to get a better conclusion. In line with the results obtained with the 
previous study (Ieda et al. 2010), Isl1 expression is not consistent indicating that this factor 
might not be crucial for the transdifferentiation process (Supplementary figure 1, Annex III). 
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MATURE CARDIAC MARKERS 
The results obtained indicate that mature cardiac markers are differentially expressed in 
reprogrammed cells when compared to the adult cardiac cells (figure 3.3.2.6 and 3.3.2.7.). 
Thus, the forced expression of transcription factors Gata4, Hand2, Mef2c and Tbx5 in non-
myocytes present in the heart are insufficient to induce the expression of these cardiac 
markers to endogenous levels. 
 
Figure 3.3.2.6. Expression of myosin heavy chain beta on Song et al., 2012 data set. 
 
 
Figure 3.3.2.7. Expression of troponin T type 1 on Song et al., 2012 data set. 
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Figure 3.3.2.8. Expression of actin, alpha cardiac muscle 1 on Song et al., 2012 data set. 
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CARDIAC FIBROBLAST MARKERS 
The obtained results are not that obvious as demonstrated in the previous study [5], 
since the expression patterns of the fibroblast markers are still very high (figure 3.3.2.9 and 
3.3.2.10.). This pattern could demonstrate that the cells did not have time to completely 
transdifferentiate, since they still show fibroblast marker genes. But their studies revealed 
that the injection of the transcription factors on the heart improve reprogramming of 
cardiac fibroblast to iCM in vivo, that could be due to the native milieu existing in the heart, 
leading to a better reprogramming [5]. Since the results analysed come from an in vitro 
experiment, it is not possible to see clearly the down regulation of the cardiac fibroblast 
markers. 
 
Figure 3.3.2.9. Expression of fibroblast growth factor receptor 1 on Song et al., 2012 data 
set. 
 
Figure 3.3.2.10. Expression of discoidin domain receptor family, member 1, on Song et al., 
2012 data set.  
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3.3.3. HIPSC DIFFERENTIATION TOWARD CARDIOMYOCYTES 
The difference between this Uosaki (2011) data set [3] and the general genetic 
expression in mouse embryonic stem cells of Gaspar (2012) publication [21] is that the day 0 
starts with the beginning of cardiac differentiation, while in Gaspar [21] day 0 corresponds to 
undifferentiated mouse stem cells that started to differentiate. Uosaki (2011) and colleagues 
obtained cardiac myocytes through differentiated human iPSc towards cardiomyocytes 
applying sequential administration of activin, bone morphogenetic protein 4 (BMP4), 
fibroblast growth factor 4 (FGF4) and Dickkopf 1 homolog (DKK1). Through the cluster 
dendrogram it is possible to see that the days of cardiac differentiation are clustering as 
expected, meaning that genetic expression in those days are very similar. So with these 
results, we can at least see that the expressions for the replicates are matching together, 
indicating that the expression values obtained are reproducible. For a further analysis it was 
necessary to check gene expression for each day, to see if specific genes were expression at 
the expected times according to other studies [13, 21, 44]. 
 
Figure 3.3.3.1. Cluster dendrogram for the Uosaki et al., 2012 data set. Cardiac diff0 
(Differentiation into cardiomyocytes – Day 0); Cardiac diff2 (Differentiation into 
cardiomyocytes – Day 2); Cardiac diff5 (Differentiation into cardiomyocytes – Day 5); Cardiac 
diff7 (Differentiation into cardiomyocytes – Day 7); Cardiac diff9 (Differentiation into 
cardiomyocytes – Day 9); Cardiac diff11 (Differentiation into cardiomyocytes – Day11). 
 
With the “topTables” obtained through “limma”, that is an R package, it was possible to 
see which genes were more expressed in each day. To verify which genes were up-regulated 
each day, they were sorted by “logFC” and it was chosen the ones with a positive fold 
change.  
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After filtering the obtained genes, It was performed a biological functional analysis 
through Babelomics (http://babelomics.bioinfo.cipf.es), using FatiGO. It was obtained 1 table 
for each day and sorted then by “p-value”, choosing the top scores and most relevant 
functions. 
 
Table 3.3.3.1. Temporal alignment (in days) between some key marker genes present in 
Mouse and Human. (General Genetic Expression In Mouse Embryonic Stem Cells [21] and 
hiPSc Differentiation Toward Cardiomyocytes [3]). 
Data sets Org. 
Nanog, 
Lefty1, 
Pou5f1 
T, Eomes, 
Sox17 
Snai2, 
Meis1 
Lum 
Hand2, 
Zfpm2, 
Myh6 
Myl4 
General Genetic Expression 
In Mouse Embryonic Stem 
Cells 
Mouse 0, 1 & 2 3, 4 6,7 10 10 10 
hiPSc Differentiation 
Toward Cardiomyocytes 
Human 0 2 5 7 9 11 
 
I also compare the peak times for gene expression observed for the differentiation of 
mouse ESc with those observed for hiPSc. According to these findings (table 3.3.3.1.), 
comparing these two data sets, the peak expression for these marker genes occur in 
different days. Moreover, it seems that the expression peaks in human come earlier, which 
could be result of the use of additional factors for differentiation. For an early stage it was 
used the pluripotency markers Nanog, Lefty1 and Pou5f1; for an intermediate stage it was 
used cell fate/commitment markers like T-brachyury, Eomes and Sox17; and for a late stage 
it was used general cardiac markers like Meis1, Hand2 and Myh6. Unfortunately, Gaspar 
(2012) dataset do not have a measurement for all days, and only has for some days. This was 
the best comparison I was able to perform. Even so, it is possible to observe that the 
expression of these specific gene markers start first in human stem cells and in mouse start 
more or less a day later. 
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DAY 0 
At day 0 of differentiation towards cardiac cells, it is possible to see the main 
transcription factors for maintenance of the pluripotent stem cells (figure 3.3.3.2.; figure 
3.3.3.3; figure 3.3.3.4) are strongly up-regulated. This roughly corresponds to the period of 
day 0 to day 2 of Gaspar dataset [21], as rapidly in the next time points, their expression 
decreased quickly. 
 
Figure 3.3.3.2. Expression of Nanog homeobox on Uosaki et al., 2011 data set. 
 
Figure 3.3.3.3. Expression of Pou domain, class 5, transcription factor 1 on Uosaki et al., 2011 
data set. 
 
 
Figure 3.3.3.4. Expression of SRY-box containing gene 2 on Uosaki et al., 2011 data set. 
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We also observed at day 0 that high expression of transcription factors are not only 
involved in the pluripotency state of ESCs but are also involved in heart development in 
particular (Table 3.3.3.2). This observation is in agreement with observations by other 
groups and strengthen the idea that human ESC although they are pluripotent and 
undifferentiated, they are primed, in other words are ready, to undergo differentiation 
processes by expressing messengers of master regulators of cell fate decisions. 
 
Table 3.3.3.2. Biological functional analysis in Day 0 on Uosaki et al., 2011 data set. 
GO Description Input genes Positives %Perc Adj p-value 
GO:0007507 heart development 342 30 8.77 6.73E-18 
GO:0009790 embryo development 342 46 13.45 9.13E-18 
GO:0048738 
cardiac muscle tissue 
development 
342 18 5.26 3.54E-16 
GO:0007517 muscle organ development 342 30 8.77 3.90E-15 
GO:0048646 
anatomical structure formation 
involved in morphogenesis 
342 33 9.65 7.47E-15 
GO:0009888 tissue development 342 46 13.45 2.06E-14 
GO:0009887 organ morphogenesis 342 46 13.45 2.06E-14 
GO:0006936 muscle contraction 342 25 7.31 2.08E-14 
GO:0007399 nervous system development 342 55 16.08 1.30E-13 
GO:0003007 heart morphogenesis 342 16 4.68 5.30E-13 
GO:0048468 cell development 342 47 13.74 1.93E-12 
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DAY 2 
The transient expression T Brachyury, Eomes, is maximal at this time point and quickly 
fades away in the next time points. These results are comparable to the observations made 
with mouse ESC in Gaspar’s study (sub-chapter 3.1, Day3). 
T Brachyury (figure 3.3.3.5) is known as a canonical marker for early mesoderm [21, 44]. 
Lhx1 is expressed in early mesodermal tissue and later in organ development. Comparing to 
the mouse data set [21] it is possible to see that the peak expression of T brachyury occurs in 
day 2, contrarily to what is observed in Gaspar (2012) dataset [44]. Although the figure 
3.3.3.5. presents a high expression oscillation for T brachyury. 
 
Figure 3.3.3.5. Expression of T Brachyury on Uosaki et al., 2011 data set. 
 
Eomes (figure 3.3.3.6), participating also mesoderm formation, and also controlling 
gastrulation and trophoblast differentiation in mammals [45], appears to be highly 
expressed at day2. 
 
Figure 3.3.3.6. Expression of eomesodermin homolog on Uosaki et al., 2011 data set. 
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Once again, since the differentiation process of these cells were directed to towards a 
specific cell fate, in this case cardiac cell fate, they demonstrate a strong biological function 
linked to heart development and morphogenesis. Additionally, the cardiac differentiation 
program is also one of the first programs to be initiated in ESc differentiation. 
 
Table 3.3.3.3. Biological functional analysis in Day 2 on Uosaki et al., 2011 data set. 
GO Description Input genes Positives %Perc Adj p-value 
GO:0006936 muscle contraction 154 20 12.99 1.13E-14 
GO:0048738 
cardiac muscle tissue 
development 
154 14 9.09 1.13E-14 
GO:0007507 heart development 154 20 12.99 3.92E-14 
GO:0009887 organ morphogenesis 154 32 20.78 6.30E-14 
GO:0009888 tissue development 154 32 20.78 7.18E-14 
GO:0008015 blood circulation 154 19 12.34 1.19E-12 
GO:0007517 muscle organ development 154 19 12.34 2.92E-11 
GO:0035051 cardiac cell differentiation 154 9 5.84 2.92E-11 
GO:0048729 tissue morphogenesis 154 16 10.39 4.23E-11 
GO:0009790 embryo development 154 24 15.58 5.19E-10 
GO:0051146 striated muscle cell differentiation 154 9 5.84 5.63E-09 
GO:0003007 heart morphogenesis 154 10 6.49 1.46E-08 
GO:0060047 heart contraction 154 10 6.49 1.69E-07 
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DAY 5 
Figures 3.3.3.7 and 3.3.3.8 present the expression of Isl1 and Hand1, we can observe a 
large expression of these genes at day 5 into cardiac differentiation, indicating that they are 
important in the early stage of heart development and morphogenesis [46, 47]. Indeed, 
mutations of these genes can lead to several heart disease conditions [47, 56]. These to 
transcription factors are essential to begin the differentiation of hESc towards a cardiac fate. 
 
 
Figure 3.3.3.7. Expression of ISL LIM homeobox 1 on Uosaki et al., 2011 data set. 
 
 
Figure 3.3.3.8. Expression of heart and neural crest derivatives expressed transcript 1 on 
Uosaki et al., 2011 data set. 
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Processes related to heart development are quite highly active (table 3.3.3.4) indicating 
that the cells are specifically going along the desired cardiac differentiation path. 
 
Table 3.3.3.4. Biological functional analysis in Day 5 on Uosaki et al., 2011 data set. 
GO Description Input genes Positives %Perc Adj p-value 
GO:0006936 muscle contraction 231 22 9.52 1.16E-13 
GO:0048738 
cardiac muscle tissue 
development 
231 14 6.06 3.94E-12 
GO:0007517 muscle organ development 231 23 9.96 5.53E-12 
GO:0007507 heart development 231 20 8.66 4.45E-11 
GO:0008015 blood circulation 231 19 8.23 1.84E-09 
GO:0060047 heart contraction 231 13 5.63 5.93E-09 
GO:0008016 regulation of heart contraction 231 12 5.19 1.11E-08 
GO:0003007 heart morphogenesis 231 11 4.76 3.67E-08 
GO:0009887 organ morphogenesis 231 30 12.99 3.67E-08 
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DAY 7 
Gata4 expression increases from day 2 and peaks at day 7 of cardiac differentiation, and 
could mean this gene could be an important transcription factor that could influence the 
expression of other genes like, Nkx2-5, Mef2c and Tbx5 [53, 57]. 
 
Figure 3.3.3.9. Expression of GATA binding protein 4 on Uosaki et al., 2011 data set. 
 
Gata4 actively participates in heart morphogenesis and development, tissue 
development, embryo development and vasculature development. In day 7 it is possible to 
observe that some processes related to anatomical structure morphogenesis start to come 
up, but still it is strongly expressed genes related to heart development. 
 
Table 3.3.3.5. Biological functional analysis in Day 7 on Hideki et al., data set. 
GO Description Input genes Positives %Perc Adj p-value 
GO:0009887 organ morphogenesis 373 46 12.33 2.74E-11 
GO:0007507 heart development 373 25 6.7 2.74E-11 
GO:0048646 
anatomical structure formation 
involved in morphogenesis 
373 31 8.31 4.96E-11 
GO:0048468 cell development 373 48 12.87 8.19E-11 
GO:0006928 cellular component movement 373 40 10.72 1.32E-10 
GO:0009888 tissue development 373 44 11.8 1.32E-10 
GO:0009790 embryo development 373 38 10.19 1.40E-10 
GO:0007155 cell adhesion 373 48 12.87 2.28E-10 
GO:0007517 muscle organ development 373 25 6.7 9.56E-10 
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DAY 9 
Nkx2-5 (figure 3.3.3.10.), Mef2c (figure 3.3.3.11.) and Tbx5 (3.3.3.12.) exhibit similar 
expression patterns across all time points, suggesting that they could be interacting with 
each other, generating a positive feedback for their expression such as they do during 
embryonic development [53, 57]. They have an ambiguous expression in day 7, but in day 9 
they are highly expressed. They essentially participate in muscle organ development, cardiac 
muscle tissue development, heart development, heart morphogenesis and organ 
morphogenesis. Nkx2-5 particularly also participates in heart contraction, regulation of heart 
contraction and striated heart contraction. 
 
Figure 3.3.3.10. Expression of Nkx2 homeobox 5 on Uosaki et al., 2011 data set. 
 
 
Figure 3.3.3.11. Expression of myocyte enhancer factor 2C on Uosaki et al., 2011 data set. 
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Figure 3.3.3.12. Expression of T-box 5 on Uosaki et al., 2011 data set. 
 
In comparison to day 7 (table 3.3.3.5), in day 9 all processes linked to embryo 
development and anatomical structure cease to function. This means that day 7 
measurements are slightly altered due to some measurement error, since we can see an 
ambiguous expression in day 7 in these 3 genes, possibly associated with the embryo 
development and anatomical structure ranking high in table 3.3.3.5. 
 
Table 3.3.3.6. Biological functional analysis in Day 9 on Hideki et al., data set. 
GO Description Input genes Positives %Perc Adj p-value 
GO:0006936 muscle contraction 273 34 12.45 6.74E-26 
GO:0007517 muscle organ development 273 36 13.19 5.64E-23 
GO:0048738 
cardiac muscle tissue 
development 
273 21 7.69 5.36E-22 
GO:0007507 heart development 273 31 11.36 3.26E-21 
GO:0008015 blood circulation 273 31 11.36 2.70E-20 
GO:0009888 tissue development 273 45 16.48 4.71E-16 
GO:0060047 heart contraction 273 18 6.59 3.41E-14 
GO:0003007 heart morphogenesis 273 16 5.86 1.31E-13 
GO:0008016 regulation of heart contraction 273 16 5.86 4.23E-13 
GO:0006941 striated muscle contraction 273 14 5.13 1.58E-11 
GO:0009887 organ morphogenesis 273 38 13.92 2.04E-11 
GO:0051146 
striated muscle cell 
differentiation 
273 12 4.4 6.13E-11 
GO:0035051 cardiac cell differentiation 273 10 3.66 7.72E-11 
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DAY 11 
Myh7 (figure 3.3.3.13), Actc1 (figure 3.3.3.14) and Tnnt2 (figure 3.3.3.15) are involved in 
basically every biological process related to heart morphology and development, 
participating in all processes that are showed in the table 3.3.3.7. These are well known 
markers for mature cardiac, indicating that the heart development and morphogenesis is 
coming to an end. 
These biomarkers are very important, because they help us understand in the cells that 
we are looking for, in this case cardiac cells, differentiated [3, 51] or transdifferentiated [4, 
52, 53] correctly and if presents a similar expression compared to normal cardiac cells [4, 5]. 
 
Figure 3.3.3.13. Expression of myosin, heavy chain 7, cardiac muscle, beta on Uosaki et al., 
2011 data set. 
 
 
Figure 3.3.3.14. Expression of actin, alpha, cardiac muscle 1 on Uosaki et al., 2011 data set. 
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Figure 3.3.3.15. Expression of troponin T type 2 (cardiac) on Uosaki et al., 2011 data set. 
 
The expression of mature cardiomyocyte genes represents the end of heart 
morphogenesis. In the next days would be expected to see a less important biological 
function in heart development and morphogenesis. Moreover, it is possible to compare with 
table 3.1.9, but since these cells were directed to only go forward a heart cell fate, they will 
not express any other type of biological functions. 
 
Table 3.3.3.7. Biological functional analysis in Day 11 on Uosaki et al., 2011 data set. 
GO Description Input genes Positives %Perc Adj p-value 
GO:0006936 muscle contraction 177 29 16.38 4.06E-25 
GO:0007517 muscle organ development 177 30 16.95 4.28E-22 
GO:0007507 heart development 177 25 14.12 4.74E-19 
GO:0048738 
cardiac muscle tissue 
development 
177 17 9.6 4.74E-19 
GO:0008015 blood circulation 177 23 12.99 4.90E-16 
GO:0009888 tissue development 177 35 19.77 1.12E-14 
GO:0060047 heart contraction 177 15 8.47 2.94E-13 
GO:0006941 striated muscle contraction 177 13 7.34 1.40E-12 
GO:0003007 heart morphogenesis 177 13 7.34 4.60E-12 
GO:0008016 regulation of heart contraction 177 13 7.34 9.74E-12 
GO:0009887 organ morphogenesis 177 29 16.38 3.67E-10 
GO:0042692 muscle cell differentiation 177 12 6.78 8.43E-09 
GO:0051146 
striated muscle cell 
differentiation 
177 9 5.08 1.67E-08 
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3.4. COMPARISON OF BIOLOGICAL PROCESS, MOLECULAR FUNCTIONS AND KEGG 
PATHWAYS BETWEEN CARDIAC DATA SETS AND MOUSE ESC 
For this analysis, we used Gaspar (2012) [21], Song (2012) [5], Ieda (2010) [4] and Hideki 
(2011) [3] data sets (table 3.4.1.). The Gaspar (2012) [21] dataset was used as control to 
determine which processes are only present in cardiac differentiation (Gaspar et al., 2012 VS 
all other data sets) and cell transdifferentiation into induced cardiomyocytes-like cell 
(Gaspar et al., 2012 VS Hideki et al., 2011) and which are present in all data sets except for 
the Gaspar et al., 2012 dataset. 
This approach was used to verify which processes/functions/pathways are exclusive to 
the heart development and morphology with transdifferentiated cells and confirm if the 
filtered genes are responsible for obtaining these processes/functions/pathways. 
 
Table 3.4.1. Data sets used for the comparison of the multiple processes 
Organism Authors Description 
Mus musculus Song et al.,2012 
Heart repair by reprogramming non-myocytes with 
cardiac transcription factors 
Mus musculus Ieda et al., 2012 
Direct reprogramming of fibroblast into functional 
cardiomyocytes by defined factors 
Homo sapiens Hideki et al., 2011 
Time course expression of hiPSc differentiation 
towards induced cardiomyocytes-like cells 
Mus musculus Gaspar et al., 2012 Mouse embryonic stem cell differentiation 
 
3.4.1. BIOLOGICAL PROCESS 
Through this heat map it is possible to inspect which biological processes are similar 
between reprogrammed fibroblasts and hiPSc differentiation toward cardiomyocytes and 
which biological processes are similar between direct reprogramming of fibroblast. 
Furthermore, there are many processes that are present in transdifferentiating cells and 
cells differentiating towards cardiomyocytes cell fate, such as, heart contraction, striate 
muscle contraction, muscle organ development, heart morphogenesis, and cardiac cell 
differentiation (figure 3.4.1.1). 
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One of the main points is the biological processes that are only common to 
transdifferentiation of cardiac fibroblast into induced cardiomyocytes-like cells, such as, 
heart morphogenesis and development and cardiac muscle contraction, which all could be 
linked to the transdifferentiation process. Using Gaspar et al., 2012 data set, it is possible to 
reject the most common and normal biological processes and make sure that we are only 
getting the most important biological processes. 
Regarding this results, it is possible to infer that there are even few processes common 
between iCM and differentiation of hiPSc into cardiac cells (only heart morphogenesis). 
 
Figure 3.4.1.1. Heat map for biological processes. S – Song et al., 2012; I – Ieda et al., 2012; H 
– Hideki et al., 2011; A – Gaspar et al., 2012.  
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3.4.2. MOLECULAR FUNCTIONS 
The heat map shown in figure 3.4.2.1. represents some selected molecular functions 
present in the different data sets. Another heat map was obtained (Supplementary figure 1, 
Annex IV), with a more comprehensive set of molecular functions. 
One of the striking things is that it is possible to notice in these molecular functions is 
that transdifferentiated cells and the normal cells present the same molecular functions, 
looking like the normal cells. This can suggest that after the transdifferentiation, the cells 
present a normal molecular function, when compared to the normal cells. 
All the molecular binding functions are not exclusive of the transdifferentiated cells, but 
common processes between transdifferentiated cells are troponin I binding, calcium ion 
biding, actin filament biding, actin binding, cytoskeletal protein biding, excluding structural 
molecule activity. 
Nevertheless, there are few processes that are not the same between 
transdifferentiated cells, such as, enzyme inhibitor activity, protein homodimerization, 
protein dimerization and igG binding (Supplementary figure 1, Annex IV). 
 
Figure 3.4.2.1. Heat map for molecular function. S – Song et al., 2012; I – Ieda et al., 2012; H 
– Hideki et al., 2011; A – Gaspar et al., 2012.  
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3.4.3. KEGG PATHWAYS 
This heat map (figure 3.4.3.1.) represents some of the main KEGG pathways present in 
the different data sets. In contrast of what it was observed in the biological process, it is 
possible to see that some of the KEGG pathways ”up regulated” in the transdifferentiated 
cell are also present in the cardiac fibroblast, such pathways as, focal adhesion, has this 
could still be a side effect of the transformation of the cardiac fibroblast into iCM. 
 
Figure 3.4.3.1. Heat map for KEGG pathways. S – Song et al., 2012; I – Ieda et al., 2012; H – 
Hideki et al., 2011; A – Gaspar et al., 2012. 
 
 
There are other KEGG pathways that it was not possible to understand why they were 
coming up, such as, malaria, amoebiasis and leishmaniasis. It is interesting to see that in one 
experiment (4WiCM), p53 signalling pathway is shut down and that allows the cells to 
maintain alive even after the transdifferentiation. All normal cells (NNC, AH) and 
transdifferentiated cells (ACFGHMT, 2WiCM, 4WiCM) show the normal KEGG pathways for 
cardiac “fate”. PPAR signalling is involved in several processes, such as, regulation expression 
in liver and skeletal muscle or cell proliferation.   
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3.5. COMPARISON OF INDIVIDUAL GENE PROFILES BETWEEN CARDIAC DATA 
SETS AND MOUSE ESC 
It was done a comparative differential gene expression analysis for the 4 data set that 
were used so far for the study of heart development and morphogenesis. They include: 
differentiation of mouse embryonic stem cells [21]; hiPSc differentiation towards 
cardiomyocytes [3]; Reprogramming non-cardiomyocytes with cardiac transcription factors 
[5]; Reprogramming mouse fibroblast into functional cardiomyocytes by defined factors 
[4](table 3.5.1). 
 
Table 3.5.1. Gene lists used for comparative analysis regarding heart gene expression in 
early, intermediate and late stage. 
Description Abbreviation 
Gaspar et al., 2012 mESCDiff / G 
Uosaki et al., 2011 iPS into iCM / H 
Song et al., 2012 CF into iCM / S 
Ieda et al., 2010 Rep into iCM / I 
 
This created a broad basis, which is essential to distinguish between genes that show 
conserved expression patterns across conditions and genes whose expression changes are 
specific to certain conditions. This type of study can be of great help to identify some new 
genes that possibly have not been yet associated to heart development and transformation 
of cells towards a cardiac cell fate, providing new possible pointers to a future experimental 
laboratorial analysis. 
In these next sub-chapters only the positively expressed genes in the different time 
stages were analysed, showing the most interesting result. Regarding the negatively 
expressed gene, none striking outcome was observe during the analysis, so it will be not 
included in the thesis.  
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3.5.1. POSITIVE EARLY GENE EXPRESSION 
For the comparison of genes positively regulated in the early phase of differentiation, it 
was only used the only two data sets that have time points (differentiation of mouse 
embryonic stem cells [21] and hiPSc differentiation towards cardiomyocytes [3]). The 
experimental conditions used in this comparison were mESc Differentiation assessed at Day0 
and Day1, and at Day0 for the iPS differentiation into iCM. It was only used one time point 
for the iPS into iCM, because the second time point is Day2 and that was not regarded to fall 
into the early gene expression, since T brachyury is already being expressed. 
 
Figure 3.5.1.1. Venn diagram with number of shared genes for the comparative analysis for 
heart expression. 
 
467 genes have a common positive expression in these two dataset. To narrow this list 
of genes down, I performed a functional analysis to determine whether any of those genes 
have already been linked to any type of biological function. Amongst these genes, 140 genes 
have described biological functions on GO annotations, the remaining 337 genes have no 
clear function. 
From the subgroup of gene with determined function, at least 59 genes participate in 
regulation of transcription, regulation of gene expression and DNA binding, in which 6 of 
those participate also in stem cell differentiation and stem cell maintenance (Nanog, Pou5f1, 
Sox2, Tet1, Rbpj and Sall4). 
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Table 3.5.1.1. Number of genes present in the overlap with determined biological functions 
in an early stage 
Biological Function Number of Genes 
Regulation of transcription 100 
Regulation of gene expression 111 
DNA binding 78 
Stem cell maintenance 11 
Stem cell differentiation 9 
 
Rbpj is a known gene which is linked to the notch signalling and more specifically in 
heart development. It is also linked to positive regulation of cell proliferation in heart 
development [58]. The knock out of this gene, triggers the aortic valve degenerative disease, 
suggesting that this gene mediates Notch signalling, being critically involved in heart 
homeostasis and disease [58]. 
Sall4 interacts with Tbx5 to regulate and modulate morphogenesis a patterning in heart 
[59]. These two genes interact in regulation of heart morphology. When Sall4 is not 
expressed correctly, this results in abnormal formation of the interventricular groove and 
disorganized myocardium [59]. 
The pattern of expression and biological functions for the most important genes in the 
early differential stage is presented (figure 3.6.1.1.A and figure 3.6.1.1.B). Notably, a large 
number of the genes included in figure 3.6.1.1.B have not been associated with stem cell 
differentiation and stem cell maintenance at least in Gene Ontology. These genes have 
similar expression, indicating that they are involved in the early differentiation process (early 
trigger for expression of genes related to heart development) and are involved in 
maintenance of pluripotency. Thus, the set of genes in figure 3.6.1.1.B provide numerous 
candidates for stem cell biology. The candidate list provide a rational basis for further 
experimental studies. 
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Figure 3.5.1.2. Biological function (on the right) and expression (on the left) for some of the 
obtained genes in the overlap for positive early gene expression. RT – Regulation of 
Transcription; RGE – Regulation of gene Expression; DNAB – DNA Binding; StemCD – Stem 
Cell Differentiation; StemCM – Stem Cell Maintenance. A – Well known genes linked to 
pluripotency; B – Other possible genes linked to maintenance of pluripotency or linked to 
premature heart gene expression.  
A 
B 
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3.5.2. POSITIVE INTERMEDIATE GENE EXPRESSION 
For this analysis, we used the same data set as the previous study, in which the only 
modification was in the experimental conditions. The experimental conditions used in this 
study for the mESC Diff was Day3 and Day4Gaspar (2012)data set [21] and for the iPSc into 
iCM was Day2 and Day5 Uosaki (2011) data set [3]. This time points were chosen based on 
the expression of T brachyury that peaks in the transition of stem cells into the different 
types of tissue and in this case is the transformation into mesoderm. 
 
Figure 3.5.2.1. Venn diagram with number of shared genes for the comparative analysis for 
heart expression. 
 
25 genes were obtained in the overlap between these two dataset. A functional analysis 
was performed to establish if any of those genes have already been linked to any type of 
biological function. There are 11 genes with described biological functions, according to GO 
annotations, in this overlap; the remaining 14 genes have not been described with any type 
of biological functions regarding these five biological functions (table 3.5.2.1.). From this 11 
genes that present described biological functions, 3 of them are associated with stem cell 
maintenance and differentiation, which are Eomes, Lin28a and Sall4. 
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Table 3.5.2.1. Number of genes present in the overlap with determined biological functions 
in an intermediate stage. 
Biological Function Number of Genes 
Regulation of transcription 8 
Regulation of gene expression 10 
DNA binding 9 
Stem cell maintenance 5 
Stem cell differentiation 3 
 
T brachyury is considered to be one of the best markers of early mesoderm and is 
greatly used for keep track in the development of this germ layer, because this gene is 
present in all mesoderm and down-regulated as these cells are submitted to patterning and 
specification into the derivate tissues, among them cardiac muscle [44]. This shows that 
brachyury expression is very brief and cells undergo differentiation do to his expression. 
Eomes role in cardiac development is unknown, but this gene is required for early 
mesoderm pattering and differentiation, some studies that Eomes is expressed in the 
developing heart, with a great presence in the myocardium [45, 60]. 
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Figure 3.5.2.2. Biological function (on the right) and expression (on the left) for the obtained 
genes in the overlap for positive intermediate gene expression. RT – Regulation of 
Transcription; RGE – Regulation of gene Expression; DNAB – DNA Binding; StemCD – Stem 
Cell Differentiation; StemCM – Stem Cell Maintenance. 
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Sox17 has established roles in endoderm formation and also participates in mesoderm 
patterning but not for mesoderm formation. It has an important role in cardiac specification 
[61]. Studies indicate that the controlled expression of Sox17 during early differentiation 
affects cardiovascular and more specifically cardiomyocytes differentiation through other 
gene [62]. 
In figure 3.5.2.2. is presented the biological functions and expressions for the 11 genes 
in intermediate stage. Some of the other represented genes could be linked to an 
intermediate stage of transition or activation of the genes linked to heart development and. 
Once again this could be proven through experimental procedures.  
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3.5.3. POSITIVE LATE GENE EXPRESSION 
For the positive late gene expression, all microarray studies were used, since all of them 
had time pointed included for the late phase of differentiation(table 4.5.3.1.). The 
experimental conditions included were for the mESC Diff Day6 and Day7, (Gaspar 2012) data 
set [21]; for iPSc into iCM Day7 and Day9, (Uosaki 2011) data set [3]; for CF into iCM the 
ACFGHMT Sample (Song 2012) data set [5]; Rep into iCM was 2WiCM and 4WiCM (Ieda 
2010) data set [4]. These time points were used, because they show significant expression in 
genes that are known to have high expression in heart development such as Gata4, Tbx5, 
Mef2c and Hand2 (figure 3.5.3.2.A) [56]. 
 
 
Figure 3.5.3.1. Venn diagram with number of shared genes for the comparative analysis for 
heart expression. 
 
There are 13 genes present in the overlap of all data sets and 661 genes are present at 
least in two overlapping data sets. To get a smaller number of genes, it was performed a 
functional analysis regarding their biological function resorting to GO annotations. So from 
the 674 only 147 had described biological functions (table 3.5.3.1.). From those 147 genes, 
42 presented regulation of transcription, regulation of gene expression and DNA binding 
functions. Also from those 147 genes, 3 have stem cell differentiation and stem cell 
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maintenance functions (Tbx3, Bmpr1a and Fzd7) and 3 have only a stem cell differentiation 
function (Sox5, Pdgfra and Megf10) from the biological processes. 
 
Table 3.5.3.1. Number of genes present in the overlap with determined biological functions 
in a late stage 
Biological Function Number of Genes 
Regulation of transcription 100 
Regulation of gene expression 111 
DNA binding 78 
Stem cell maintenance 11 
Stem cell differentiation 9 
 
This four well known genes (figure 3.5.3.2.A) have been extensively studied linked to 
heart development and cardiac cell fate [4, 5, 11, 12, 59, 63-65]. Since these genes are well 
known linked to heart, this analysis focus in the identification of possibly new players in 
heart development. 
From the 13 genes that are present in the overlap of all data sets (figure 3.5.3.2.B), only 
3 have been associated with selected biological functions: Ankrd1, Igfbp5 and Tgfb2, but 
only Ankrd1 is specifically linked to heart development. 
Ankrd1, also known as Carp, is an early transcription cofactor and early differentiation 
marker of cardiac myogenesis. It is suggested to have an important role in cardiac muscle 
function in physiological and pathological conditions [54] and to be involved in biomechanic 
sensing and regulates cardiac stress responses [55]. In pathological conditions, this gene is 
up-regulated in the adult heart at end-stage heart failure [54]. Torrado (2005) study 
suggested that in cardiac Purkinje cells the augmented level of Ankrd1 is due to the high 
Nkx2-5 gene expression [55]. 
For the remaining 130 genes, a few genes that could be linked to heart development 
(figure 3.5.3.2.C), but have not been widely studied linked to heart cell fate. Some of those 
genes will be focused next. 
Smyd1, also known as BOP, is capable of cardiomyocyte differentiation and chamber-
specific differentiation in human, and is expressed specifically in cardiac and skeletal muscle 
precursors and in cardiomyocytes throughout chick and mouse development, beginning 
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before cardiac differentiation and can also function as a transcriptional repressor [48] This 
gene is an essential downstream effector of Mef2c in heart development and is also part of a 
transcriptional cascade involved in development of the anterior heart field [66]. Another 
remarking observation is mouse embryos that lack Smyd1 gene, which encodes for a 
transcription repressor and putative histone methyltransferase, die from cardiac 
abnormalities similar to embryos that have mutations in genes like Isl1, Mef2c, and Hand2 
[48, 64, 66] 
Hand1 is expressed at a cardiac crescent stage and throughout cardiac development. It 
exhibits a sided expression pattern, where hand1 is expressed on the left ventricle and 
hand2 is expressed on the right ventricle [47].This transcription factor regulates cell cycle of 
cardiomyocytes balancing between cell proliferation and differentiation. It can also promote 
proliferation is sub-regions of the developing heart, while allowing adjacent myocardial 
precursors to differentiate. Down-regulation of this gene results in the hypertrophy of 
cardiomyocytes [47]. Nevertheless, it is still necessary to understand the molecular pathways 
involved in directing cardiomyocytes proliferation and differentiation regarding this gene 
and how to generate bigger numbers of functional cardiomyocytes [46]. Hand1 can induce 
proliferation of cardiomyocytes precursors during heart development, directing progenitor 
cells towards integrated myocardium [46]. 
Myocd is a strong co-activator cardiac transcription factor [53] and enhance the cardio-
induced effect of established genes related to heart development and cardiac cell fate [57]. 
This gene alone activates genes involved in several cardiac related processes and inhibits 
genes involved in non-cardiac processes [53]. The combination of this gene with Tbx5 and 
Gata4 contributed differently to cardiac gene activation and non-cardiac gene suppression, 
being the most effective genes for the activation of genes associated to cardiac-related 
processes [53]. Recent findings by Zhou (2013), the combination of Tbx5, Gata4 and Myocd 
enhance cardiac gene expression. Combination of Myocd with SFR or Tbx5 can lead to 
muscle differentiation or cardiomyocyte differentiation [46, 53]. 
Zfpm2, also known has Fog2, is a co-factor of genes linked to heart development, such 
as Gata4, modulating transcriptional activity in vitro and in vivo during heart development 
and morphogenesis [67, 68]. This gene could be a strong candidate for heart development 
and his absence is lethal due to consistent defects in heart morphogenesis [67]. Tevosian 
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(2000) study established that this gene has an essential role in myocardium and his absence 
causes multiple morphological abnormalities [67]. 
Recent studies regarding Meis1 revealed that the deletion of this gene in mouse 
cardiomyocytes could lead to an extension of the postnatal cardiomyocytes proliferation 
window and re-activation of cardiomyocyte mitosis in adult heart with no deleterious effect 
on cardiac function [69]. Meis1 overexpression in cardiomyocytes decrease neonatal 
myocyte proliferation and inhibited neonatal heart regeneration [69]. Mahmoud and co-
workers (2013) concluded that this gene is a critical transcription regulator of cardiomyocyte 
proliferation and greatly regulates postnatal cardiomyocytes cell cycle arrest. Taking these 
results in to account, this gene should be analysed more thoroughly, because it could be an 
important therapeutic target for heart regenerative medicine. 
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Figure 3.5.3.2. Biological function (on the right) and expression (on the left) for the obtained 
genes in the overlap for positive late gene expression. RT – Regulation of Transcription; RGE 
– Regulation of gene Expression; DNAB – DNA Binding; StemCD – Stem Cell Differentiation; 
Stems – Stem Cell Maintenance. A – Genes greatly related to heart development; B – Genes 
related to heart development present in the overlap of all data sets with known biological 
functions; C – Genes that could be linked to heart development, because there are little or 
none studies linked to heart.  
C 
B 
A 
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3.6.  NETWORK STRUTURAL ANALYSIS 
I performed two distinctive types of analysis in this part of work: (i) Correlation network, 
to link genes according to their expression temporal pattern. In this way, it is possible to 
obtain sub-cluster of similarly expressed genes; (ii) Interaction Data Network was created 
based on publically available published protein-protein interaction data. This later allows to 
analyse how genes from different or similar temporal expression interact, regarding the 
positive and negative correlation. 
3.6.1. CORRELATION NETWORK 
The Correlation Network was made from the 296 genes obtained through the 
comparative differential gene expression analysis of the 4 different data sets that were used 
in the previous section. To reduce and prioritize the number of genes, I applied a filter using 
a Pearson correlation coefficient >0.75, so that all linked genes had a correlation higher than 
0.75. After applying that filter, the resulting number of genes was still too large (209 genes) 
to permit a good visual representation in Cytoscape. Thus, for a better interpretation of the 
results and expression correlation between genes, I have chosen the path in which genes 
from all temporal expression are represented (figure 3.6.1.1). 
The most important genes for each temporal expression here highlighted, so it is 
possible to see with which direct partners they are highly correlated. Almost of all genes 
represented in figure 3.6.1.1 are transcription factor, with the exception of the H2afy2, that 
is not a transcription factor, but it is a regulator of gene expression. Notably, we can observe 
some sub-clusters, for example, all the first interacting partners of the highlighted genes 
have a very similar biological function. So we can assume that the first interacting partners 
of, for example, Meis1 have a similar function to it and of course a very similar temporal 
expression. 
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Figure 3.6.1.1. Correlation Network with main gene markers for each temporal expression 
stage, with a correlation >0.75 in cytoscape. Triangles mean transcription factors; Circle 
mean non-transcription factors. Green represents early gene expression stage (from day0 to 
day 2); Purple represents intermediate expression stage (from day 3 to day 5); Red 
represents late gene expression stage (from day 6, day 7 and day 11).  
 
Although these genes are highly correlated, it is also interesting to see their temporal 
expression, where these genes show their expression through the different days. Basically, in 
figure 3.6.1.2, is represented the expression of day 0 in Gaspar (2012) data set [21]. 
So as the days pass by, it is possible to see the expression variation in the different 
genes. In the first days, the expression appears in the genes linked to maintenance of 
pluripotency [1, 2, 13, 41], in the intermediate days it appears in the genes that are 
responsible for mesoderm cell fate/formation [44, 45] and in a later stage expression shifts 
to genes linked to heart development and morphogenesis [4, 47, 48, 69]. 
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Figure 3.6.1.2. Gene expression network with correlation >0.75 in cytoscape for Day 0 
expression values in Gaspar (2012) data set [21]. Triangles mean transcription factors; Circle 
mean non-transcription factors. Yellow represents genes that are expressed; Blue represents 
genes that are not expressed. 
 
For a more interactive analysis of the temporal gene expression for these genes, a video 
(digital attachment I) as created demonstrating gene expression for all days from the Gaspar 
(2012) data set [21], this video is attached in the digital support. This video allow us to get a 
better idea of how gene expression correlated at the different days and how expression 
shifts from the early to late gene expression. Figure 3.6.2.2 gives a little preview of day 0 in 
the video. As it was referred earlier, all first interacting partners with the major transcription 
factors, are co-expressing in the different temporal stages, so this sub-clusters appear not 
only to have the same temporal expression, but they possible can also have similar biological 
functions. 
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3.6.2. PPI DATA NETWORK 
For a second type of analysis, the objective was to see what type of protein-protein 
interactions are occurring between the obtained genes from the previous analysis. Protein-
Protein interactions information was obtained through Unihi website [70], and it was 
obtained 232 PPI and 136 genes. For a better visualization, most of the correlation 
interactions were removed and it was only considered the literature-based protein 
interactions, since computationally predicted interactions do not provide us much 
information of how they interact.  
Considering the literature-based interactions only, it was obtained a total of 117 genes 
and 183 PPI. To narrow down even further the number of genes, it was filtered only for the 
transcription factors, since they are the major responsible for initiate gene expression. 
Taking into account all these parameters the total number of obtained genes has 52 genes 
and 66PPI based on literature interactions. 
 
 
Figure 3.6.2.1. Protein-Protein Interaction Network filtered from publically available 
interaction studies. Triangles mean transcription factor. Green represents early gene 
expression stage; Purple represents intermediate gene expression stage; Red represents late 
gene expression stage. White stands for positive correlation interaction; Black stands for 
negative correlation interaction. 
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From these 66 PPI, some interesting interactions came up, particularly regarding 
inhibitory or repressive regulation, which are represented by black edges. The thicker the 
edge is, the higher is correlation of expression. One striking outcome is that genes from 
different temporal expression (early stage represented in green and late stage represented 
in red) are interacting. Regarding such behaviour it was important to understand what was 
happening between some genes that are major factors for pluripotency maintenance and 
major factors for heart development, so we focused in genes such as Jarid1, Zfpm2 and 
Gata4 that showed more promising results. 
Zfpm2 (also known as Fog2) has been under analysis since the importance of this 
transcript regarding cardiac development is still not very well understood [71]. The protein 
of Fog-2 is capable of mediating Gata4 biding and repression and it was also a binding site 
for the transcriptional co-repressor Ctbp2 (C-terminal binding protein 2) [71]. Also the 
combination of Zfpm2 and Mta factors, maximize the repressive activity over Gata4 [72], so 
the knock down of the MTA protein expression impairs the ability of Zfpm2 to repress Gata4 
activity [72]. 
Gata4 is a well-known transcription factor highly expressed in cardiac progenitors cells 
and plays a critical role in regulation of cardiogenesis [4, 51, 52]. After analysing some 
literature regarding the interactions of Gata4, a very interesting hit was obtain, about the 
Gata4-Id2 interaction. This protein ectopic or endogenous expression has the capability of 
inhibiting the transdifferentiation of murine embryonic carcinoma cells into myocytes [73]. 
The binding of this protein to Gata4 results in the inhibition of this transcription factor, not 
allowing him to bind with the DNA, thereby blocking the transdifferentiation of cancer cells 
into cardiac myocytes [73]. 
Jarid2 (also known as Jmj, Jumonji) is a transcription factor that plays a relevant role in 
the heart development [74, 75]. This protein contains domains of powerful transcriptional 
repression, DNA binding and interacts physically with cardiac transcription, such as, Nkx2-5 
and Gata4 and represses their abilities to activate target gene expression [74]. Studies have 
shown that Jmj interacts with the N-terminal region of Gata4, which is the transactivation 
domain of Gata4. Therefore this protein-protein interaction may lead to inhibition of the 
transcriptional activity of Gata4, and it may also interfere in the interaction of Gata4 with 
Nkx2-5 [74]. 
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3.7. GENE COMPARATIVE ANALYSIS WITH STEM CELLS AND CANCER CELLS 
To assess the extent and molecular basis of the putative connection between cancer and 
stem cells, I compared several gene lists associated with stem cells and cancer. The analysis 
showed that both stem and cancer cells can be share a significant number of common genes, 
which points to the activation of a common molecular program in both types of cells. 
All possible combinations of comparison between the different gene lists were carried 
out. For each detected overlap, I recorded which genes are present in each data set and 
which genes are overlapping in the different combinations of these data sets. Genes that are 
shared between the lists are documented in the supplementary tables. Up- or down-
regulated genes from Gaspar 2012 and whether they can also be found in the other gene 
lists (Supplementary Table 2 and 3, Annex V). 
 
Down Regulated Genes 
In this study, genes detected in common with either the list for up-or down-regulated 
genes collected in the Supplementary table 1 (Annex V). First, list for the down-regulated 
genes (i.e. those that are down-regulated during differentiation) were compared with the 
gene lists from the Oct4 RNAi screen, the Cancer Census and the Genetic Association 
database. 
In the supplementary table 2 (Annex V) are genes shared with other lists are 
represented by 1 and highlighted by green colour green, while genes that are absent in the 
overlap are represented by 0 and have shown in red colour red. Note that a separate column 
shows the association with transcriptional regulator activity of gene as determined in Gaspar 
et al., 2012. 
The statistical assessment of the number of shared genes demonstrated that the down-
regulated genes are significantly enriched in the two cancer gene sets (Cancer I p= 0.008, N= 
9; CancerII: p= 0.002, N= 40) as well as in the Oct4 gene set (p=0.02, N= 8). With the 
exception of the triple comparison (Down-regulated/Genetic Association Database/Oct4), all 
comparisons showed significance demonstrating that the number of shared genes were 
clearly larger than we would expect by chance (see table 3.7.2. and figure 3.7.1. below). 
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Table 3.7.1. Gene lists used for comparative analysis 
Description Abbreviation 
Down D/Down 
Genetic Association Database CII/CancerII 
Oct4 Screen Hits O/Oct4 
Cancer gene Census CI/CancerI 
 
Table 3.7.2. Significance of common genes in different combinations of gene lists. 
Combinations Hypergeometric test (p-value) 
D/CII 0.002 
D/O 0.0192 
D/CI  0.0077 
CII/O 0.0135 
CII/CI 0 
O/CI 0.023 
D/CII/O 0.2659 
D/CII/CI 0.0184 
D/O/CI 0.0008 
CII/O/CI 0.0008 
D/CII/O/CI 0.0019 
 
 
Figure 3.7.1. Venn diagram with number of shared genes for the comparative analysis for 
genes down-regulated during ESc differentiation. 
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Several notable genes are shared, but one of the most striking and surprising gene in the 
intersection of all 4 data set was TCL1A (T-cell leukaemia/lymphoma 1A). A preliminary 
literature review revealed that most of the studies conducted about this gene were linked to 
tumor associated gene, especially to lymphocytic leukaemia and that overexpression of the 
TCL1A gene in humans has been implicated in the development of mature T-cell leukaemia. 
Interestingly, however, this genes seems not be linked to ESc so far [76]. In the intersection 
of the down-regulated genes with CI and CII, we have found two genes: (i) NF2 is a tumor 
suppressor that encodes for Merlin, which inhibits mitogenic signalling at or near the plasma 
membrane. With the accumulation of Merlin in the nucleus, it binds with an ubiquitin ligase 
and supresses mitotic activity [77]. In the observation by Li (2010) group, many pathogenic 
NF2 mutations disrupt the capability of Merlin supress tumorgenesis [77]; (ii) TET1 is highly 
expressed in undifferentiated ES cells and the expression level of this gene decreases upon 
ES cell differentiation [78]. Their study not only establishes a role of Tet1 in modulating DNA 
methylation, but also promotes transcription of pluripotency factors as well as participating 
in the repression of developmental regulators [78]. 
 
Up Regulated Genes 
Second list is for the up-regulated genes (i.e. those that are up-regulated during 
differentiation) were compared with the gene lists from the Oct4 RNAi screen, the Cancer 
Census and the Genetic Association database. In the supplementary table 3 (Annex I), genes 
that are present in the overlap are represented by 1 and are marked by green colour, and 
the genes that are absent in the overlap are represented by 0 and have the red colour. Note 
that a separate column shows the association with transcriptional regulator activity of gene 
as determined in Gaspar et al. 
It was found that the overlap of the up regulated gene list with the other lists (even 
having statistical significance) tend to be smaller compared to those found for the down 
regulated genes (table 3.7.4 and figure 3.7.2). The overlap with cancer associative genes is 
marginally significant (Cancer I p=0.15; Cancer II p=0.04, N=31). No significant overlap with 
Oct4 screen was detected with only two genes in common (TPM1 & ADAMTS1). This can be 
expected, since Oct4 hits should be important for stem cell maintenance and thus expressed 
in ESc, whereas the list of up regulated genes are likely not to be expressed in ESc. 
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Remarkable, number of genes common to all three gene lists (Up-regulated gene, CancerI 
and CancerII) is highly significant (p0.0076, n=3). 
 
 
Table 3.7.3. Gene lists compared. 
Description Abbreviation 
Up U/Up regulated 
Genetic Association Database CII/CancerII 
Oct4 Screen Hits O/Oct4 
Cancer gene Census CI/CancerI 
 
Table 3.7.4. Significance of common genes in different combinations of gene lists. 
Combinations Hypergeometric test (p-value) 
U/CII 0.0368 
U/O 0.6913 
U/CI  0.152 
CII/O 0.0135 
CII/CI 0 
O/CI 0.023 
U/CII/O 0.5457 
U/CII/CI 0.0076 
U/O/CI 0.0503 
CII/O/CI 0.0008 
U/CII/O/CI 0.0684 
 
Figure 3.7.2. Venn diagram with number of shared genes for the comparative analysis for 
genes up-regulated during ESc differentiation.  
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For this gene list, it was not found any overlap between the 4 different data sets, 
although it was found 3 genes in the overlap of the Up/CancerI/CancerII: (i) Ccnd2, which the 
encoded protein by this gene belongs to the highly conserved cyclin family, whose members 
are characterized by a periodicity in protein abundance through the cell cycle. Cyclins 
function as regulators of CDK kinases, in which these regulate cell cycle; (ii) Klf6 is a 
transcriptional factor and functions as a tumor suppressor and it was found that isoforms of 
this gene are implicated in carcinogenesis and is interestingly an inhibitor of Jun [79]. KLF6 
overexpression down regulated c-Jun-dependent transcription and a physical interaction 
between c-Jun and KLF6 was detected [79]; (iii) Jun is a very well-known transcription factor 
and proto-oncogene in early responsive gene product with unique properties that positively 
regulate cell proliferation and interacts directly with specific target DNA sequences to 
regulate gene expression. This gene is mapped to a chromosomal region that is responsible 
for translocation and deletions in human malignancies [79]. Last examples shows that both 
tumour suppressors as well as oncogenes can be found to be shared between ESc 
differentiations associated genes and cancer associated genes. To gain more insight into this 
putative connection, it would be interesting to check for the single genes whether the 
recorded genetic mutations lead to a loss or gain of function in cancer. 
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3.8. “HEARTEXPRESS” INTERACTIVE PLATFORM 
Additionally to this work, it was created a web based program (Heart Express: 
http://heartexpress.sysbiolab.eu/) that provides researchers a direct access to the collected 
data and enables independent investigations. HeartEXpress is a friendly user and straight 
forward tool to use, which enables interactive exploration of genome-wide expression data 
from heart development and morphogenesis, where the user can input their genes of 
interest and see their correlation with other genes. It also enables visualization of changes in 
gene expression in the different conditions of the experiments. 
The data present in Heart Express was retrieved from public repositories: Gene 
Expression Omnibus and ArrayExpress, it comprises 38 microarrays from 7 different 
published papers. It enables visualization of changes in gene expression in the different 
conditions of the experiments. Currently, it is possible to analyse two types of that, which 
consist in: (i) Only genes included in all experiments (No missing data) and;(ii) All genes 
included in more than 40% of microarrays. 
 
 
Figure 3.8.1. HeartEXpress user interface [34]. 
 
Genes were clustered regarding similarities in the expression changes in order to help in 
the identification of expression patterns across different conditions. HeartEXpress can be 
used to examine transcription response of co-expressed genes in order to identify potential 
regulatory associations. 
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The user can choose a set of genes, whose expression changes will be displayed. This 
can be done either by selecting a gene from the miniature heat map, or by inputting a gene 
symbol or name. Expression changes for each gene are coloured by a blue/yellow gradient, 
in which decreasing (blue) and increasing (yellow). Black squares represent no differentiation 
in expression. Graphical view is given as a matrix, for by rows (genes) and columns 
(experiment conditions). For a more detailed information about the used microarrays the 
integrated data sets page. 
 
 
Figure 3.8.2. A mouse click on the displayed expression of a gene will open another page 
displaying all genes that are co-expressed with the chosen gene [34]. The orange bar 
indicates spearman correlation coefficient regarding the top gene, which in this case is 
Smyd1. 
 
Overall, this is an available database online that allows the user an independent and 
interactive exploration of genes related to heart development. The development of this 
visualization tool also has the aim of sharing all collected and treated data with the scientific 
community and assist researchers in the characterization and functional annotation in heart 
development.  
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4. CONCLUSION 
Since the heart development is a very complex and intricate process with precise spatial 
and temporal events it was important to perform such type of study, because this was the 
first study that involves the meta-analysis of different published works regarding heart 
development and their molecular and genetic events. This study allowed us to do a cross 
comparison between the different data sets regarding several genes, but mainly the ones 
responsible for heart development and potential new candidates. 
In sub-chapters 3.1, 3.3, 3.5 and 3.7, it was made an extensive analysis of the 
microarrays used for the study. This study consisted to verify the different gene expression 
in the different microarrays; (i) General genetic expression of mouse embryonic stem cells – 
although this microarray is not directly linked to heart development and morphogenesis, it is 
possible to observe that several of the main transcription factor related to heart 
development are being expression from day 4, allowing us to determine in a normal 
development to establish when heart-related genes start to express; (ii) Genetic expression 
between cardiac fibroblasts and induced cardiomyocytes and differentiation into 
cardiomyocytes; (iii) A thorough analysis of genes present in each stage of development 
towards the cardiac cell fate; (iv) Comparative analysis of gene lists associated with stem 
cells and cancer cells– This is also not directly related to heart development, but it helped us 
to understand if any of the genes that are associated to cancer or stem cells are also linked 
to heart development, so in that way it was possible to prevent the use of such genes to 
avoid the possible formation of teratomas in the development of cardiac cells. The 
comparative analysis of these data allowed us to get a general view of the different gene 
expression related to heart development, but most the most important of all, it allowed to 
confirm that the gene expression presented in the 3.1, 3.3, 3.5 chapters are accurate since 
they presented the expected expression according to the different papers [3-5, 21] and the 
biological functions in chapter 3.4 showed processes linked to heart development and 
morphogenesis. 
To get a better insight of the heart development, it was analysed the biological 
functions, molecular functions and KEGG pathways. To get a smaller list, the genes were 
filtered for an adjusted p-value of 0.1, to have a higher confidence of the obtained results. 
For the biological processes, most of the results were linked to heart development. We 
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observed that heart development starts to occur in day 4-5 in the iPSc and mESc and, the 
transdifferentiated cells also present heart development and morphogenesis, and 
additionally, cardiac muscle tissue development and cardiac muscle contraction. This shows 
that the genes responsible for the development of the heart are present in the 
transdifferentiated cells, showing that not only the known transcription factors for heart 
development are present but also new possible candidate genes.  
From those filtered genes, they were divided according to their temporal expression and 
analysed between the possible data sets: (i) Early stage – differentiation of mouse embryonic 
stem cells [21], day 0 and day 1 vs. hiPSc differentiation towards cardiomyocytes day 0 [3]); 
(ii) Intermediate stage – differentiation of mouse embryonic stem cells [21], day 3 and 4 vs. 
hiPSc differentiation towards cardiomyocytes day 2 and day 5 [3]); (iii) Late stage – Mouse 
embryonic stem cell Differentiation [21], Day 6 and Day 7 vs. iPSc into iCM [3], Day7 and 
Day9 vs. CF into iCM [5], ACFGHMT vs. Rep into iCM [4], 2WiCM and 4WiCM. With this type 
of analysis it was possible to see the integral expression of the gene in each temporal stage, 
allowing to classify the genes into genes that are responsible for maintenance and 
differentiation of stem cells, genes that are responsible of establishing the cell fate of the 
differentiating cells and genes that are responsible for inducing the transformation of these 
cells into the heart cell fate. With the analysis of the late gene expression stage, we could 
find some interesting genes that could be important for heart development and new 
pointers for heart regenerative medicine. These new pointers are quite recent and there are 
few studies of them related to heart development, such is the case of Meis1, Smyd1 and 
Myocd. There are already some studies regarding Meis1 and Myocd [53, 57, 69], but they 
are from late 2012 and early 2013, showing to be promising pointers for heart development 
and regenerative medicine. 
For a complete analysis of all obtained results it was created a network structural 
analysis, to visually examine how the filtered genes correlated between themselves and how 
strong and relevant were their protein-protein interactions. For the correlation network we 
could verify that all genes obtained were highly correlated and to diminish the number of 
present genes, the correlation threshold was raise to ≈ 0.75, reducing from 296 to 209 
genes. The temporal gene expression changes showed that they can not only be highly 
correlated, but they could also be interacting at a protein level, since some sub-clusters 
present in the correlation network fluctuates in a similar time frame. In the PPI network, it 
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was required more filtering, since there was still present a lot of genes, so we looked 
specifically to all transcription factors that had protein-protein interactions already 
described in literature. With this analysis we were able to find some interesting interactions, 
which could majorly guide cells to maintain in a progenitor state and proliferate and/or 
make somatic cells transdifferentiate into cardiac cell fate. The main hits on this study were 
Jarid2 and Id2, that appear to regulate and represses the activity of Gata4. So the regulation 
or repression of these 2 genes could also be a main focus in the heart development, allowing 
for the cardiac cells to proliferate. 
The many approaches taken in this work helped to find new pointers for heart 
development, such as, Meis1 and Smyd, and/or regulate other genes that can influence the 
expression of well-known transcription factors that are strongly linked to heart 
development, such as, Gata4. Since this work used microarrays from different studies, the 
obtained overlapping genes are robust candidates for what we have been looking for, i.e., 
heart regenerating medicine and cellular therapy. 
It would be important to keep performing the same type of work, that was made so far, 
since the technologies and new studies are coming up every day. Even from the beginning of 
this year and late 2012, about 3 studies with microarrays were published [6, 52, 53, 57], so it 
would be important to continue to analyse new data and strengthen the previous obtained 
data. For a continuous tracking and analysis of the upcoming publications related to heart 
expression experiments, the results will be threaten and publically displayed in the 
HeartEXpress website [34]. The continuation of this study would be essential, not only to 
complement the known information, but also to try to get the best and most efficient 
combination of genes/transcription factor for an efficient transdifferentiation of somatic 
cells into iCM and/or for cell therapy to directly transdifferentiate cardiac fibroblasts into 
cardiomyocytes in vivo.   
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ANNEX I 
 
Supplementary figure 1. Distribution of mean expression i of transcription factor that are up 
regulated vs. down regulated Rosetta 2. 
 
Supplementary figure 2. Mean expression in density of all genes that are up regulated vs. 
down regulated Rosetta 2. 
 
Supplementary figure 3. Mean expression in density of transcription factor that are up 
regulated vs. down regulated Stanford. 
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Supplementary figure 4. Mean expression in density of genes that are up regulated vs. down 
regulated Stanford. 
 
 
Supplementary figure 5. Mean expression in density of transcription factor that are up vs. 
down regulated Human Gene Atlas data set 
 
 
Supplementary figure 6. Mean expression in density of genes that are up vs. down regulated 
Human Gene Atlas data set 
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Supplementary figure 7. Mean expression in density of genes that are up vs. down regulated 
Mouse Gene Atlas data set 
 
 
Supplementary figure 8. Mean expression in density of genes that are up vs. down regulated 
Mouse Gene Atlas data set 
 
This bar plots shows which genes are most expressed in differentiated tissue and we can 
see the same pattern of expression as in Rosetta 1. In this bar plot Tpm1, Lgals1, Tnnc1, 
Rpl13, Timp2, Jun seem to be highly up-regulated.  
 
 
Supplementary figure 9. Genes with the highest averaged expression in all tissue in Rosetta 2 
data set 
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Similar to what happened in Rosetta 1, the genes down regulated in every differentiated 
tissue are the expected, like Fgf4, Esrrb, Morc1, Dnmt3l, Pou5f1, Nanog. All this are linked to 
the undifferentiated cell state. 
 
 
Supplementary figure 10. Genes with the highest averaged expression in all tissue in Rosetta 
1 data set 
 
The results of bar plots in Stanford match the previous 2 analysed data sets show again 
almost the same up and down regulated genes, in the several tissues. The up regulated 
genes consist in Timp2, Jun, Tpm1, Klf6. 
 
 
Supplementary figure 11. Genes with the highest expression in all tissue in Stanford data set. 
 
In the down regulated genes we can find genes that linked to pluripotent state, such as, 
Pou5f1, Klf5, Morc1, Fgf5 and Dppa2. 
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Supplementary figure 12. Genes with the lowest expression in all tissue in Stanford data set. 
 
Could not do clustering for these genes, since the values in the database where between -3 
and 3. 
Once again we can see a similar pattern in the expression of genes. Tnnc1, Jun, Tpm1. 
We can also see that down regulated genes are also similar to the other data set, Sox2, 
Esrrb, Dppa2. So basically, it is very standard the type of expression in every data set, so it 
would be safe to assume that in the different tissues these are the most up and down 
regulated genes. 
 
 
Supplementary figure 13. Genes with the highest averaged expression in all tissue in Human 
Gene Atlas data set. 
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Supplementary figure 14. Genes with the lowest averaged expression in all tissue in Human 
Gene Atlas data set 
 
 
Supplementary figure 15 Genes with the lowest averaged expression in all tissue in Mouse 
Gene Atlas data set 
 
 
Supplementary figure 16. Genes with the lowest averaged expression in all tissue in Human 
Gene Atlas data set 
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In the clustering analysis, once again we can see the Nanog and Pou5f1 clustering 
together, being this last ones responsible for maintenance of the cells in the undifferentiated 
state. 
 
 
Supplementary figure 17. Group of genes that are clustering together in Rosetta 1. 
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ANNEX II 
 
Supplementary figure 1. Expression of NK2 homeobox 5 in several cells types on Ieda et al., 
2010 data set. 
 
 
Supplementary figure 2. Expression of ISL1 transcription factor, LIM/homeodomain in 
several cells types on Ieda et al., 2010 data set. 
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ANNEX III 
 
Supplementary figure 1. Expression of ISL1 transcription factor, LIM/homeodomain on Song 
et al., 2012 data set. 
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ANNEX IV 
 
Supplementary figure 1. Heat map for molecular function with missing values and less 
important functions. 
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ANNEX V 
Supplementary table 1. Up- and down-regulated genes from Gaspar 2012.  
In differentiated cells 
Up regulated genes Down regulated genes 
2610002M06Rik Inadl Samd4 1190003J15Rik Cth Klf2 Psma8 
Adamts1 Irs1 Sema4c 1700019N12Rik D14Ertd668e Klf4 Psph 
Akt3 Irx3 Sepn1 1700029I01Rik D15Ertd55e Klf5 Pycard 
Amot Itm2c Sepw1 1700029I01Rik  D1Pas1 Kndc1 Rad9b 
Amotl1 Itpripl2 Serf1 1700029P11Rik Depdc6 Krt42 Ranbp17 
Antxr2 Jun Serpinh1 1700061G19Rik Dleu7 Lars Rbpj 
App Kctd10 Setd7 1700097N02Rik Dnajc6 Liph Rfx2 
Armcx3 Kitl Sgce 2200001I15Rik Dnase2a Rbmxl2 Rinl 
Arrb1 Klf6 Sh3bgrl 2210409E12Rik Dnmt3l Lrch4 Rnf125 
Bag2 Krt18 Sh3glb1 2310043M15Rik Dppa2 Lrrc2 Rnf138 
Bin1 Krt8 Slc22a23 2410004A20Rik Dpys Lrrc31 Rpp25 
Casp6 L3mbtl3 Slc25a24 2610305D13Rik Enox1 Lrrc34 Rtel1 
Cbx4 Lgals1 Slc25a4 4833420G11Rik Enpp3 Ltbp4 Rwdd2a 
Ccnd2 Lhfp Slc30a4 4930453N24Rik Epb4.1l4a Ly6g6e Sema4a 
Cd44 Lhfpl2 Slc36a4 4930486G11Rik Ephx2 Ly75 Serpinb6c 
Cdk14 LOC100048050 Slc39a8 4930566F21Rik Eras Mageb16 Sh3gl2 
Chmp2b Lxn Slc40a1 5730507C01Rik Esrrb Manba Shmt2 
Cmtm3 Maf Smarca2 9630033F20Rik Etv5 Mapt Si 
Cnn2 Man1a Snx33 A230050P20Rik Fam13c Mars Slc17a9 
Cobll1 Mef2a Soat1 Aard Fbxo15 Mcf2 Slc1a1 
Col4a1 Mfhas1 Sox4 Abcb1a Fbxo2 Mia1 Slc1a5 
Col4a2 Mpdz Speg Abcc4 Fgf4 Mkrn1 Slc25a36 
Col4a5 Msl3 Spg20 Accsl Foxd3 Mlh3 Slc7a3 
Cpd Mum1l1 Stbd1 Acss1 Frrs1 Morc1 Sox2 
Cyth3 Ndn Stk39 Adam23 Fut9 Mras Stat4 
Dsp Nedd9 Sypl Adrb3 Fzd5 Mtf2 Sult6b1 
Dynlt3 Nrp1 Tanc2 Aire Gdf3 Mthfd2 Susd2 
Efna5 Parva Tax1bp3 Ak7 Gli1 Mybl2 Tcea3 
Ets1 Pdzrn3 Tdrd7 Ano9 Gm13138 Mylpf Tcf15 
Fabp5 Pea15a Tes Aoah Gm13139 Myst4 Tcfcp2l1 
Fam115a Pfkfb3 Tgfb2 Apobec3 Gm14430 Nanog Tcl1 
Farp1 Phlda1 Tgfbr3 Apod Gm5101 Napepld Tdh 
Flt1 Phldb2 Timp2 As3mt Gm6792 Napsa Tdrd12 
Fndc3c1 Pitx2 Tmem181a Asns Gm7325 Nf2 Tet1 
Fosl2 Pkdcc Tnnc1 AU018091 Gpa33 Nfu1 Tex14 
Fzd2 Plekho1 Tox3 BC032203 Gpr133 Nkx6-3 Tgm1 
Gabarapl1 Pmp22 Tpm1 Bcat2 Gpt2 Nphs1 Trim2 
Ghr Pogk Trio Bdh2 Grtp1 Nr0b1 Triml1 
Gng12 Ppapdc1b Tshz1 C330019L16Rik Gsta4 Nr5a2 Ttpa 
Gpsm1 Prickle1 Tspan12 C730049O14Rik Gtsf1 Ooep Tubb2b 
Gpx8 Prkd1 Ube2e2 Calca Gtsf1l Patl2 Xist 
Gsn Prnp Ube2j1 Camk1d Hck Pcolce2 Zbtb8a 
Gyg Prss23 Vopp1 Caps2 Helb Phc1 Zfp229 
H2-T10 Pxdn Vwa5a Capsl Hsd17b14 Pim3 Zfp296 
Hdgfrp3 Reep5 Yaf2 Cars Hsf2bp Pipox Zfp42 
Hivep2 Rhob Zfand3 Ccdc160 I1C0022H11Rik Pla1a Zfp518b 
Hs6st2 Rhou Zfp386 Cdyl2 Ildr1 Pla2g10 Zfp59 
Hspb11 Rnf103 Zfp672 Chac1 Irak3 Pla2g1b Zfp819 
Ier5 Rnf217 Zfp703 Clca4 Jam2 Pou5f1 Zmat4 
Igf2 Rpl13 Zyx Cnpy1 Jarid2 Prdm14   
      Cobl Kbtbd11 Prkcb   
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Supplementary table 2. Overlapping down regulated genes between the different data sets. 
Human 
Entrez 
Gene Symbol Agapios CancerI CancerII Oct4 
25 ABL1 0 1 1 0 
100 ADA 0 0 1 1 
155 ADRB3 1 0 1 0 
207 AKT1 0 1 1 0 
208 AKT2 0 1 1 0 
217 ALDH2 0 1 1 0 
238 ALK 0 1 1 0 
324 APC 0 1 1 1 
326 AIRE 1 0 1 0 
330 BIRC3 0 1 1 0 
355 FAS 0 1 1 0 
405 ARNT 0 1 1 0 
466 ATF1 0 1 1 0 
471 ATIC 0 1 1 0 
472 ATM 0 1 1 0 
546 ATRX 0 1 1 0 
595 CCND1 0 1 1 0 
596 BCL2 0 1 1 0 
604 BCL6 0 1 1 0 
605 BCL7A 0 1 1 0 
608 TNFRSF17 0 1 1 0 
613 BCR 0 1 1 0 
641 BLM 0 1 1 1 
657 BMPR1A 0 1 1 0 
668 FOXL2 0 1 1 0 
672 BRCA1 0 1 1 0 
673 BRAF 0 1 1 0 
675 BRCA2 0 1 1 0 
688 KLF5 1 0 1 0 
701 BUB1B 0 1 1 0 
768 CA9 0 0 1 1 
796 CALCA 1 0 1 0 
824 CAPN2 0 0 1 1 
833 CARS 1 1 0 0 
835 CASP2 0 0 1 1 
861 RUNX1 0 1 1 0 
865 CBFB 0 1 1 0 
867 CBL 0 1 1 0 
894 CCND2 0 1 1 0 
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896 CCND3 0 1 1 0 
898 CCNE1 0 1 1 0 
947 CD34 0 0 1 1 
966 CD59 0 0 1 1 
973 CD79A 0 1 1 0 
974 CD79B 0 1 1 0 
999 CDH1 0 1 1 0 
1009 CDH11 0 1 1 0 
1019 CDK4 0 1 1 0 
1021 CDK6 0 1 1 0 
1029 CDKN2A 0 1 1 0 
1031 CDKN2C 0 1 1 0 
1045 CDX2 0 1 1 1 
1050 CEBPA 0 1 1 0 
1277 COL1A1 0 1 1 0 
1301 COL11A1 0 0 1 1 
1316 KLF6 0 1 1 0 
1345 COX6C 0 1 1 0 
1376 CPT2 0 0 1 1 
1387 CREBBP 0 1 1 0 
1491 CTH 1 0 1 0 
1499 CTNNB1 0 1 1 0 
1535 CYBA 0 0 1 1 
1540 CYLD 0 1 1 0 
1585 CYP11B2 0 0 1 1 
1589 CYP21A2 0 0 1 1 
1615 DARS 0 0 1 1 
1616 DAXX 0 1 1 0 
1643 DDB2 0 1 1 0 
1649 DDIT3 0 1 1 1 
1769 DNAH8 0 0 1 1 
1785 DNM2 0 1 1 0 
1788 DNMT3A 0 1 1 0 
1807 DPYS 1 0 1 0 
1956 EGFR 0 1 1 0 
2014 EMP3 0 0 1 1 
2033 EP300 0 1 1 1 
2053 EPHX2 1 0 1 0 
2064 ERBB2 0 1 1 0 
2068 ERCC2 0 1 1 0 
2071 ERCC3 0 1 1 0 
2072 ERCC4 0 1 1 0 
2073 ERCC5 0 1 1 0 
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2078 ERG 0 1 1 0 
2103 ESRRB 1 0 1 0 
2115 ETV1 0 1 1 0 
2119 ETV5 1 1 0 0 
2120 ETV6 0 1 1 0 
2122 MECOM 0 1 1 0 
2131 EXT1 0 1 1 0 
2146 EZH2 0 1 1 0 
2175 FANCA 0 1 1 0 
2176 FANCC 0 1 1 0 
2177 FANCD2 0 1 1 0 
2178 FANCE 0 1 1 0 
2188 FANCF 0 1 1 0 
2189 FANCG 0 1 1 0 
2206 MS4A2 0 0 1 1 
2213 FCGR2B 0 1 1 0 
2249 FGF4 1 0 1 0 
2260 FGFR1 0 1 1 0 
2261 FGFR3 0 1 1 0 
2263 FGFR2 0 1 1 0 
2267 FGL1 0 0 1 1 
2271 FH 0 1 1 0 
2272 FHIT 0 1 1 0 
2308 FOXO1 0 1 1 0 
2322 FLT3 0 1 1 0 
2494 NR5A2 1 0 1 0 
2512 FTL 0 0 1 1 
2623 GATA1 0 1 1 0 
2624 GATA2 0 1 1 0 
2625 GATA3 0 1 1 0 
2638 GC 0 0 1 1 
2705 GJB1 0 0 1 1 
2735 GLI1 1 0 1 0 
2739 GLO1 0 0 1 1 
2767 GNA11 0 1 1 0 
2776 GNAQ 0 1 1 0 
2778 GNAS 0 1 1 0 
2941 GSTA4 1 0 1 0 
2950 GSTP1 0 0 1 1 
2953 GSTT2 0 0 1 1 
2956 MSH6 0 1 1 0 
3030 HADHA 0 0 1 1 
3094 HINT1 0 0 1 1 
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3265 HRAS 0 1 1 0 
3320 HSP90AA1 0 1 1 0 
3417 IDH1 0 1 1 0 
3418 IDH2 0 1 1 0 
3489 IGFBP6 0 0 1 1 
3492 IGH@ 0 1 1 0 
3558 IL2 0 1 1 0 
3572 IL6ST 0 1 1 0 
3662 IRF4 0 1 1 0 
3716 JAK1 0 1 1 0 
3717 JAK2 0 1 1 0 
3718 JAK3 0 1 1 0 
3720 JARID2 1 0 1 0 
3725 JUN 0 1 1 0 
3791 KDR 0 1 1 0 
3811 KIR3DL1 0 0 1 1 
3815 KIT 0 1 1 0 
3817 KLK2 0 1 1 0 
3845 KRAS 0 1 1 0 
3977 LIFR 0 1 1 0 
4004 LMO1 0 1 1 1 
4005 LMO2 0 1 1 0 
4089 SMAD4 0 1 1 0 
4126 MANBA 1 0 1 0 
4137 MAPT 1 0 1 0 
4141 MARS 1 0 1 0 
4193 MDM2 0 1 1 0 
4194 MDM4 0 1 1 0 
4214 MAP3K1 0 0 1 1 
4221 MEN1 0 1 1 0 
4233 MET 0 1 1 0 
4261 CIITA 0 1 1 0 
4286 MITF 0 1 1 0 
4292 MLH1 0 1 1 0 
4297 MLL 0 1 1 0 
4300 MLLT3 0 1 1 0 
4352 MPL 0 1 1 0 
4436 MSH2 0 1 1 0 
4515 MTCP1 0 1 1 0 
4582 MUC1 0 1 1 0 
4595 MUTYH 0 1 1 0 
4605 MYBL2 1 0 1 0 
4609 MYC 0 1 1 0 
Analysis of the transcriptional regulatory network underlying heart development 
 
Rui Sotero Rodrigues Machado   125 
4610 MYCL1 0 1 1 0 
4613 MYCN 0 1 1 0 
4615 MYD88 0 1 1 0 
4629 MYH11 0 1 1 0 
4683 NBN 0 1 1 0 
4761 NEUROD2 0 0 1 1 
4763 NF1 0 1 1 0 
4771 NF2 1 1 1 0 
4780 NFE2L2 0 1 1 0 
4790 NFKB1 0 0 1 1 
4791 NFKB2 0 1 1 0 
4798 NFRKB 0 0 1 1 
4851 NOTCH1 0 1 1 0 
4853 NOTCH2 0 1 1 0 
4869 NPM1 0 1 1 0 
4893 NRAS 0 1 1 0 
4914 NTRK1 0 1 1 0 
4916 NTRK3 0 1 1 0 
4926 NUMA1 0 1 1 0 
4958 OMD 0 1 0 1 
5055 SERPINB2 0 0 1 1 
5077 PAX3 0 1 1 0 
5079 PAX5 0 1 1 0 
5155 PDGFB 0 1 1 0 
5156 PDGFRA 0 1 1 0 
5159 PDGFRB 0 1 1 0 
5187 PER1 0 1 1 0 
5243 ABCB1 1 0 1 0 
5245 PHB 0 0 1 1 
5273 SERPINB10 0 0 1 1 
5290 PIK3CA 0 1 1 0 
5292 PIM1 0 1 1 0 
5295 PIK3R1 0 1 1 0 
5334 PLCL1 0 0 1 1 
5371 PML 0 1 1 0 
5378 PMS1 0 1 1 0 
5395 PMS2 0 1 1 0 
5429 POLH 0 0 1 1 
5434 POLR2E 0 0 1 1 
5450 POU2AF1 0 1 1 0 
5460 POU5F1 1 1 0 1 
5468 PPARG 0 1 1 0 
5518 PPP2R1A 0 1 1 0 
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5551 PRF1 0 1 1 0 
5573 PRKAR1A 0 1 1 0 
5648 MASP1 0 0 1 1 
5723 PSPH 1 0 0 1 
5727 PTCH1 0 1 1 0 
5728 PTEN 0 1 1 0 
5781 PTPN11 0 1 1 0 
5829 PXN 0 0 1 1 
5884 RAD17 0 0 1 1 
5890 RAD51B 0 1 1 0 
5894 RAF1 0 1 1 0 
5900 RALGDS 0 1 0 1 
5909 RAP1GAP 0 0 1 1 
5925 RB1 0 1 1 0 
5966 REL 0 1 1 0 
5979 RET 0 1 1 0 
6098 ROS1 0 1 1 0 
6184 RPN1 0 1 1 0 
6347 CCL2 0 0 1 1 
6390 SDHB 0 1 1 0 
6391 SDHC 0 1 1 0 
6392 SDHD 0 1 1 0 
6416 MAP2K4 0 1 1 0 
6421 SFPQ 0 1 1 1 
6428 SRSF3 0 1 0 1 
6456 SH3GL2 1 0 1 0 
6472 SHMT2 1 0 1 0 
6490 PMEL 1 0 1 0 
6597 SMARCA4 0 1 1 0 
6598 SMARCB1 0 1 1 0 
6608 SMO 0 1 1 0 
6657 SOX2 1 1 0 0 
6688 SPI1 0 0 1 1 
6775 STAT4 1 0 1 0 
6789 STK4 0 0 1 1 
6794 STK11 0 1 1 0 
6840 SVIL 0 0 1 1 
6850 SYK 0 1 1 0 
6886 TAL1 0 1 1 0 
6888 TALDO1 0 0 1 1 
6927 HNF1A 0 1 1 0 
6934 TCF7L2 0 1 1 0 
6938 TCF12 0 1 1 0 
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6940 ZNF354A 0 0 1 1 
6957 TRB@ 0 1 1 0 
7029 TFDP2 0 0 1 1 
7037 TFRC 0 1 1 0 
7051 TGM1 1 0 1 0 
7080 NKX2-1 0 1 1 0 
7113 TMPRSS2 0 1 1 0 
7128 TNFAIP3 0 1 1 0 
7157 TP53 0 1 1 0 
7175 TPR 0 1 0 1 
7248 TSC1 0 1 1 0 
7249 TSC2 0 1 1 0 
7253 TSHR 0 1 1 0 
7268 TTC4 0 0 1 1 
7274 TTPA 1 0 1 0 
7356 SCGB1A1 0 0 1 1 
7428 VHL 0 1 1 0 
7430 EZR 0 1 1 0 
7450 VWF 0 0 1 1 
7486 WRN 0 1 1 0 
7490 WT1 0 1 1 0 
7507 XPA 0 1 1 0 
7508 XPC 0 1 1 0 
7515 XRCC1 0 0 1 1 
7531 YWHAE 0 1 1 0 
7704 ZBTB16 0 1 1 0 
7849 PAX8 0 1 1 0 
7918 GPANK1 0 0 1 1 
7979 SHFM1 0 0 1 1 
8028 MLLT10 0 1 1 0 
8030 CCDC6 0 1 1 0 
8031 NCOA4 0 1 1 0 
8091 HMGA2 0 1 1 0 
8115 TCL1A 1 1 1 1 
8242 KDM5C 0 1 0 1 
8314 BAP1 0 1 1 0 
8425 LTBP4 1 0 1 0 
8435 SOAT2 0 0 1 1 
8648 NCOA1 0 1 1 0 
8651 SOCS1 0 1 1 0 
8764 TNFRSF14 0 1 1 0 
8880 FUBP1 0 1 0 1 
8887 TAX1BP1 0 0 1 1 
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8915 BCL10 0 1 1 0 
8929 PHOX2B 0 1 1 0 
9150 CTDP1 0 0 1 1 
9321 TRIP11 0 1 1 0 
9338 TCEAL1 0 0 1 1 
9401 RECQL4 0 1 1 0 
9817 KEAP1 0 0 1 1 
9935 MAFB 0 1 1 0 
9968 MED12 0 1 0 1 
9969 MED13 0 0 1 1 
10039 PARP3 0 0 1 1 
10142 AKAP9 0 1 1 0 
10257 ABCC4 1 0 1 0 
10320 IKZF1 0 1 1 0 
10397 NDRG1 0 1 1 0 
10413 YAP1 0 0 1 1 
10499 NCOA2 0 1 1 0 
10797 MTHFD2 1 0 1 0 
10892 MALT1 0 1 1 0 
11064 CNTRL 0 1 1 0 
11197 WIF1 0 1 1 0 
11200 CHEK2 0 1 1 0 
11213 IRAK3 1 0 1 0 
23092 ARHGAP26 0 1 1 0 
23242 COBL 1 0 1 0 
23305 ACSL6 0 1 1 0 
23332 CLASP1 0 0 1 1 
23405 DICER1 0 1 1 0 
23522 KAT6B 1 1 0 0 
25818 KLK5 0 0 1 1 
27030 MLH3 1 0 1 0 
27063 ANKRD1 0 0 1 1 
27436 EML4 0 1 1 0 
29844 TFPT 0 1 0 1 
29947 DNMT3L 1 0 1 0 
29998 GLTSCR1 0 0 1 1 
50802 IGK@ 0 1 1 0 
50939 IMPG2 0 0 1 1 
51094 ADIPOR1 0 0 1 1 
51131 PHF11 1 0 1 0 
51199 NIN 0 1 1 0 
51378 ANGPT4 0 0 1 1 
51520 LARS 1 0 0 1 
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51684 SUFU 0 1 1 0 
51750 RTEL1 1 0 1 0 
51755 CDK12 0 1 1 1 
54790 TET2 0 1 1 0 
55234 SMU1 0 0 1 1 
55259 CASC1 0 0 1 1 
55294 FBXW7 0 1 1 0 
55862 ECHDC1 0 0 1 1 
55971 BAIAP2L1 0 0 1 1 
56155 TEX14 1 0 1 0 
57103 C12orf5 1 0 1 0 
57118 CAMK1D 1 0 1 0 
57412 AS3MT 1 0 1 0 
63910 SLC17A9 1 0 0 1 
63976 PRDM16 0 1 1 0 
63978 PRDM14 1 0 0 1 
64241 ABCG8 0 0 1 1 
64746 ACBD3 0 0 1 1 
64805 P2RY12 0 0 1 1 
64901 RANBP17 1 1 0 0 
79723 SUV39H2 0 0 1 1 
79728 PALB2 0 1 1 0 
80312 TET1 1 1 1 0 
80380 PDCD1LG2 0 1 1 0 
81623 DEFB126 0 0 1 1 
83990 BRIP1 0 1 1 0 
84441 MAML2 0 1 1 0 
84532 ACSS1 1 0 0 1 
84651 SPINK7 0 0 1 1 
92689 FAM114A1 0 0 1 1 
121227 LRIG3 0 1 1 0 
139285 FAM123B 0 1 1 0 
140767 NRSN1 0 0 1 1 
143187 VTI1A 0 1 1 0 
144715 RAD9B 1 0 0 1 
151393 FAM82A1 0 0 1 1 
171023 ASXL1 0 1 1 0 
221895 JAZF1 0 1 1 0 
285733   0 0 1 1 
374378 GALNTL4 0 0 1 1 
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Supplementary table 2. Overlapping up regulated genes between the different data sets. 
Human Entrez Symbol 
Up 
Agapios 
CancerII Oct4 CancerI 
25 ABL1 0 1 0 1 
100 ADA 0 1 1 0 
207 AKT1 0 1 0 1 
208 AKT2 0 1 0 1 
217 ALDH2 0 1 0 1 
238 ALK 0 1 0 1 
324 APC 0 1 1 1 
330 BIRC3 0 1 0 1 
355 FAS 0 1 0 1 
405 ARNT 0 1 0 1 
466 ATF1 0 1 0 1 
471 ATIC 0 1 0 1 
472 ATM 0 1 0 1 
546 ATRX 0 1 0 1 
595 CCND1 0 1 0 1 
596 BCL2 0 1 0 1 
604 BCL6 0 1 0 1 
605 BCL7A 0 1 0 1 
608 TNFRSF17 0 1 0 1 
613 BCR 0 1 0 1 
641 BLM 0 1 1 1 
657 BMPR1A 0 1 0 1 
668 FOXL2 0 1 0 1 
672 BRCA1 0 1 0 1 
673 BRAF 0 1 0 1 
675 BRCA2 0 1 0 1 
701 BUB1B 0 1 0 1 
768 CA9 0 1 1 0 
824 CAPN2 0 1 1 0 
835 CASP2 0 1 1 0 
839 CASP6 1 1 0 0 
861 RUNX1 0 1 0 1 
865 CBFB 0 1 0 1 
867 CBL 0 1 0 1 
894 CCND2 1 1 0 1 
896 CCND3 0 1 0 1 
898 CCNE1 0 1 0 1 
947 CD34 0 1 1 0 
960 CD44 1 1 0 0 
966 CD59 0 1 1 0 
973 CD79A 0 1 0 1 
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974 CD79B 0 1 0 1 
999 CDH1 0 1 0 1 
1009 CDH11 0 1 0 1 
1019 CDK4 0 1 0 1 
1021 CDK6 0 1 0 1 
1029 CDKN2A 0 1 0 1 
1031 CDKN2C 0 1 0 1 
1045 CDX2 0 1 1 1 
1050 CEBPA 0 1 0 1 
1277 COL1A1 0 1 0 1 
1284 COL4A2 1 1 0 0 
1301 COL11A1 0 1 1 0 
1316 KLF6 1 1 0 1 
1345 COX6C 0 1 0 1 
1376 CPT2 0 1 1 0 
1387 CREBBP 0 1 0 1 
1499 CTNNB1 0 1 0 1 
1535 CYBA 0 1 1 0 
1540 CYLD 0 1 0 1 
1585 CYP11B2 0 1 1 0 
1589 CYP21A2 0 1 1 0 
1615 DARS 0 1 1 0 
1616 DAXX 0 1 0 1 
1643 DDB2 0 1 0 1 
1649 DDIT3 0 1 1 1 
1769 DNAH8 0 1 1 0 
1785 DNM2 0 1 0 1 
1788 DNMT3A 0 1 0 1 
1956 EGFR 0 1 0 1 
2014 EMP3 0 1 1 0 
2033 EP300 0 1 1 1 
2064 ERBB2 0 1 0 1 
2068 ERCC2 0 1 0 1 
2071 ERCC3 0 1 0 1 
2072 ERCC4 0 1 0 1 
2073 ERCC5 0 1 0 1 
2078 ERG 0 1 0 1 
2115 ETV1 0 1 0 1 
2120 ETV6 0 1 0 1 
2122 MECOM 0 1 0 1 
2131 EXT1 0 1 0 1 
2146 EZH2 0 1 0 1 
2175 FANCA 0 1 0 1 
2176 FANCC 0 1 0 1 
2177 FANCD2 0 1 0 1 
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2178 FANCE 0 1 0 1 
2188 FANCF 0 1 0 1 
2189 FANCG 0 1 0 1 
2206 MS4A2 0 1 1 0 
2213 FCGR2B 0 1 0 1 
2260 FGFR1 0 1 0 1 
2261 FGFR3 0 1 0 1 
2263 FGFR2 0 1 0 1 
2267 FGL1 0 1 1 0 
2271 FH 0 1 0 1 
2272 FHIT 0 1 0 1 
2308 FOXO1 0 1 0 1 
2321 FLT1 1 1 0 0 
2322 FLT3 0 1 0 1 
2512 FTL 0 1 1 0 
2623 GATA1 0 1 0 1 
2624 GATA2 0 1 0 1 
2625 GATA3 0 1 0 1 
2638 GC 0 1 1 0 
2690 GHR 1 1 0 0 
2705 GJB1 0 1 1 0 
2739 GLO1 0 1 1 0 
2767 GNA11 0 1 0 1 
2776 GNAQ 0 1 0 1 
2778 GNAS 0 1 0 1 
2950 GSTP1 0 1 1 0 
2953 GSTT2 0 1 1 0 
2956 MSH6 0 1 0 1 
3030 HADHA 0 1 1 0 
3094 HINT1 0 1 1 0 
3265 HRAS 0 1 0 1 
3320 HSP90AA1 0 1 0 1 
3417 IDH1 0 1 0 1 
3418 IDH2 0 1 0 1 
3481 IGF2 1 1 0 0 
3489 IGFBP6 0 1 1 0 
3492 IGH@ 0 1 0 1 
3558 IL2 0 1 0 1 
3572 IL6ST 0 1 0 1 
3662 IRF4 0 1 0 1 
3667 IRS1 1 1 0 0 
3716 JAK1 0 1 0 1 
3717 JAK2 0 1 0 1 
3718 JAK3 0 1 0 1 
3725 JUN 1 1 0 1 
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3791 KDR 0 1 0 1 
3811 KIR3DL1 0 1 1 0 
3815 KIT 0 1 0 1 
3817 KLK2 0 1 0 1 
3845 KRAS 0 1 0 1 
3956 LGALS1 1 1 0 0 
3977 LIFR 0 1 0 1 
4004 LMO1 0 1 1 1 
4005 LMO2 0 1 0 1 
4089 SMAD4 0 1 0 1 
4094 MAF 1 0 0 1 
4193 MDM2 0 1 0 1 
4194 MDM4 0 1 0 1 
4214 MAP3K1 0 1 1 0 
4221 MEN1 0 1 0 1 
4233 MET 0 1 0 1 
4254 KITLG 1 1 0 0 
4261 CIITA 0 1 0 1 
4286 MITF 0 1 0 1 
4292 MLH1 0 1 0 1 
4297 MLL 0 1 0 1 
4300 MLLT3 0 1 0 1 
4352 MPL 0 1 0 1 
4436 MSH2 0 1 0 1 
4515 MTCP1 0 1 0 1 
4582 MUC1 0 1 0 1 
4595 MUTYH 0 1 0 1 
4609 MYC 0 1 0 1 
4610 MYCL1 0 1 0 1 
4613 MYCN 0 1 0 1 
4615 MYD88 0 1 0 1 
4629 MYH11 0 1 0 1 
4683 NBN 0 1 0 1 
4692 NDN 1 1 0 0 
4761 NEUROD2 0 1 1 0 
4763 NF1 0 1 0 1 
4771 NF2 0 1 0 1 
4780 NFE2L2 0 1 0 1 
4790 NFKB1 0 1 1 0 
4791 NFKB2 0 1 0 1 
4798 NFRKB 0 1 1 0 
4851 NOTCH1 0 1 0 1 
4853 NOTCH2 0 1 0 1 
4869 NPM1 0 1 0 1 
4893 NRAS 0 1 0 1 
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4914 NTRK1 0 1 0 1 
4916 NTRK3 0 1 0 1 
4926 NUMA1 0 1 0 1 
4958 OMD 0 0 1 1 
5055 SERPINB2 0 1 1 0 
5077 PAX3 0 1 0 1 
5079 PAX5 0 1 0 1 
5155 PDGFB 0 1 0 1 
5156 PDGFRA 0 1 0 1 
5159 PDGFRB 0 1 0 1 
5187 PER1 0 1 0 1 
5245 PHB 0 1 1 0 
5273 SERPINB10 0 1 1 0 
5290 PIK3CA 0 1 0 1 
5292 PIM1 0 1 0 1 
5295 PIK3R1 0 1 0 1 
5334 PLCL1 0 1 1 0 
5371 PML 0 1 0 1 
5378 PMS1 0 1 0 1 
5395 PMS2 0 1 0 1 
5429 POLH 0 1 1 0 
5434 POLR2E 0 1 1 0 
5450 POU2AF1 0 1 0 1 
5460 POU5F1 0 0 1 1 
5468 PPARG 0 1 0 1 
5518 PPP2R1A 0 1 0 1 
5551 PRF1 0 1 0 1 
5573 PRKAR1A 0 1 0 1 
5621 PRNP 1 1 0 0 
5648 MASP1 0 1 1 0 
5727 PTCH1 0 1 0 1 
5728 PTEN 0 1 0 1 
5781 PTPN11 0 1 0 1 
5829 PXN 0 1 1 0 
5884 RAD17 0 1 1 0 
5890 RAD51B 0 1 0 1 
5894 RAF1 0 1 0 1 
5900 RALGDS 0 0 1 1 
5909 RAP1GAP 0 1 1 0 
5925 RB1 0 1 0 1 
5966 REL 0 1 0 1 
5979 RET 0 1 0 1 
6098 ROS1 0 1 0 1 
6184 RPN1 0 1 0 1 
6347 CCL2 0 1 1 0 
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6390 SDHB 0 1 0 1 
6391 SDHC 0 1 0 1 
6392 SDHD 0 1 0 1 
6416 MAP2K4 0 1 0 1 
6421 SFPQ 0 1 1 1 
6428 SRSF3 0 0 1 1 
6595 SMARCA2 1 1 0 0 
6597 SMARCA4 0 1 0 1 
6598 SMARCB1 0 1 0 1 
6608 SMO 0 1 0 1 
6688 SPI1 0 1 1 0 
6789 STK4 0 1 1 0 
6794 STK11 0 1 0 1 
6840 SVIL 0 1 1 0 
6850 SYK 0 1 0 1 
6886 TAL1 0 1 0 1 
6888 TALDO1 0 1 1 0 
6927 HNF1A 0 1 0 1 
6934 TCF7L2 0 1 0 1 
6938 TCF12 0 1 0 1 
6940 ZNF354A 0 1 1 0 
6957 TRB@ 0 1 0 1 
7029 TFDP2 0 1 1 0 
7037 TFRC 0 1 0 1 
7042 TGFB2 1 1 0 0 
7049 TGFBR3 1 1 0 0 
7077 TIMP2 1 1 0 0 
7080 NKX2-1 0 1 0 1 
7113 TMPRSS2 0 1 0 1 
7128 TNFAIP3 0 1 0 1 
7157 TP53 0 1 0 1 
7168 TPM1 1 0 1 0 
7175 TPR 0 0 1 1 
7248 TSC1 0 1 0 1 
7249 TSC2 0 1 0 1 
7253 TSHR 0 1 0 1 
7268 TTC4 0 1 1 0 
7325 UBE2E2 1 1 0 0 
7356 SCGB1A1 0 1 1 0 
7428 VHL 0 1 0 1 
7430 EZR 0 1 0 1 
7450 VWF 0 1 1 0 
7486 WRN 0 1 0 1 
7490 WT1 0 1 0 1 
7507 XPA 0 1 0 1 
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7508 XPC 0 1 0 1 
7515 XRCC1 0 1 1 0 
7531 YWHAE 0 1 0 1 
7704 ZBTB16 0 1 0 1 
7782 SLC30A4 1 1 0 0 
7849 PAX8 0 1 0 1 
7918 GPANK1 0 1 1 0 
7979 SHFM1 0 1 1 0 
8028 MLLT10 0 1 0 1 
8030 CCDC6 0 1 0 1 
8031 NCOA4 0 1 0 1 
8091 HMGA2 0 1 0 1 
8115 TCL1A 0 1 1 1 
8242 KDM5C 0 0 1 1 
8314 BAP1 0 1 0 1 
8435 SOAT2 0 1 1 0 
8648 NCOA1 0 1 0 1 
8651 SOCS1 0 1 0 1 
8764 TNFRSF14 0 1 0 1 
8829 NRP1 1 1 0 0 
8880 FUBP1 0 0 1 1 
8887 TAX1BP1 0 1 1 0 
8915 BCL10 0 1 0 1 
8929 PHOX2B 0 1 0 1 
9150 CTDP1 0 1 1 0 
9321 TRIP11 0 1 0 1 
9338 TCEAL1 0 1 1 0 
9401 RECQL4 0 1 0 1 
9510 ADAMTS1 1 0 1 0 
9817 KEAP1 0 1 1 0 
9935 MAFB 0 1 0 1 
9968 MED12 0 0 1 1 
9969 MED13 0 1 1 0 
10000 AKT3 1 1 0 0 
10039 PARP3 0 1 1 0 
10142 AKAP9 0 1 0 1 
10186 LHFP 1 0 0 1 
10320 IKZF1 0 1 0 1 
10397 NDRG1 0 1 0 1 
10413 YAP1 0 1 1 0 
10499 NCOA2 0 1 0 1 
10892 MALT1 0 1 0 1 
11064 CNTRL 0 1 0 1 
11197 WIF1 0 1 0 1 
11200 CHEK2 0 1 0 1 
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23092 ARHGAP26 0 1 0 1 
23305 ACSL6 0 1 0 1 
23332 CLASP1 0 1 1 0 
23405 DICER1 0 1 0 1 
23710 GABARAPL1 1 1 0 0 
25818 KLK5 0 1 1 0 
26136 TES 1 1 0 0 
27063 ANKRD1 0 1 1 0 
27324 TOX3 1 1 0 0 
27347 STK39 1 1 0 0 
27436 EML4 0 1 0 1 
29844 TFPT 0 0 1 1 
29998 GLTSCR1 0 1 1 0 
30061 SLC40A1 1 1 0 0 
50802 IGK@ 0 1 0 1 
50939 IMPG2 0 1 1 0 
51094 ADIPOR1 0 1 1 0 
51100 SH3GLB1 1 1 0 0 
51199 NIN 0 1 0 1 
51378 ANGPT4 0 1 1 0 
51684 SUFU 0 1 0 1 
51755 CDK12 0 1 1 1 
54790 TET2 0 1 0 1 
55234 SMU1 0 1 1 0 
55259 CASC1 0 1 1 0 
55294 FBXW7 0 1 0 1 
55862 ECHDC1 0 1 1 0 
55971 BAIAP2L1 0 1 1 0 
58480 RHOU 1 1 0 0 
63976 PRDM16 0 1 0 1 
64116 SLC39A8 1 1 0 0 
64241 ABCG8 0 1 1 0 
64746 ACBD3 0 1 1 0 
64805 P2RY12 0 1 1 0 
79723 SUV39H2 0 1 1 0 
79728 PALB2 0 1 0 1 
80312 TET1 0 1 0 1 
80380 PDCD1LG2 0 1 0 1 
81623 DEFB126 0 1 1 0 
83892 KCTD10 1 1 0 0 
83990 BRIP1 0 1 0 1 
84441 MAML2 0 1 0 1 
84651 SPINK7 0 1 1 0 
92689 FAM114A1 0 1 1 0 
121227 LRIG3 0 1 0 1 
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139285 FAM123B 0 1 0 1 
140767 NRSN1 0 1 1 0 
143187 VTI1A 0 1 0 1 
151393 FAM82A1 0 1 1 0 
171023 ASXL1 0 1 0 1 
221895 JAZF1 0 1 0 1 
285733   0 1 1 0 
374378 GALNTL4 0 1 1 0 
 
